| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000259387 uM | Activity at 0.0000710850 uM | Activity at 0.0001271514 uM | Activity at 0.0003024044 uM | Activity at 0.0005030064 uM | Activity at 0.0006524306 uM | Activity at 0.00193 uM | Activity at 0.00341 uM | Activity at 0.00584 uM | Activity at 0.010 uM | Activity at 0.018 uM | Activity at 0.052 uM | Activity at 0.078 uM | Activity at 0.156 uM | Activity at 0.276 uM | Activity at 0.478 uM | Activity at 0.883 uM | Activity at 1.507 uM | Activity at 3.884 uM | Activity at 7.354 uM | Activity at 12.96 uM | Activity at 21.63 uM | Activity at 38.41 uM | Activity at 76.33 uM | Activity at 137.0 uM | Activity at 204.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1 | 104.9664 | 88 | Complete curve; high efficacy | -6 | 3.5117 | 0.6658 | -104.9664 | 0 | -1.1 | 0 0 0 | -97.13 | -85.6484 | -112.8671 | -97.13 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 0.3162 | 59.3278 | 88 | Complete curve; high efficacy | -6.5 | 0.8 | 1 | -84.7193 | -25.3915 | -1.1 | 0 0 0 | -83.9327 | -75.7429 | -81.922 | -83.9327 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inhibitor | 3.1623 | 20.4987 | 85 | Complete curve; high efficacy | -5.5 | 4.9549 | 0.4756 | -107.8212 | -87.3224 | -1.1 | 0 0 0 | -101.1849 | -96.9354 | -114.4343 | -101.1849 | QC'd by SIGMA | ||||||||||||||||||||||||
| Inhibitor | 0.7492 | 66.1511 | 66 | Complete curve; partial efficacy | -6.1254 | 1 | 0.8229 | -74.6135 | -8.4624 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -67.099 | -7.8787 | -22.7216 | -1.4525 | -29.6562 | -23.5194 | -8.332 | -25.0891 | -62.4832 | -68.6466 | -63.9027 | -67.099 | QC'd by Microsource | ||||||||||||||||
| Inhibitor | 1 | 21.6845 | 66 | Complete curve; partial efficacy | -6 | 4.9549 | 0.9699 | -77.7873 | -56.1028 | -1.2 | 0 0 0 | -76.43 | -65.0857 | -78.9894 | -76.43 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inhibitor | 1.122 | 59.6758 | 65 | Complete curve; partial efficacy | -5.95 | 1.21 | 0.9999 | -66.8495 | -7.1736 | -1.2 | 0 0 0 | -66.096 | -42.6313 | -61.4055 | -66.096 | QC'd by Vitas | ||||||||||||||||||||||||
| Inhibitor | 1.9953 | 34.0263 | 64 | Complete curve; partial efficacy | -5.7 | 4.9549 | 0.9891 | -73.9118 | -39.8855 | -1.2 | 0 0 0 | -72.1972 | -47.1162 | -75.3813 | -72.1972 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 12.5893 | 37.2665 | 62 | Complete curve; partial efficacy | -4.9 | 1 | 1 | -78.1117 | -40.8452 | -1.2 | 0 0 0 | -68.8431 | -44.9463 | -54.9089 | -68.8431 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 14.1254 | 32.4297 | 62 | Complete curve; partial efficacy | -4.85 | 1.2216 | 0.9999 | -88.7022 | -56.2725 | -1.2 | 0 0 0 | -81.3177 | -58.1227 | -66.7029 | -81.3177 | QC'd by Enzo | ||||||||||||||||||||||||
| Inhibitor | 10 | 29.8983 | 62 | Complete curve; partial efficacy | -5 | 3.2975 | 0.9999 | -76.1051 | -46.2067 | -1.2 | 0 0 0 | -75.9694 | -46.234 | -54.866 | -75.9694 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 11.2202 | 26.8497 | 61 | Complete curve; partial efficacy | -4.95 | 4.095 | 0.9996 | -65.1082 | -38.2585 | -1.2 | 0 0 0 | -65.0072 | -38.2023 | -43.2866 | -65.0072 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 25.1189 | 45.7844 | 61 | Complete curve; partial efficacy | -4.6 | 1.5386 | 1 | -101.459 | -55.6745 | -1.2 | 0 0 0 | -85.8367 | -56.2934 | -62.0903 | -85.8367 | QC'd by SigmaAldrich | ||||||||||||||||||||||||
| Inhibitor | 31.6228 | 32.298 | 60 | Complete curve; partial efficacy | -4.5 | 2.1876 | 0.9999 | -141.8428 | -109.5448 | -1.2 | 0 0 0 | -129.0357 | -109.6207 | -111.066 | -129.0357 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 31.6228 | 35.9772 | 60 | Complete curve; partial efficacy | -4.5 | 1.1 | 0.9999 | -99.0432 | -63.0659 | -1.2 | 0 0 0 | -82.9526 | -64.2216 | -69.1965 | -82.9526 | QC'd by Microsource | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 37.6242 | 60 | Complete curve; partial efficacy | -4.45 | 4.9549 | 0.9762 | -81.2779 | -43.6537 | -1.2 | 0 0 0 | -66.0936 | -45.7944 | -41.8015 | -66.0936 | QC'd by Tocris | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 50.1885 | 60 | Complete curve; partial efficacy | -4.45 | 4.4495 | 0.9982 | -87.6877 | -37.4992 | -1.2 | 0 0 0 | -66.8089 | -38.2236 | -36.8414 | -66.8089 | QC'd by Pharmacopeia | ||||||||||||||||||||||||
| Inhibitor | 35.4813 | 47.3405 | 60 | Complete curve; partial efficacy | -4.45 | 4.9549 | 0.9906 | -107.1544 | -59.8139 | -1.2 | 0 0 0 | -87.9757 | -61.3159 | -58.1701 | -87.9757 | QC'd by Prestwick Chemical; Inc. | ||||||||||||||||||||||||
| Inhibitor | 5.9508 | 124.6251 | 45 | Partial curve; high efficacy | -5.2254 | 2.7202 | 0.864 | -126.7319 | -2.1068 | -2.1 | 0 0 0 0 0 0 0 0 0 0 1 | 0 | 0 | 0 | -13.748 | -1.3723 | -25.9483 | -11.2825 | 26.6518 | 8.4521 | -36.83 | -113.8031 | 0 | QC'd by ChemAxon | ||||||||||||||||
| Inhibitor | 11.8734 | 89.5441 | 42 | Partial curve; partial efficacy | -4.9254 | 1.2475 | 0.9863 | -91.1278 | -1.5837 | -2.2 | 0 0 0 0 0 1 0 0 0 0 0 | -74.7046 | 0 | 0 | 0 | -4.6868 | -8.0974 | -38.1516 | 1.1319 | -8.2196 | -21.8072 | -47.3218 | -74.7046 | QC'd by Cayman | ||||||||||||||||
| Inhibitor | 25.1189 | 267.3838 | 41 | Partial curve; partial efficacy | -4.6 | 4.9549 | 0.8835 | -100.7065 | 166.6773 | -2.2 | 0 0 0 | -71.9482 | 116.4983 | 215.4265 | -71.9482 | QC'd by Tocris |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| ER-phagy suppression | = | -5.515 | % | |
| ER-phagy suppression | = | 11.49 | % | |
| ER-phagy suppression | = | -63.24 | % | Suppressor |
| ER-phagy suppression | = | -37.11 | % | Suppressor |
| ER-phagy suppression | = | 6.149 | % | Suppressor |
| ER-phagy suppression | = | 46.79 | % | Suppressor |
| ER-phagy suppression | = | -2.879 | % | |
| ER-phagy suppression | = | 2.788 | % | |
| ER-phagy suppression | = | 9.958 | % | |
| ER-phagy suppression | = | 17.86 | % | |
| ER-phagy suppression | = | 4.664 | % | |
| ER-phagy suppression | = | -2.854 | % | |
| ER-phagy suppression | = | -6.061 | % | |
| ER-phagy suppression | = | -17.19 | % | |
| ER-phagy suppression | = | -21.85 | % | |
| ER-phagy suppression | = | -36.6 | % | |
| ER-phagy suppression | = | -35.46 | % | |
| ER-phagy suppression | = | -31.72 | % | |
| ER-phagy suppression | = | -0.3871 | % | |
| ER-phagy suppression | = | -17.27 | % |
| Phenotype | Analysis Comment | Activity_Score | Max_Response | Activity at 0.029 uM | Activity at 0.115 uM | Activity at 0.144 uM | Activity at 0.230 uM | Activity at 0.575 uM | Activity at 1.257 uM | Activity at 2.059 uM | Activity at 2.870 uM | Activity at 3.790 uM | Activity at 5.750 uM | Activity at 7.911 uM | Activity at 11.54 uM | Activity at 17.22 uM | Activity at 25.95 uM | Activity at 38.35 uM | Activity at 57.50 uM | Activity at 85.10 uM | Activity at 115.2 uM | Activity at 153.0 uM | Activity at 245.0 uM | Activity at 288.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -0.96 | 3.5361 | -0.96 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9559 | -3.6852 | -0.9559 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9553 | -5.7534 | -0.9553 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9545 | -5.6084 | -0.9545 | QC'd by ChemRoutes | ||||||||||||||||||||
| Inactive | 0 | -0.953 | -2.3216 | -0.953 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9492 | 2.2186 | -0.9492 | QC'd by Edelris | ||||||||||||||||||||
| Inactive | 0 | -0.9486 | -1.2758 | -0.9486 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9467 | 4.4666 | -0.9467 | QC'd by ChemRoutes | ||||||||||||||||||||
| Inactive | 0 | -0.9436 | -8.9932 | -0.9436 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9422 | -1.7826 | -0.9422 | QC'd by Analyticon | ||||||||||||||||||||
| Inactive | 0 | -0.941 | 5.2115 | -0.941 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9398 | 4.3972 | -0.9398 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9362 | 4.3836 | -0.9362 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9299 | 2.8643 | -0.9299 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9293 | 4.8772 | -0.9293 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9286 | -10.0521 | -0.9286 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9253 | -2.1742 | -0.9253 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9204 | 0.4163 | -0.9204 | QC'd by Edelris | ||||||||||||||||||||
| Inactive | 0 | -0.9193 | -0.0183 | -0.9193 | QC'd by Analyticon | ||||||||||||||||||||
| Inactive | 0 | -0.9182 | -0.8109 | -0.9182 | QC'd by Analyticon |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Delta TM | = | 0.1409 | C | Thermal Shift Assay |
| Delta TM | = | -0.01457 | C | Thermal Shift Assay |
| Delta TM | = | -0.19 | C | |
| Delta TM | = | 1.16 | C | Thermal Shift Assay |
| Delta TM | = | 1.921 | C | Thermal Shift Assay |
| Delta TM | = | -0.3406 | C | Thermal Shift Assay |
| Delta TM | = | 0.6 | C | Thermal Shift Assay |
| Delta TM | = | -0.1127 | C | Thermal Shift Assay |
| Delta TM | = | -1.169 | C | Thermal Shift Assay |
| Delta TM | = | 0.82 | C | |
| Delta TM | = | 0.31 | C | Thermal Shift Assay |
| Delta TM | = | -0.02 | C | Thermal Shift Assay |
| Delta TM | = | 0.46 | C | Thermal Shift Assay |
| Delta TM | = | -1.475 | C | Thermal Shift Assay |
| Delta TM | = | -0.6313 | C | Thermal Shift Assay |
| Delta TM | = | 0 | C | Thermal Shift Assay |
| Delta TM | = | -0.6762 | C | Thermal Shift Assay |
| Delta TM | = | 1.46 | C | Thermal Shift Assay |
| Delta TM | = | 0.98 | C | Thermal Shift Assay |
| Delta TM | = | 0.83 | C | Thermal Shift Assay |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000386857 uM | Activity at 0.0001060182 uM | Activity at 0.0001896372 uM | Activity at 0.0004510146 uM | Activity at 0.0007501981 uM | Activity at 0.0009728036 uM | Activity at 0.00288 uM | Activity at 0.00508 uM | Activity at 0.00871 uM | Activity at 0.015 uM | Activity at 0.026 uM | Activity at 0.053 uM | Activity at 0.079 uM | Activity at 0.232 uM | Activity at 0.457 uM | Activity at 0.692 uM | Activity at 1.068 uM | Activity at 2.292 uM | Activity at 3.859 uM | Activity at 11.39 uM | Activity at 17.02 uM | Activity at 25.62 uM | Activity at 57.25 uM | Activity at 87.55 uM | Activity at 183.4 uM | Activity at 286.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -6.75 | 4.9549 | 0.9727 | 0.0901 | 17.5 | 4 | 0 0 0 1 | 8.9408 | 15.9527 | -1.5916 | 1.4969 | 8.9408 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.3 | 4.095 | 0.9996 | 5.5 | -7.7823 | 4 | 0 0 0 1 | -11.1081 | -7.5736 | -7.7353 | 5.034 | -11.1081 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.15 | 4.9549 | 0.907 | -15.9207 | 9.5 | 4 | 0 0 0 1 | 17.8725 | 5.2874 | 13.9021 | -13.6839 | 17.8725 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 35.4813 | 46.4095 | 0 | Single point of activity | -4.45 | 2.5884 | 1 | 45.9404 | -0.4691 | 3 | 1 0 0 0 | 35.593 | 40.1678 | -0.3909 | 1.933 | 35.593 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 39.8107 | 72.2646 | 0 | Single point of activity | -4.4 | 4.9549 | 0.9515 | 68.1912 | -4.0733 | 3 | 0 0 0 0 | 58.0117 | 5.8738 | -9.2278 | -8.5224 | 58.0117 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 14.1254 | 45.3319 | 0 | Partial curve; partial efficacy; poor fit | -4.85 | 2.4064 | 0.9982 | 40.7728 | -4.5591 | 2.4 | 1 0 0 0 | 40.0933 | -24.9557 | -3.8845 | 11.5254 | 40.0933 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -5.75 | 4.9549 | 0.9291 | -20.6086 | 33.1545 | 4 | 1 0 0 0 | -12.8464 | 45.4569 | 28.2161 | -28.42 | -12.8464 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.35 | 4.9549 | 0.855 | -24.2184 | -0.5 | 4 | 0 0 0 0 | -18.932 | -3.6477 | -2.409 | 4.988 | -18.932 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.7 | 3.6272 | 0.8625 | 15 | -8.5523 | 4 | 0 0 0 0 | 14.477 | -2.951 | -13.7936 | -5.9646 | 14.477 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.7 | 4.9549 | 0.6637 | 3 | -16.864 | 4 | 0 0 0 0 | 8.8169 | -15.72 | 6.3794 | -6.3599 | 8.8169 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 2.4064 | 0.9999 | 21.5 | -2.4101 | 4 | 1 0 0 0 | 20.2184 | 33.3778 | -2.4251 | 3.5771 | 20.2184 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.4 | 4.9549 | 0.8117 | 2.5 | -8.345 | 4 | 0 0 0 0 | 1.096 | -8.966 | -5.5054 | -11.1209 | 1.096 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 39.8107 | 38.7945 | 0 | Single point of activity | -4.4 | 4.9549 | 0.6241 | 41.7557 | 2.9612 | 3 | 0 0 0 0 | 36.2039 | 21.355 | -6.3904 | -4.5325 | 36.2039 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -6.05 | 4.095 | 0.9994 | -6.0518 | 20 | 4 | 0 0 0 1 | 20.5156 | 19.7377 | 1.4122 | -6.2932 | 20.5156 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 4.095 | 1 | 10.5 | -10.1683 | 4 | 1 0 0 1 | -15.9884 | 36.1362 | -10.1402 | 8.7939 | -15.9884 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 1.3905 | 0.9999 | -24.241 | 0.2745 | 4 | 0 0 0 1 | -5.5981 | -4.3546 | -20.7587 | -23.9509 | -5.5981 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.711 | -2.4459 | 21 | 4 | 0 0 0 0 | -3.3453 | 17.3219 | -9.9549 | 5.5495 | -3.3453 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Activator | 39.8107 | 47.809 | 0 | Partial curve; partial efficacy; poor fit | -4.4 | 4.9549 | 0.5212 | 50.2399 | 2.4309 | 2.4 | 0 0 0 0 | 43.4722 | 30.2363 | -10.9855 | -11.5143 | 43.4722 | QC'd by Sytravon | |||||||||||||||||||||||
| Activator | 22.3872 | 75.5081 | 0 | Partial curve; high efficacy; poor fit | -4.65 | 1.9673 | 0.9829 | 96.5324 | 21.0243 | 2.3 | 0 0 0 0 | 86.4985 | 26.0932 | 16.3365 | 36.2613 | 86.4985 | QC'd by Sytravon | |||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.7429 | -1 | -13.0738 | 4 | 0 0 0 0 | 1.8063 | -11.3115 | 0.8702 | -5.1757 | 1.8063 | QC'd by Sytravon |
| Standard Type | Standard Relation | Standard Value | Activity Comment |
|---|---|---|---|
| Cell Viability Ratio | = | 1.077 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.735 | Strong Effect In Tumor Organoids |
| Cell Viability Ratio | = | 0.9777 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.9298 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.673 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.9902 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.062 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.9407 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.9821 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.055 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 3.874 | Strong Effect In Tumor Organoids |
| Cell Viability Ratio | = | 0.3535 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.431 | Strong Effect In Tumor Organoids |
| Cell Viability Ratio | = | 0.957 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.247 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.903 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.309 | Strong Effect In Tumor Organoids |
| Cell Viability Ratio | = | 0.6872 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 0.9253 | Pronounced Effect In Normal Organoids |
| Cell Viability Ratio | = | 1.056 | Pronounced Effect In Normal Organoids |
| Phenotype | Potency | Efficacy | Analysis Comment | FF-overN-Activity_Score | FF-overN-Curve_Description | FF-overN-Fit_LogAC50 | FF-overN-Fit_HillSlope | FF-overN-Fit_R2 | FF-overN-Fit_InfiniteActivity | FF-overN-Fit_ZeroActivity | FF-overN-Fit_CurveClass | FF-overN-Excluded_Points | FF-overN-Max_Response | FF-overN-Activity at 0.0000389080 uM | FF-overN-Activity at 0.0001066275 uM | FF-overN-Activity at 0.0001907270 uM | FF-overN-Activity at 0.0004536066 uM | FF-overN-Activity at 0.0007545096 uM | FF-overN-Activity at 0.0009786459 uM | FF-overN-Activity at 0.00290 uM | FF-overN-Activity at 0.00503 uM | FF-overN-Activity at 0.00876 uM | FF-overN-Activity at 0.015 uM | FF-overN-Activity at 0.026 uM | FF-overN-Activity at 0.052 uM | FF-overN-Activity at 0.080 uM | FF-overN-Activity at 0.235 uM | FF-overN-Activity at 0.459 uM | FF-overN-Activity at 0.740 uM | FF-overN-Activity at 1.165 uM | FF-overN-Activity at 2.228 uM | FF-overN-Activity at 5.999 uM | FF-overN-Activity at 11.47 uM | FF-overN-Activity at 19.13 uM | FF-overN-Activity at 25.10 uM | FF-overN-Activity at 57.49 uM | FF-overN-Activity at 115.7 uM | FF-overN-Activity at 221.8 uM | FF-overN-Activity at 288.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -8.5233 | -2.8988 | -12.5908 | -2.7412 | -8.5233 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.3 | 4.9549 | 0.5242 | -0.0894 | -10.9265 | 4 | 0 0 0 0 | -0.0745 | -3.5393 | -17.8554 | -0.1186 | -0.0745 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.5515 | -1.0417 | -4.8967 | 0.166 | -2.5515 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.25 | 2.6384 | 0.9993 | 6 | -4.4279 | 4 | 0 0 0 0 | 5.847 | -4.5232 | -4.121 | 4.7547 | 5.847 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.2043 | 0.5279 | -0.6989 | -3.0106 | 0.2043 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -20.4584 | -16.0227 | -10.542 | -12.7 | -20.4584 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.3811 | 1.9328 | 2.0137 | 3.5425 | 0.3811 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.6 | 1.8617 | 0.9679 | -30.78 | -11.3123 | 4 | 0 0 0 0 | -27.3167 | -13.1248 | -9.8436 | -15.1075 | -27.3167 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.65 | 1.8851 | 0.9245 | -20.4108 | -4.6526 | 4 | 0 0 0 0 | -18.259 | -6.997 | -2.6272 | -8.4549 | -18.259 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 7.0749 | 12.0764 | 9.4363 | 10.9955 | 7.0749 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.65 | 2.3332 | 0.9933 | -31.579 | -4.4538 | 4 | 0 0 0 0 | -28.8158 | -5.5887 | -3.2948 | -9.4116 | -28.8158 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.8635 | 4.4516 | 3.8206 | 7.1937 | 2.8635 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -5.65 | 1.7529 | 0.9999 | 3.5 | -15.007 | 4 | 0 0 0 1 | -13.3605 | -15.0059 | -10.5774 | 2.4893 | -13.3605 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.7 | 1.9673 | 0.9934 | -42.2319 | -13.8044 | 4 | 0 0 0 0 | -38.812 | -14.9413 | -12.7536 | -21.2969 | -38.812 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.9 | 3.132 | 0.6223 | -3.5849 | -13.7261 | 4 | 0 0 0 0 | -3.8208 | -9.1712 | -18.1051 | -9.386 | -3.8208 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.45 | 0.4 | 0.8262 | 1.069 | -18.8346 | 4 | 0 0 0 0 | -2.4425 | -15.6955 | -9.0343 | -9.4911 | -2.4425 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.132 | 0.7705 | 1.5 | -12.3707 | 4 | 0 0 0 0 | 1.5975 | -7.9378 | -16.9756 | -5.1738 | 1.5975 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.5045 | 0.3905 | -9.2851 | -1.5746 | 4 | 0 0 0 0 | -7.9625 | -2.9788 | -14.4042 | -5.0533 | -7.9625 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.4 | 4.9549 | 0.8608 | -22.7116 | -5.6684 | 4 | 0 0 0 0 | -20.1763 | -4.2865 | -9.9046 | -3.4737 | -20.1763 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.15 | 4.9549 | 0.5637 | 1 | -8.3478 | 4 | 0 0 0 1 | -11.1241 | -3.9652 | -12.7899 | 0.2253 | -11.1241 | QC'd by Sytravon |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -8.3213 | 4.9549 | 0.6423 | 4 | -4.8346 | 4 | 0 0 0 0 0 0 1 | -4.4443 | -2.7788 | 7.3689 | 5.3693 | 2.3397 | 3.3383 | 1.6715 | -4.4443 | QC'd by Sytravon | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 2.3919 | 69.7049 | 84 | Complete curve; high efficacy | -5.6213 | 0.9 | 0.993 | -69.4929 | 0.212 | -1.1 | 0 0 0 0 0 0 0 | -66.6604 | -0.2513 | 1.2197 | -5.3806 | -9.9311 | -37.162 | -53.3921 | -66.6604 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 9.5221 | 76.4074 | 42 | Partial curve; high efficacy | -5.0213 | 1.111 | 0.9951 | -75.9094 | 0.498 | -2.1 | 0 0 0 0 0 0 0 | -66.5912 | 3.4283 | -1.6815 | -1.5622 | -0.1199 | -13.7121 | -41.7015 | -66.5912 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.5213 | 1.7529 | 0.9212 | -24.9877 | 5.5 | 4 | 0 0 0 0 0 0 0 | -17.4897 | 7.3623 | 2.4616 | 9.8416 | 3.3605 | 3.9651 | 0.8896 | -17.4897 | QC'd by Sytravon | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 1.5092 | 115.264 | 87 | Complete curve; high efficacy | -5.8213 | 1.4641 | 0.9934 | -109.8568 | 5.4073 | -1.1 | 0 0 0 0 0 0 0 | -110.2979 | -0.8149 | 9.8634 | 3.518 | -7.3368 | -73.6123 | -100.848 | -110.2979 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.6933 | 117.9781 | 87 | Complete curve; high efficacy | -5.7713 | 4.5045 | 0.9912 | -112.73 | 5.2481 | -1.1 | 0 0 0 0 0 0 0 | -115.2658 | 15.9372 | 2.4103 | -1.2409 | 2.2518 | -88.9575 | -109.7932 | -115.2658 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 4.7724 | 81.2956 | 43 | Partial curve; high efficacy | -5.3213 | 1 | 0.9946 | -78.6057 | 2.6899 | -2.1 | 0 0 0 0 0 0 0 | -71.671 | -0.6447 | 6.4302 | 0.1885 | -3.4582 | -24.3313 | -55.7062 | -71.671 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 94.3951 | 83 | Complete curve; high efficacy | -5.1213 | 4.9549 | 0.9967 | -94.6258 | -0.2307 | -1.1 | 0 0 0 0 0 0 0 | -93.8748 | 3.4317 | -2.5012 | -1.7201 | -2.4455 | 2.6182 | -85.3984 | -93.8748 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.6837 | 65.0297 | 84 | Complete curve; high efficacy | -5.5713 | 4.095 | 0.989 | -65.3833 | -0.3537 | -1.1 | 0 0 0 0 0 0 0 | -70.4739 | -2.312 | -0.8042 | -1.2281 | 3.0628 | -22.6396 | -60.696 | -70.4739 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 57.2061 | 42 | Partial curve; partial efficacy | -5.1213 | 1.6259 | 0.9942 | -54.1319 | 3.0742 | -2.2 | 0 0 0 0 0 0 0 | -52.3087 | 6.207 | 2.8252 | 1.4762 | 0.0987 | -3.9796 | -35.0702 | -52.3087 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.1988 | 74.6197 | 85 | Complete curve; high efficacy | -5.9213 | 1.1341 | 0.9933 | -70.9204 | 3.6993 | -1.1 | 0 0 0 0 0 0 0 | -71.4906 | 4.2219 | -0.1886 | 4.5237 | -17.1469 | -46.9199 | -63.4145 | -71.4906 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.1317 | 118.4516 | 86 | Complete curve; high efficacy | -5.6713 | 2.7202 | 0.993 | -110.0886 | 8.3631 | -1.1 | 0 0 0 0 0 0 0 | -116.1272 | 7.5782 | 5.1028 | 5.8814 | 12.5352 | -56.6231 | -102.2879 | -116.1272 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.1317 | 122.7031 | 87 | Complete curve; high efficacy | -5.6713 | 2.4064 | 0.9787 | -115.7272 | 6.9759 | -1.1 | 0 0 0 0 0 0 0 | -122.0751 | 3.8589 | 17.443 | -6.0833 | 11.7009 | -62.2871 | -106.7609 | -122.0751 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 6.7412 | 121.0829 | 84 | Complete curve; high efficacy | -5.1713 | 4.095 | 0.9954 | -126.4671 | -5.3842 | -1.1 | 0 0 0 0 0 0 0 | -126.975 | -0.8069 | -3.4445 | -2.4548 | -11.8834 | -10.2564 | -113.7668 | -126.975 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 4.7724 | 86.827 | 44 | Partial curve; high efficacy | -5.3213 | 1 | 0.9941 | -85.383 | 1.444 | -2.1 | 0 0 0 0 0 0 0 | -78.6992 | -2.4316 | 1.8612 | -0.004 | -1.8987 | -28.5107 | -58.6303 | -78.6992 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 125.154 | 84 | Complete curve; high efficacy | -5.1213 | 3.9295 | 0.9979 | -122.5872 | 2.5668 | -1.1 | 0 0 0 0 0 0 0 | -123.0795 | 3.0986 | 3.1267 | 1.8871 | -2.1093 | 5.2605 | -101.0355 | -123.0795 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 0.6741 | 119.9199 | 89 | Complete curve; high efficacy | -6.1713 | 1.3723 | 0.9986 | -109.7454 | 10.1745 | -1.1 | 0 0 0 0 0 0 0 | -110.854 | 8.8459 | 7.7415 | 6.7576 | -35.5397 | -88.9969 | -106.7803 | -110.854 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 6.7412 | 115.9813 | 84 | Complete curve; high efficacy | -5.1713 | 2.3031 | 0.9963 | -113.5967 | 2.3846 | -1.1 | 0 0 0 0 0 0 0 | -113.37 | -1.2322 | -1.5984 | 5.8599 | 5.7708 | -6.0722 | -86.9448 | -113.37 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.5092 | 114.0509 | 88 | Complete curve; high efficacy | -5.8213 | 1.9673 | 0.9946 | -113.9158 | 0.1351 | -1.1 | 0 0 0 0 0 0 0 | -113.0117 | -0.8223 | -4.0553 | -2.3728 | -1.6822 | -81.3904 | -111.2484 | -113.0117 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 8.4866 | 60.7927 | 42 | Partial curve; partial efficacy | -5.0713 | 2.4064 | 0.9868 | -57.9639 | 2.8287 | -2.2 | 0 0 0 0 0 0 0 | -56.5473 | 6.8781 | 4.8766 | 1.3348 | -2.2008 | 1.3516 | -39.1581 | -56.5473 | QC'd by Sytravon | 0 |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -7.26 | 0.7 | 0.9831 | 22 | 0 | 4 | 0 0 0 0 0 0 0 0 | 18.7243 | 0.7509 | 0.7403 | 0.1615 | 0.2208 | 2.5712 | 9.0624 | 12.4905 | 18.7243 | QC'd by Labotest | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.0813 | 2.9095 | 4.1819 | 3.0683 | 1.5475 | 1.9993 | -1.4829 | 3.8282 | 3.0813 | QC'd by Labotest | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 10.964 | 62.6971 | 10 | Partial curve; high efficacy; poor fit | -4.96 | 4.9549 | 0.998 | -66.9977 | -4.3007 | -2.3 | 1 0 0 0 0 0 0 0 | -65.7875 | -42.8846 | -3.6636 | -4.8429 | -3.3836 | -3.8623 | -4.4736 | -41.4229 | -65.7875 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||
| Inhibitor | 38.9018 | 33.8501 | 10 | Partial curve; partial efficacy; poor fit | -4.41 | 4.9549 | 0.924 | -33.3501 | 0.5 | -2.4 | 0 0 0 0 0 0 0 0 | -29.0418 | -1.5551 | 0.5206 | 0.875 | -1.2476 | -0.5605 | -1.8092 | 7.4199 | -29.0418 | QC'd by SIGMA | 0 | |||||||||||||||||||||||||||
| Inhibitor | 1.7377 | 81.2298 | 85 | Complete curve; high efficacy | -5.76 | 1.9673 | 0.9976 | -79.9564 | 1.2734 | -1.1 | 0 0 0 0 0 0 0 0 | -78.332 | 4.4795 | 0.7606 | 0.0181 | -0.701 | -3.7995 | -49.0322 | -80.0522 | -78.332 | QC'd by Tocris | 0 | |||||||||||||||||||||||||||
| Inhibitor | 34.6713 | 37.2317 | 10 | Partial curve; partial efficacy; poor fit | -4.46 | 2.3531 | 0.9195 | -37.2317 | 0 | -2.4 | 0 0 0 0 0 0 0 0 | -28.5264 | 3.9692 | 5.0423 | -3.0201 | -3.1048 | -1.1738 | -0.8348 | -2.4447 | -28.5264 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||
| Inhibitor | 15.4871 | 71.273 | 41 | Partial curve; high efficacy | -4.81 | 1.4487 | 0.9928 | -70.4113 | 0.8617 | -2.1 | 0 0 0 0 0 0 0 0 | -61.7643 | 0.2853 | 1.9381 | -1.2811 | -0.3436 | 4.6186 | -4.2001 | -27.4432 | -61.7643 | QC'd by GVK | 0 | |||||||||||||||||||||||||||
| Inhibitor | 0.2188 | 91.9728 | 90 | Complete curve; high efficacy | -6.66 | 0.8 | 0.9894 | -90.0102 | 1.9626 | -1.1 | 0 0 0 0 0 0 0 0 | -83.8769 | 2.7707 | 0.8657 | -14.6874 | -27.4321 | -55.0254 | -79.0233 | -92.6031 | -83.8769 | QC'd by Prestwick Chemical; Inc. | 0 | |||||||||||||||||||||||||||
| Inhibitor | 34.6713 | 45.8288 | 10 | Single point of activity | -4.46 | 2.3531 | 0.9938 | -45.8288 | 0 | -3 | 0 0 0 0 0 0 0 0 | -35.0976 | -0.4182 | -0.112 | -0.9148 | 2.1786 | -0.5211 | -0.77 | -3.3082 | -35.0976 | QC'd by Vitas | 0 | |||||||||||||||||||||||||||
| Inhibitor | 13.8029 | 116.5981 | 42 | Partial curve; high efficacy | -4.86 | 0.7 | 0.9704 | -115.474 | 1.1242 | -2.1 | 0 0 0 0 0 0 0 0 | -87.4803 | -1.207 | 1.2781 | -1.1552 | -1.0641 | -0.761 | -34.877 | -47.6739 | -87.4803 | QC'd by Vitas | 0 | |||||||||||||||||||||||||||
| Inhibitor | 19.4971 | 71.1695 | 41 | Partial curve; high efficacy | -4.71 | 2.3332 | 0.9649 | -71.6292 | -0.4597 | -2.1 | 0 0 0 0 0 0 0 0 | -66.007 | -7.507 | 3.5896 | -6.5823 | 3.2102 | 2.0494 | 2.4442 | -17.4355 | -66.007 | QC'd by Enzo | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -0.3397 | 0.6834 | 1.1935 | -3.1601 | -7.1353 | -6.692 | -3.5353 | -4.6055 | -0.3397 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 38.9018 | 99.7077 | 10 | Single point of activity | -4.41 | 2.9023 | 0.9979 | -103.2475 | -3.5398 | -3 | 0 0 0 0 0 0 0 0 | -78.9754 | -2.6538 | -1.9475 | -2.4198 | -3.036 | -5.7354 | -4.4174 | -6.1242 | -78.9754 | QC'd by Labotest | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.5579 | 4.2966 | 3.8697 | 0.914 | 1.5784 | 2.7763 | 2.2827 | -0.2746 | 0.5579 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.2893 | 4.5048 | 5.9389 | 2.7905 | 6.1256 | 1.1364 | 5.7573 | 5.7586 | -2.2893 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 12.3018 | 42.2827 | 21 | Partial curve; partial efficacy | -4.91 | 2.3332 | 0.9667 | -45.1528 | -2.8702 | -2.2 | 0 0 0 0 0 0 0 0 | -43.5551 | -8.1379 | -5.4062 | -0.9215 | 0.1464 | -0.2747 | -3.1761 | -22.7908 | -43.5551 | QC'd by Labotest | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.7074 | -0.3729 | 0.324 | 2.0766 | 2.6464 | 1.1615 | -0.7088 | 4.4781 | 2.7074 | QC'd by Prestwick | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.9964 | 3.7048 | 1.6527 | 3.6208 | 3.1922 | 5.0362 | 4.9342 | -1.7586 | -1.9964 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | -6.36 | 0.8 | 0.8961 | 5 | -7.0477 | 4 | 0 0 0 0 0 0 0 0 | 4.9227 | -4.8515 | -7.6164 | -8.7898 | -3.2699 | 0.2917 | 0.3418 | 5.5058 | 4.9227 | QC'd by Vitas | Inactive | 0 | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 3.4671 | 109.1625 | 45 | Partial curve; high efficacy | -5.46 | 0.9 | 0.9982 | -103.5313 | 5.6312 | -2.1 | 0 0 0 0 0 0 0 0 | -96.3979 | 5.9869 | 3.177 | 3.4783 | 4.7559 | -9.3266 | -39.4946 | -74.1667 | -96.3979 | QC'd by Enzo | 0 |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 21.3174 | 85.5207 | 41 | Partial curve; high efficacy | -4.6713 | 3.1925 | 0.957 | -74.5207 | 11 | -2.1 | 0 0 0 0 0 0 0 | -71.2673 | 6.6581 | 8.6616 | 5.0342 | 9.0296 | 24.6831 | 0.5948 | -71.2673 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.3186 | 7.062 | 5.197 | 5.6925 | 7.2359 | 1.267 | 0.5201 | 0.3186 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 93.5447 | 43 | Partial curve; high efficacy | -5.1213 | 1.9282 | 0.9984 | -89.2795 | 4.2653 | -2.1 | 0 0 0 0 0 0 0 | -87.5289 | 7.1656 | 5.0788 | 2.7979 | 2.1575 | -3.7741 | -60.4613 | -87.5289 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 48.6356 | 10 | Single point of activity | -4.5713 | 2.2481 | 0.9788 | -42.8484 | 5.7872 | -3 | 0 0 0 0 0 0 0 | -35.4677 | 5.9629 | 5.4796 | 2.7092 | 10.2755 | 4.6543 | -0.1967 | -35.4677 | QC'd by NCI | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 8.4866 | 130.7668 | 43 | Partial curve; high efficacy | -5.0713 | 1 | 0.9992 | -119.8967 | 10.8701 | -2.1 | 0 0 0 0 0 0 0 | -102.4758 | 11.9466 | 11.2427 | 7.1554 | 5.0781 | -16.0537 | -65.0649 | -102.4758 | QC'd by BIOMOL | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 5.3547 | 99.1896 | 44 | Partial curve; high efficacy | -5.2713 | 0.9 | 0.9888 | -96.5712 | 2.6185 | -2.1 | 0 0 0 0 0 0 0 | -87.001 | -0.2592 | -1.637 | 6.8143 | -4.5159 | -32.2161 | -61.4841 | -87.001 | QC'd by BIOMOL | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.6713 | 2.3332 | 0.6923 | -15.1448 | -0.5 | 4 | 0 0 0 0 0 0 0 | -13.8707 | -3.7401 | -1.2778 | 5.1005 | -4.6904 | 1.916 | -3.5213 | -13.8707 | QC'd by InterBioScreen | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 25.4012 | 56.2022 | 40 | Partial curve; partial efficacy | -4.5951 | 4.5045 | 0.9727 | -57.7888 | -1.5865 | -2.2 | 0 0 0 0 0 0 0 0 | -57.6748 | -1.4876 | -4.4957 | -6.2296 | 2.8676 | 3.1906 | -3.7494 | -18.0858 | -57.6748 | QC'd by LightBiologicals | Inhibitor | 40.2582 | 41.121 | 10 | Single point of activity | -4.3951 | 2.9523 | 0.943 | -42.7254 | |||||||||||||||||||
| Inhibitor | 7.5637 | 97.4712 | 43 | Partial curve; high efficacy | -5.1213 | 1.9282 | 0.9955 | -91.4517 | 6.0195 | -2.1 | 0 0 0 0 0 0 0 | -89.1342 | 6.428 | 11.1902 | 4.9868 | 1.8065 | -2.3315 | -62.2028 | -89.1342 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 21.3174 | 76.6638 | 41 | Partial curve; partial efficacy | -4.6713 | 1.2475 | 0.9713 | -70.1638 | 6.5 | -2.2 | 0 0 0 0 0 0 0 | -53.0597 | 11.8628 | 10.1962 | -0.3079 | 4.293 | 1.9517 | -17.9254 | -53.0597 | QC'd by SigmaAldrich | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 101.6656 | 40 | Partial curve; high efficacy | -4.5713 | 1.5936 | 0.9916 | -96.2704 | 5.3952 | -2.1 | 0 0 0 0 0 0 0 | -73.3109 | 5.6238 | 8.7858 | 6.2448 | 2.4666 | -0.9326 | -13.5438 | -73.3109 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 3.7908 | 87.1465 | 44 | Partial curve; high efficacy | -5.4213 | 0.8 | 0.9942 | -85.1952 | 1.9512 | -2.1 | 0 0 0 0 0 0 0 | -78.8845 | 1.4625 | -1.8716 | 1.6032 | -10.9203 | -35.4628 | -58.552 | -78.8845 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 37.9083 | 129.9148 | 10 | Single point of activity | -4.4213 | 4.9549 | 0.9896 | -129.2975 | 0.6173 | -3 | 0 0 0 0 0 0 0 | -114.6255 | -1.4437 | -2.5082 | -0.9019 | 8.8381 | -4.5458 | 3.1106 | -114.6255 | QC'd by SigmaAldrich | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 109.0621 | 40 | Partial curve; high efficacy | -4.5713 | 1.3437 | 0.9459 | -109.3538 | -0.2917 | -2.1 | 0 0 0 0 0 0 0 | -82.8438 | 2.5325 | 5.0732 | 0.7828 | 0.5149 | -19.3744 | -20.4297 | -82.8438 | QC'd by Bosche | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.41 | 2.9023 | 0.8395 | -17.3952 | -0.5 | 4 | 0 0 0 0 0 0 0 0 | -13.246 | -3.8469 | 1.9539 | -0.2562 | -2.6537 | 1.477 | 0.7446 | -0.9487 | -13.246 | QC'd by ACC | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | -8.36 | 3.132 | 0.3628 | 3 | -4.5164 | 4 | 0 0 0 0 0 0 0 0 | 2.109 | -4.1803 | -1.8377 | 5.2557 | -1.0504 | 8.3001 | -3.1085 | 6.745 | 2.109 | QC'd by Pharmaron | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.5041 | -8.5785 | 2.7045 | 0.1138 | -10.5842 | 0.9358 | 2.0884 | 0.5041 | QC'd by Toronto Research | 0 | |||||||||||||||||||||||||||||||||||
| Inhibitor | 44.4932 | 35.2765 | 10 | Single point of activity | -4.3517 | 3.6772 | 0.8478 | -34.7273 | 0.5492 | -3 | 0 0 0 0 0 0 0 0 | -32.3137 | -1.4989 | -3.7044 | -1.139 | -0.4924 | 12.1946 | -1.1884 | -3.139 | -32.3137 | QC'd by RTI | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.6308 | 7.6331 | 6.024 | 7.3986 | 0.2263 | 3.1874 | 3.4285 | 6.6308 | QC'd by Tocris | 0 | |||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.3261 | 12.5764 | 10.1122 | 11.5363 | 11.262 | 7.195 | 3.9591 | 5.3261 | QC'd by NCGCChem | 0 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 2.5119 | 89.963 | 85 | Complete curve; high efficacy | -5.6 | 2.4064 | 0.9988 | -81.963 | 8 | -1.1 | 0 0 0 0 | -81.0256 | 4.3424 | -26.1944 | -82.8623 | -81.0256 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 3.1623 | 94.5377 | 85 | Complete curve; high efficacy | -5.5 | 4.5045 | 0.9999 | -94.3225 | 0.2153 | -1.1 | 0 0 0 0 | -94.7013 | -0.2373 | -13.1526 | -93.6408 | -94.7013 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 94.817 | 85 | Complete curve; high efficacy | -5.55 | 2.0479 | 0.9999 | -95.8221 | -1.005 | -1.1 | 0 0 0 0 | -95.0616 | -6.2542 | -35.3146 | -94.5292 | -95.0616 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 90.5207 | 85 | Complete curve; high efficacy | -5.55 | 3.0654 | 0.9989 | -88.5207 | 2 | -1.1 | 0 0 0 0 | -86.8835 | 0 | -24.056 | -89.9601 | -86.8835 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 5.6234 | 96.9742 | 84 | Complete curve; high efficacy | -5.25 | 4.095 | 1 | -95.4742 | 1.5 | -1.1 | 0 0 0 0 | -95.8576 | 1.6559 | 0 | -94.7507 | -95.8576 | QC'd by SynKinase | |||||||||||||||||||||
| Cytotoxic | 3.9811 | 96.1006 | 84 | Complete curve; high efficacy | -5.4 | 4.5045 | 1 | -95.1006 | 1 | -1.1 | 0 0 0 0 | -94.9108 | 0.5692 | -4.2795 | -94.8159 | -94.9108 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 2.5119 | 77.6563 | 84 | Complete curve; high efficacy | -5.6 | 2.0479 | 0.9997 | -80.7421 | -3.0858 | -1.1 | 0 0 0 0 | -80.0369 | -5.0715 | -39.0219 | -77.613 | -80.0369 | QC'd by Microsource | |||||||||||||||||||||
| Cytotoxic | 7.9433 | 99.4986 | 83 | Complete curve; high efficacy | -5.1 | 4.9549 | 0.9997 | -96.9986 | 2.5 | -1.1 | 0 0 0 0 | -96.805 | 1.2306 | 3.5418 | -95.9316 | -96.805 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.8358 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 0.9993 | -95.8358 | 2 | -1.1 | 0 0 0 0 | -95.6445 | 0 | 3.4249 | -95.1788 | -95.6445 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.3751 | 83 | Complete curve; high efficacy | -5.15 | 4.095 | 1 | -97.3751 | 0 | -1.1 | 0 0 0 0 | -97.1807 | 0 | -0.6843 | -95.5282 | -97.1807 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 102.4399 | 83 | Complete curve; high efficacy | -5.15 | 1.6924 | 0.9998 | -100.4399 | 2 | -1.1 | 0 0 0 0 | -96.7629 | 0 | -9.8984 | -85.0051 | -96.7629 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 96.3568 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -96.3568 | 0 | -1.1 | 0 0 0 0 | -96.1644 | 0 | 0 | -95.5939 | -96.1644 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 93.6127 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -93.6127 | 0 | -1.1 | 0 0 0 0 | -93.4258 | 0 | 0 | -92.8807 | -93.4258 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 97.1357 | 83 | Complete curve; high efficacy | -5.05 | 4.9549 | 1 | -97.1357 | 0 | -1.1 | 0 0 0 0 | -96.9418 | 0 | 0 | -94.9322 | -96.9418 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 105.034 | 83 | Complete curve; high efficacy | -5.05 | 1.6436 | 0.9999 | -100.034 | 5 | -1.1 | 0 0 0 0 | -94.7292 | 3.0536 | -3.9173 | -76.9038 | -94.7292 | QC'd by Glixx | |||||||||||||||||||||
| Cytotoxic | 10 | 91.3037 | 82 | Complete curve; high efficacy | -5 | 2.1876 | 1 | -85.8037 | 5.5 | -1.1 | 0 0 0 0 | -84.1212 | 4.8646 | 2.5388 | -67.7158 | -84.1212 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 10 | 98.1252 | 82 | Complete curve; high efficacy | -5 | 2.8473 | 0.9999 | -97.6252 | 0.5 | -1.1 | 0 0 0 0 | -96.8504 | 0 | 0 | -83.9555 | -96.8504 | QC'd by Cayman | |||||||||||||||||||||
| Cytotoxic | 11.2202 | 93.8772 | 82 | Complete curve; high efficacy | -4.95 | 2.4064 | 0.9998 | -92.8772 | 1 | -1.1 | 0 0 0 0 | -91.0561 | 0 | 0 | -72.1776 | -91.0561 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.8913 | 60.2348 | 67 | Complete curve; partial efficacy | -6.05 | 3.5117 | 0.9985 | -93.1767 | -32.9418 | -1.2 | 0 0 0 0 | -93.5509 | -51.1212 | -90.8041 | -91.9137 | -93.5509 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.7943 | 56.6802 | 67 | Complete curve; partial efficacy | -6.1 | 3.9295 | 0.9999 | -91.2497 | -34.5695 | -1.2 | 0 0 0 0 | -91.0675 | -40.2642 | -90.3425 | -90.8279 | -91.0675 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.7079 | 34.8288 | 10 | Complete curve; partial efficacy; poor fit | -6.15 | 4.9549 | 0.7525 | -34.8113 | 0.0174 | -1.4 | 0 0 0 0 | -43.6793 | -3.7355 | -37.8905 | -22.6342 | -43.6793 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 35.4813 | 36.7648 | 10 | Single point of activity | -4.45 | 2.4064 | 0.8748 | -40.7648 | -4 | -3 | 0 0 0 0 | -31.8873 | -11.4596 | 0 | -6.0521 | -31.8873 | QC'd by Pharmaron | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.3927 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7948 | -48.5731 | -8.1804 | -3 | 0 0 0 0 | -41.7275 | -5.1127 | -20.8986 | -3.4837 | -41.7275 | QC'd by FLUKA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 36.3021 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9302 | -39.3021 | -3 | -3 | 0 0 0 0 | -33.1684 | -8.7659 | 0 | -0.1246 | -33.1684 | QC'd by Prestwick | |||||||||||||||||||||
| Inhibitor | 10 | 91.8254 | 10 | Partial curve; high efficacy; poor fit | -5 | 3.9295 | 1 | -91.3254 | 0.5 | -2.3 | 1 0 0 0 | -91.1431 | -30.038 | 0 | -57.0259 | -91.1431 | QC'd by APExBIO | |||||||||||||||||||||
| Inhibitor | 39.8107 | 88.8726 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9981 | -87.8726 | 1 | -3 | 0 0 0 0 | -75.3105 | 0 | 0 | 3.3645 | -75.3105 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 39.8107 | 39.074 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9982 | -38.574 | 0.5 | -3 | 0 0 0 0 | -32.9783 | 0 | 0 | 1.4313 | -32.9783 | QC'd by Carbosynth | |||||||||||||||||||||
| Inhibitor | 17.7828 | 45.6593 | 10 | Partial curve; partial efficacy; poor fit | -4.75 | 1.9673 | 0.9887 | -54.3257 | -8.6664 | -2.4 | 0 0 0 0 | -50.2467 | -11.0836 | -6.8054 | -21.6158 | -50.2467 | QC'd by TargetMol | |||||||||||||||||||||
| Inhibitor | 39.8107 | 74.9786 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9815 | -77.9786 | -3 | -3 | 0 0 0 0 | -65.3989 | -8.9317 | 0 | 0 | -65.3989 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 35.788 | 10 | Single point of activity | -4.4 | 4.4495 | 0.945 | -39.8408 | -4.0529 | -3 | 0 0 0 0 | -34.034 | -8.1712 | -5.8755 | -0.0441 | -34.034 | QC'd by Adooq | |||||||||||||||||||||
| Inhibitor | 19.9526 | 98.5475 | 10 | Partial curve; high efficacy; poor fit | -4.7 | 1.9673 | 0.9936 | -101.5475 | -3 | -2.3 | 0 0 0 0 | -90.5058 | -6.6702 | 0 | -28.4282 | -90.5058 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 94.2096 | 10 | Partial curve; high efficacy; poor fit | -4.4 | 4.4495 | 0.9731 | -106.3898 | -12.1802 | -2.3 | 0 0 0 0 | -90.4675 | -6.8168 | -21.693 | -10.2877 | -90.4675 | QC'd by Axon Medchem | |||||||||||||||||||||
| Inhibitor | 39.8107 | 68.3394 | 10 | Single point of activity | -4.4 | 4.9549 | 0.8933 | -61.3394 | 7 | -3 | 0 0 0 0 | -51.5329 | 0 | 0 | 21.3412 | -51.5329 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 11.2202 | 45.0575 | 10 | Partial curve; partial efficacy; poor fit | -4.95 | 1.8579 | 0.9996 | -42.5575 | 2.5 | -2.4 | 1 0 0 0 | -40.794 | -21.6798 | 0 | -20.0057 | -40.794 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 22.3872 | 113.3323 | 10 | Partial curve; high efficacy; poor fit | -4.65 | 1.6924 | 1 | -111.3323 | 2 | -2.3 | 1 0 0 0 | -91.8583 | -33.8793 | 0 | -25.3979 | -91.8583 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 7.0795 | 44.42 | 10 | Single point of activity | -5.15 | 4.9549 | 0.6152 | -48.42 | -4 | -3 | 0 0 0 0 | -44.8333 | -14.7954 | -20.376 | 0 | -44.8333 | QC'd by SIGMA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 32.9185 | 10 | Single point of activity | -4.4 | 4.9549 | 0.6127 | -36.9185 | -4 | -3 | 0 0 0 0 | -32.0154 | 2.7163 | -20.0828 | 0 | -32.0154 | QC'd by Selleck | |||||||||||||||||||||
| Inhibitor | 39.8107 | 51.1844 | 10 | Single point of activity | -4.4 | 4.4495 | 1 | -51.1844 | 0 | -3 | 0 0 0 0 | -42.6537 | 0 | 0 | 0 | -42.6537 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 10 | 58.1799 | 10 | Partial curve; partial efficacy; poor fit | -5 | 3.5117 | 0.9887 | -59.1799 | -1 | -2.4 | 0 0 0 0 | -59.8069 | -4.8747 | 2.0564 | -35.7833 | -59.8069 | QC'd by DC Chemicals | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.2901 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7334 | -45.6865 | -5.3964 | -3 | 0 0 0 0 | -38.9054 | -16.4277 | -13.0282 | -1.1636 | -38.9054 | QC'd by Adooq |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0118 | 90.0897 | 87 | Complete curve; high efficacy | -7.9292 | 2.4729 | 0.969 | 42.5966 | 132.6862 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 57.466 | 123.2938 | 140.8388 | 112.241 | 60.9016 | 44.0896 | 39.7677 | 36.4785 | 40.206 | 39.1769 | 41.4618 | 57.466 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.4176 | 75.8509 | 87 | Complete curve; high efficacy | -6.3792 | 1.5386 | 0.9498 | 72.4265 | 148.2774 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 61.5626 | 139.2774 | 158.5971 | 143.0204 | 144.9664 | 147.8567 | 136.0151 | 91.8156 | 92.9505 | 75.6746 | 74.6768 | 61.5626 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.1482 | 94.4192 | 87 | Complete curve; high efficacy | -6.8292 | 1.1 | 0.9517 | 59.4372 | 153.8564 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 55.0456 | 164.8354 | 134.704 | 151.2303 | 143.6834 | 134.7615 | 95.6484 | 70.0621 | 67.3056 | 76.1055 | 55.6924 | 55.0456 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1663 | 94.1023 | 86 | Complete curve; high efficacy | -6.7792 | 2.7202 | 0.9729 | 50.0751 | 144.1775 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 56.0568 | 132.0924 | 142.9387 | 160.1371 | 137.1338 | 142.2899 | 85.8931 | 48.2002 | 45.0417 | 52.6033 | 54.1832 | 56.0568 | QC'd by ACC | |||||||||||||||
| Cytotoxic | 0.0332 | 121.0752 | 86 | Complete curve; high efficacy | -7.4792 | 1 | 0.9841 | 42.1192 | 163.1944 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 35.7472 | 158.2854 | 158.4708 | 139.505 | 123.3406 | 71.5741 | 65.2589 | 55.0718 | 50.0867 | 42.1782 | 37.1955 | 35.7472 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.7427 | 78.6716 | 85 | Complete curve; high efficacy | -6.1292 | 1.8851 | 0.9834 | 63.6148 | 142.2865 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 58.2475 | 142.1116 | 146.4992 | 135.5304 | 145.8795 | 136.7066 | 141.0466 | 113.8331 | 74.386 | 65.1288 | 71.8868 | 58.2475 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.8333 | 86.2191 | 85 | Complete curve; high efficacy | -6.0792 | 1 | 0.9302 | 67.549 | 153.7681 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 69.8532 | 158.4753 | 142.7847 | 153.7541 | 141.7507 | 166.925 | 141.693 | 105.2958 | 104.6674 | 77.2217 | 76.1652 | 69.8532 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 3.7221 | 64.4935 | 85 | Complete curve; high efficacy | -5.4292 | 4.9549 | 0.792 | 112.0642 | 176.5577 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 89.6942 | 158.9633 | 166.2699 | 180.3984 | 167.1951 | 174.9654 | 191.2964 | 181.3214 | 193.1909 | 122.0222 | 135.5388 | 89.6942 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0526 | 123.2368 | 85 | Complete curve; high efficacy | -7.2792 | 0.6 | 0.9724 | 33.4065 | 156.6433 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 35.7651 | 153.6951 | 126.1364 | 142.4363 | 103.2491 | 92.5951 | 73.1478 | 60.6143 | 43.3887 | 40.0313 | 37.8821 | 35.7651 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0066 | 77.5262 | 84 | Complete curve; high efficacy | -8.1792 | 0.8 | 0.9753 | 21.6969 | 99.2231 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.2627 | 91.552 | 76.4137 | 56.5612 | 42.1934 | 34.0283 | 31.1809 | 27.3506 | 26.0778 | 20.6343 | 20.2144 | 13.2627 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.5258 | 123.4599 | 84 | Complete curve; high efficacy | -6.2792 | 1.3987 | 0.9682 | 42.1223 | 165.5821 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.7016 | 164.86 | 160.7689 | 152.0063 | 170.1205 | 168.2257 | 149.3034 | 88.2138 | 74.0696 | 51.7982 | 49.7901 | 25.7016 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 1.8655 | 82.3759 | 84 | Complete curve; high efficacy | -5.7292 | 2.3332 | 0.9291 | 61.702 | 144.078 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 51.7606 | 136.01 | 140.2451 | 152.6106 | 148.0124 | 143.6336 | 147.0904 | 134.4052 | 111.2842 | 54.4794 | 84.3712 | 51.7606 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 2.3485 | 101.9247 | 84 | Complete curve; high efficacy | -5.6292 | 0.6 | 0.9558 | 71.9549 | 173.8795 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 91.649 | 176.6761 | 171.0851 | 177.7813 | 159.9071 | 159.3009 | 150.4576 | 153.7054 | 126.8633 | 116.4271 | 84.8154 | 91.649 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0187 | 90.9237 | 84 | Complete curve; high efficacy | -7.7292 | 0.7 | 0.9959 | 26.7347 | 117.6584 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 29.5723 | 109.5774 | 101.7596 | 83.7496 | 73.3799 | 52.6521 | 41.57 | 35.4354 | 30.2412 | 26.6759 | 25.3877 | 29.5723 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0132 | 127.3735 | 83 | Complete curve; high efficacy | -7.8792 | 0.7 | 0.9722 | 17.3385 | 144.712 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.7384 | 132.8301 | 113.2475 | 89.3417 | 75.7175 | 55.4002 | 27.7414 | 22.1078 | 14.4402 | 14.0116 | 16.7785 | 33.7384 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 3.7221 | 86.0142 | 83 | Complete curve; high efficacy | -5.4292 | 1.21 | 0.9721 | 65.5416 | 151.5558 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 66.7748 | 154.8648 | 146.5307 | 153.6238 | 147.9405 | 153.7843 | 144.2907 | 154.4262 | 119.8728 | 100.2565 | 83.0111 | 66.7748 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.3722 | 105.7898 | 83 | Complete curve; high efficacy | -6.4292 | 2.8473 | 0.984 | 36.148 | 141.9378 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.8052 | 141.9378 | 142.9518 | 145.1156 | 141.0583 | 137.6217 | 130.5085 | 57.9133 | 51.2669 | 41.3882 | 33.0007 | 22.8052 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 1.6626 | 102.3144 | 83 | Complete curve; high efficacy | -5.7792 | 1 | 0.9242 | 40.9668 | 143.2813 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 47.0105 | 152.3961 | 124.7264 | 140.9824 | 142.6059 | 141.9566 | 147.0368 | 112.3972 | 81.2873 | 85.0891 | 38.4602 | 47.0105 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0118 | 140.013 | 83 | Complete curve; high efficacy | -7.9292 | 2.5884 | 0.9982 | 17.9926 | 158.0057 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 14.8749 | 156.5885 | 154.4434 | 130.94 | 45.1268 | 15.3104 | 17.3742 | 18.8144 | 19.4156 | 21.1886 | 21.2708 | 14.8749 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.4686 | 118.6089 | 83 | Complete curve; high efficacy | -6.3292 | 1.8579 | 0.9872 | 28.1061 | 146.7151 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 27.0205 | 138.0525 | 155.3457 | 144.6536 | 140.3247 | 148.8544 | 132.2913 | 70.3553 | 46.413 | 33.1335 | 22.0753 | 27.0205 | QC'd by Tocris |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0166 | 75.7054 | 99 | Complete curve; high efficacy | -7.7792 | 1.6259 | 0.8287 | 113.3664 | 189.0718 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 76.415 | 189.0718 | 184.1323 | 176.4162 | 143.7765 | 121.3848 | 112.8196 | 136.1769 | 124.1622 | 121.4205 | 110.849 | 76.415 | QC'd by SigmaAldrich | |||||||||||||||
| Cytotoxic | 0.0148 | 78.3238 | 95 | Complete curve; high efficacy | -7.8292 | 1.8851 | 0.8849 | 90.161 | 168.4848 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 67.4943 | 179.706 | 152.1469 | 156.7226 | 115.951 | 90.8871 | 81.2427 | 94.0684 | 108.6438 | 92.5891 | 100.3562 | 67.4943 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0093 | 193.2895 | 93 | Complete curve; high efficacy | -8.0292 | 0.5 | 0.8666 | 72.6851 | 265.9745 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 105.1458 | 244.5929 | 174.7663 | 172.838 | 154.9069 | 132.1222 | 117.3729 | 90.5899 | 87.8655 | 85.6705 | 30.7772 | 105.1458 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0021 | 162.7839 | 89 | Complete curve; high efficacy | -8.6792 | 2.2526 | 0.9095 | 41.4972 | 204.2812 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.0569 | 187.9512 | 112.2831 | 54.6119 | 32.4006 | 43.042 | 48.5635 | 47.4689 | 74.453 | 40.5481 | 25.5935 | 16.0569 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0037 | 168.1839 | 89 | Complete curve; high efficacy | -8.4292 | 1.9887 | 0.954 | 44.8326 | 213.0165 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.7704 | 206.3802 | 163.4097 | 86.4546 | 36.0223 | 49.8397 | 39.3597 | 43.2938 | 52.6884 | 61.3728 | 57.8548 | 16.7704 | QC'd by Waterstone | |||||||||||||||
| Cytotoxic | 0.0469 | 148.8106 | 89 | Complete curve; high efficacy | -7.3292 | 2.4064 | 0.85 | 61.7336 | 210.5442 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.2046 | 222.3206 | 202.2319 | 203.978 | 192.1974 | 118.2623 | 35.924 | 46.0477 | 60.9187 | 116.7207 | 98.8749 | 8.2046 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0026 | 113.2709 | 89 | Complete curve; high efficacy | -8.5792 | 3.132 | 0.8977 | 42.9988 | 156.2697 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.2361 | 152.3367 | 113.4138 | 40.5936 | 38.1277 | 40.3624 | 43.6023 | 34.1379 | 43.8713 | 64.7368 | 64.0648 | 21.2361 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0017 | 114.4953 | 89 | Complete curve; high efficacy | -8.7792 | 4.095 | 0.8416 | 43.8532 | 158.3484 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 14.1898 | 152.8039 | 67.852 | 54.5193 | 52.3593 | 57.3458 | 49.824 | 62.0593 | 47.5054 | 30.8367 | 28.4655 | 14.1898 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0026 | 72.7342 | 89 | Complete curve; high efficacy | -8.5792 | 2.7202 | 0.9074 | 41.83 | 114.5643 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 49.3766 | 112.1875 | 83.5951 | 46.535 | 30.9547 | 33.4355 | 32.3129 | 43.2452 | 44.0893 | 44.7978 | 56.0035 | 49.3766 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0743 | 128.2241 | 89 | Complete curve; high efficacy | -7.1292 | 0.3 | 0.8073 | 65.0905 | 193.3146 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 71.5247 | 186.4209 | 158.6743 | 129.1227 | 120.8146 | 138.5824 | 133.4969 | 104.1228 | 120.2992 | 101.9603 | 77.7756 | 71.5247 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0662 | 125.7204 | 89 | Complete curve; high efficacy | -7.1792 | 1.8265 | 0.9719 | 67.5385 | 193.259 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 52.5197 | 186.6163 | 181.5655 | 200.1337 | 192.1342 | 128.2412 | 83.3632 | 87.4098 | 64.6315 | 70.6854 | 65.1161 | 52.5197 | QC'd by SantaCruz Bio | |||||||||||||||
| Cytotoxic | 0.6619 | 78.2859 | 88 | Complete curve; high efficacy | -6.1792 | 1.8851 | 0.9469 | 96.3016 | 174.5875 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 101.3711 | 171.7651 | 176.8613 | 184.4702 | 181.7039 | 154.2237 | 171.0284 | 143.1726 | 100.5791 | 90.9185 | 104.0348 | 101.3711 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0935 | 125.7312 | 88 | Complete curve; high efficacy | -7.0292 | 3.99 | 0.9702 | 62.9518 | 188.683 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 71.3789 | 173.2237 | 176.4213 | 202.4283 | 200.5745 | 169.0569 | 72.0679 | 47.8354 | 55.5118 | 65.1828 | 73.8404 | 71.3789 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0743 | 119.1274 | 88 | Complete curve; high efficacy | -7.1292 | 0.7 | 0.988 | 58.8412 | 177.9686 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 65.4007 | 172.7284 | 171.0856 | 155.1599 | 146.3776 | 116.5859 | 99.7792 | 91.9843 | 65.4198 | 64.0028 | 56.2793 | 65.4007 | QC'd by Axon Medchem | |||||||||||||||
| Cytotoxic | 0.3317 | 103.9102 | 88 | Complete curve; high efficacy | -6.4792 | 0.3 | 0.8436 | 77.4858 | 181.396 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 101.3477 | 161.302 | 177.473 | 153.8803 | 133.2684 | 139.1275 | 144.3925 | 135.8497 | 117.6086 | 91.5334 | 104.8313 | 101.3477 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.1321 | 123.717 | 88 | Complete curve; high efficacy | -6.8792 | 1 | 0.9623 | 67.9127 | 191.6297 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 45.8939 | 178.5371 | 199.9241 | 184.0193 | 181.5655 | 149.5884 | 112.029 | 94.7629 | 81.7313 | 73.6169 | 83.2052 | 45.8939 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0066 | 144.591 | 88 | Complete curve; high efficacy | -8.1792 | 2.7202 | 0.9318 | 43.5813 | 188.1723 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.9675 | 169.8483 | 200.8523 | 105.2569 | 49.6054 | 42.5185 | 45.3031 | 52.1456 | 50.6329 | 56.7946 | 49.5143 | 7.9675 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.935 | 111.4763 | 87 | Complete curve; high efficacy | -6.0292 | 1.4641 | 0.9072 | 88.9886 | 200.4649 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 65.9282 | 174.089 | 200.6763 | 211.7975 | 212.4609 | 203.6327 | 185.8171 | 171.8065 | 108.7421 | 105.1811 | 115.1818 | 65.9282 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0118 | 148.7473 | 87 | Complete curve; high efficacy | -7.9292 | 1.8851 | 0.9147 | 41.9403 | 190.6876 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.0822 | 198.2962 | 171.9006 | 154.0321 | 74.6922 | 45.6818 | 59.0941 | 62.6281 | 63.4243 | 50.9038 | 13.2956 | 8.0822 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 1.6626 | 84.6257 | 87 | Complete curve; high efficacy | -5.7792 | 2.7202 | 0.9593 | 106.2986 | 190.9242 | -1.1 | 0 1 0 0 0 0 0 0 0 0 0 | 104.8088 | 197.9176 | 147.6744 | 188.5439 | 182.4788 | 196.4457 | 175.6724 | 199.742 | 148.305 | 107.0547 | 110.4851 | 104.8088 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0418 | 88.8779 | 85 | Complete curve; high efficacy | -7.3792 | 1.21 | 0.839 | 31.4966 | 120.3746 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.7124 | 132.8926 | 100.4487 | 96.9022 | 107.9527 | 67.4229 | 23.2321 | 38.2547 | 30.0741 | 55.7633 | 43.3453 | 7.7124 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0148 | 116.4503 | 85 | Complete curve; high efficacy | -7.8292 | 0.4 | 0.8832 | 27.623 | 144.0733 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 23.9089 | 133.1493 | 84.9856 | 90.6764 | 88.2038 | 80.5475 | 48.9343 | 46.7949 | 39.8461 | 48.3702 | 38.3265 | 23.9089 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.003 | 63.5074 | 84 | Complete curve; high efficacy | -8.5292 | 1.2475 | 0.8462 | 22.0615 | 85.5689 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.6855 | 78.4448 | 56.9012 | 38.378 | 27.1259 | 24.862 | 30.8508 | 33.1754 | 27.3561 | 22.2582 | 11.8504 | 4.6855 | QC'd by AG Scientific | |||||||||||||||
| Cytotoxic | 0.0662 | 81.5347 | 84 | Complete curve; high efficacy | -7.1792 | 0.5 | 0.9352 | 26.2812 | 107.8158 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 41.7013 | 104.64 | 91.6911 | 85.7103 | 74.9925 | 66.2502 | 63.8289 | 47.1436 | 40.116 | 32.6453 | 16.3981 | 41.7013 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0053 | 88.8579 | 83 | Complete curve; high efficacy | -8.2792 | 0.7 | 0.9187 | 15.3166 | 104.1745 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.2739 | 95.77 | 55.0437 | 66.1767 | 37.4873 | 30.627 | 23.9238 | 16.0289 | 19.5529 | 17.4589 | 9.8155 | 17.2739 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.2093 | 87.7813 | 83 | Complete curve; high efficacy | -6.6792 | 3.0654 | 0.986 | 28.7833 | 116.5646 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 28.0348 | 105.4018 | 124.2663 | 111.216 | 120.9286 | 117.8293 | 82.7937 | 30.9384 | 30.8224 | 27.5221 | 30.012 | 28.0348 | QC'd by ACC | |||||||||||||||
| Cytotoxic | 0.0166 | 84.332 | 83 | Complete curve; high efficacy | -7.7792 | 2.7202 | 0.9842 | 17.1644 | 101.4964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.8094 | 92.1572 | 111.7148 | 93.8225 | 44.8797 | 23.291 | 16.7021 | 14.9312 | 16.052 | 18.3141 | 17.4498 | 16.8094 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0372 | 78.6204 | 83 | Complete curve; high efficacy | -7.4292 | 2.5884 | 0.9846 | 18.7979 | 97.4182 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.8885 | 92.4206 | 95.8169 | 102.9354 | 82.0365 | 34.5038 | 24.1642 | 19.1575 | 13.7712 | 16.3222 | 26.4683 | 12.8885 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 1.049 | 96.4977 | 83 | Complete curve; high efficacy | -5.9792 | 0.5 | 0.9575 | 36.2422 | 132.7399 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 54.2766 | 130.3979 | 127.8742 | 134.2077 | 109.0067 | 109.1952 | 107.7131 | 99.926 | 78.5711 | 59.9369 | 52.6284 | 54.2766 | QC'd by LINCS | |||||||||||||||
| Cytotoxic | 0.0469 | 113.59 | 83 | Complete curve; high efficacy | -7.3292 | 1.9282 | 0.9776 | 20.8655 | 134.4556 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.4008 | 136.3735 | 118.7418 | 147.5619 | 108.8524 | 67.2042 | 21.0092 | 24.2011 | 24.5388 | 19.6988 | 20.3003 | 21.4008 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0059 | 134.114 | 83 | Complete curve; high efficacy | -8.2292 | 0.9 | 0.9582 | 14.3732 | 148.4872 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.7187 | 135.69 | 94.2555 | 92.2912 | 35.674 | 27.573 | 26.6103 | 23.4479 | 18.963 | 13.1392 | 11.2803 | 7.7187 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0166 | 82.999 | 83 | Complete curve; high efficacy | -7.7792 | 4.4495 | 0.9148 | 18.7882 | 101.7872 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 1.3065 | 89.3692 | 109.2888 | 105.2809 | 39.2597 | 12.5607 | 8.631 | 17.2452 | 27.9372 | 41.2907 | 25.0218 | 1.3065 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0026 | 124.1313 | 82 | Complete curve; high efficacy | -8.5792 | 1.4781 | 0.9864 | 11.3246 | 135.4559 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 14.9487 | 124.2782 | 72.555 | 39.0972 | 13.7633 | 18.1604 | 10.3035 | 10.5661 | 10.7649 | 8.9075 | 6.6182 | 14.9487 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0209 | 112.543 | 82 | Complete curve; high efficacy | -7.6792 | 1.9673 | 0.9326 | 14.5764 | 127.1195 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 0.7959 | 123.8363 | 116.6866 | 132.1224 | 62.1868 | 31.224 | 17.3277 | 13.6245 | 6.9603 | 45.141 | 5.1024 | 0.7959 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 0.1049 | 80.7622 | 82 | Complete curve; high efficacy | -6.9792 | 3.99 | 0.9314 | 16.2149 | 96.9771 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.1195 | 101.3823 | 75.2262 | 112.2489 | 99.8696 | 87.6321 | 24.0005 | 28.4571 | 25.408 | 16.8793 | 8.9066 | 2.1195 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.2348 | 92.6555 | 82 | Complete curve; high efficacy | -6.6292 | 0.9 | 0.9866 | 16.7612 | 109.4167 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.3983 | 112.3077 | 99.4639 | 110.1605 | 99.6185 | 92.2501 | 63.4128 | 43.1169 | 34.9892 | 25.2037 | 20.2211 | 13.3983 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.0264 | 105.2236 | 82 | Complete curve; high efficacy | -7.5792 | 2.7868 | 0.9881 | 10.1409 | 115.3645 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.3828 | 108.8197 | 112.7123 | 124.3794 | 75.0669 | 19.9744 | 11.7475 | 17.4558 | 8.7452 | 8.5941 | 7.961 | 5.3828 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.935 | 88.2613 | 82 | Complete curve; high efficacy | -6.0292 | 1.7885 | 0.8556 | 20.4336 | 108.6949 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.8527 | 85.5635 | 121.1104 | 117.0961 | 94.6507 | 99.9913 | 137.0322 | 69.8118 | 48.8332 | 29.7948 | 29.9699 | 4.8527 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0059 | 119.8687 | 82 | Complete curve; high efficacy | -8.2292 | 0.9 | 0.989 | 10.4647 | 130.3334 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 9.7544 | 119.7206 | 88.0559 | 68.5619 | 35.4928 | 30.3765 | 16.1901 | 10.809 | 12.1062 | 11.2172 | 8.007 | 9.7544 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.4176 | 152.6521 | 82 | Complete curve; high efficacy | -6.3792 | 0.4 | 0.9686 | -18.9995 | 133.6526 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.9146 | 127.427 | 102.6532 | 123.6296 | 93.0935 | 83.8593 | 62.241 | 55.7714 | 44.3209 | 18.4384 | 6.137 | 2.9146 | QC'd by Selleck |
| Standard Type | Activity Comment |
|---|---|
| Activity | Not Active |
| Activity | Not Active |
| Activity | Not Active |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0118 | 64.88 | 87 | Complete curve; high efficacy | -7.9292 | 3.99 | 0.9065 | 42.9911 | 107.8711 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 75.9379 | 117.1662 | 98.059 | 101.6667 | 44.5432 | 37.9315 | 51.796 | 45.545 | 45.898 | 55.6965 | 24.215 | 75.9379 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 86 | Complete curve; high efficacy | -9 | 0 | 0.87 | 27.003 | 27.003 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 11.714 | 116.1096 | 51.7823 | 38.4774 | 38.149 | 32.5763 | 27.003 | 21.7125 | 13.6562 | 8.2494 | 4.8318 | 11.714 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0148 | 87.33 | 85 | Complete curve; high efficacy | -7.8292 | 2.7202 | 0.8394 | 28.2225 | 115.5525 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.7164 | 112.6565 | 118.5558 | 105.2086 | 50.4614 | 32.8964 | 56.1238 | 44.2032 | 45.6856 | 13.0527 | 3.9671 | 2.7164 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0743 | 81.0479 | 85 | Complete curve; high efficacy | -7.1292 | 2.4064 | 0.9877 | 36.057 | 117.1048 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.612 | 118.1815 | 112.941 | 121.7674 | 108.9169 | 87.1333 | 42.591 | 31.0005 | 32.051 | 39.1543 | 43.5926 | 36.612 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0132 | 95.1834 | 85 | Complete curve; high efficacy | -7.8792 | 2.5884 | 0.9789 | 30.3117 | 125.4951 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.3434 | 119.5176 | 131.0238 | 109.7688 | 49.1996 | 41.2323 | 39.0944 | 29.1842 | 32.4499 | 24.9502 | 25.8886 | 22.3434 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0372 | 96.9526 | 84 | Complete curve; high efficacy | -7.4292 | 3.6772 | 0.9439 | 26.3959 | 123.3485 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 20.4921 | 101.7407 | 120.2132 | 147.5217 | 112.7694 | 37.9374 | 39.3171 | 24.3812 | 25.0767 | 27.6942 | 20.4173 | 20.4921 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1147 | 102.0262 | 84 | Complete curve; high efficacy | -6.9404 | 0.4 | 0.9457 | 28.8277 | 130.8539 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 108.0014 | 122.9006 | 125.5314 | 115.9246 | 89.8709 | 95.6128 | 75.4206 | 75.6584 | 66.6692 | 45.0649 | 45.6837 | 108.0014 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0093 | 90.1584 | 84 | Complete curve; high efficacy | -8.0292 | 1.7137 | 0.9625 | 24.1405 | 114.2989 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 20.1633 | 106.7519 | 116.4044 | 75.807 | 42.4604 | 31.6448 | 37.5173 | 19.1166 | 17.3457 | 30.1096 | 18.8668 | 20.1633 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 0.4686 | 69.6091 | 84 | Complete curve; high efficacy | -6.3292 | 1.6924 | 0.8276 | 47.7156 | 117.3247 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 95.3248 | 99.0689 | 105.4815 | 112.5472 | 134.071 | 139.2948 | 95.8636 | 78.075 | 56.205 | 61.3157 | 34.976 | 95.3248 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.2957 | 85.2258 | 83 | Complete curve; high efficacy | -6.5292 | 4.9549 | 0.9055 | 30.0023 | 115.2281 | -1.1 | 0 0 0 0 0 0 0 0 0 1 0 | 45.1208 | 102.1961 | 108.7224 | 107.4279 | 107.404 | 145.4631 | 114.1746 | 21.3489 | 22.648 | 33.1896 | 77.556 | 45.1208 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 0.0118 | 107.3878 | 83 | Complete curve; high efficacy | -7.9292 | 4.4495 | 0.9946 | 18.1514 | 125.5392 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 103.6539 | 130.2388 | 120.1313 | 117.1341 | 24.7883 | 21.8042 | 12.7468 | 20.2894 | 19.912 | 21.3667 | 15.3748 | 103.6539 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0332 | 78.3333 | 83 | Complete curve; high efficacy | -7.4792 | 4.4495 | 0.9575 | 20.8089 | 99.1422 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 105.6776 | 94.562 | 86.401 | 118.7673 | 88.3883 | 24.5215 | 23.7163 | 18.8594 | 23.3229 | 22.5677 | 16.9857 | 105.6776 | QC'd by Chemscene | |||||||||||||||
| Cytotoxic | 0.0118 | 86.291 | 83 | Complete curve; high efficacy | -7.9292 | 0.91 | 0.9712 | 20.4028 | 106.6938 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.9907 | 98.3598 | 100.6509 | 70.7724 | 45.8849 | 40.9594 | 33.2184 | 25.0445 | 19.1657 | 23.312 | 17.8226 | 13.9907 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2348 | 84.5422 | 83 | Complete curve; high efficacy | -6.6292 | 1.1 | 0.9547 | 25.2427 | 109.7849 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 114.3833 | 102.02 | 113.1558 | 103.8422 | 121.0743 | 81.3283 | 72.6842 | 51.9205 | 31.8121 | 26.3723 | 28.0582 | 114.3833 | QC'd by ChemieTek | |||||||||||||||
| Cytotoxic | 0.0148 | 86.12 | 83 | Complete curve; high efficacy | -7.8292 | 2.1876 | 0.9725 | 16.3085 | 102.4286 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.9507 | 102.9261 | 98.7333 | 90.7778 | 42.922 | 22.2997 | 23.2007 | 30.2306 | 11.6539 | 10.6579 | 13.0824 | 7.9507 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1482 | 77.0938 | 83 | Complete curve; high efficacy | -6.8292 | 4.9549 | 0.9553 | 22.4128 | 99.5066 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 9.87 | 102.0967 | 92.5449 | 98.6527 | 90.3526 | 113.4727 | 42.0252 | 28.6434 | 31.54 | 24.9793 | 14.7719 | 9.87 | QC'd by Chemscene | |||||||||||||||
| Cytotoxic | 0.4176 | 91.3736 | 83 | Complete curve; high efficacy | -6.3792 | 1.6924 | 0.9858 | 29.7282 | 121.1017 | -1.1 | 0 0 1 0 0 0 0 0 0 0 0 | 21.3801 | 116.2452 | 129.3034 | 186.5441 | 118.5918 | 113.5565 | 105.0881 | 62.7854 | 35.7629 | 34.745 | 35.3537 | 21.3801 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 1.049 | 87.3616 | 83 | Complete curve; high efficacy | -5.9792 | 1 | 0.8772 | 36.1973 | 123.5589 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 54.1491 | 117.4289 | 109.6638 | 131.7472 | 129.0154 | 136.5777 | 93.9336 | 88.9455 | 83.6425 | 43.4572 | 25.123 | 54.1491 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.1482 | 113.9905 | 83 | Complete curve; high efficacy | -6.8292 | 1.2876 | 0.8888 | 23.8075 | 137.7981 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.0453 | 114.2505 | 119.5624 | 176.2421 | 137.6679 | 106.6825 | 59.0284 | 55.2507 | 38.1823 | 24.8371 | 27.4067 | 8.0453 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 1.177 | 85.4963 | 83 | Complete curve; high efficacy | -5.9292 | 3.6272 | 0.9149 | 39.2135 | 124.7097 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 27.6517 | 113.2381 | 135.3021 | 111.0564 | 135.5045 | 142.3677 | 111.5001 | 118.8115 | 56.8306 | 33.2042 | 57.6372 | 27.6517 | QC'd by Microsource |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0148 | 138.4172 | 92 | Complete curve; high efficacy | -7.8292 | 0.8 | 0.9854 | 73.4473 | 211.8645 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 76.0615 | 206.4576 | 176.3477 | 160.675 | 143.036 | 102.2156 | 87.4586 | 76.3866 | 75.9423 | 81.5132 | 71.2845 | 76.0615 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1865 | 129.7094 | 92 | Complete curve; high efficacy | -6.7292 | 2.4729 | 0.9102 | 104.5908 | 234.3002 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 97.9499 | 212.7695 | 199.584 | 247.0735 | 277.3731 | 227.6905 | 162.5507 | 123.8591 | 102.5004 | 104.1059 | 104.3989 | 97.9499 | QC'd by SantaCruz Bio | |||||||||||||||
| Cytotoxic | 0.5258 | 72.9609 | 91 | Complete curve; high efficacy | -6.2792 | 2.7202 | 0.9263 | 121.6641 | 194.625 | -1.1 | 0 0 0 0 0 0 0 0 0 0 1 | 182.846 | 196.2276 | 201.2704 | 206.5478 | 177.6678 | 187.1047 | 193.8819 | 153.4274 | 124.7553 | 110.5225 | 133.7805 | 182.846 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.0469 | 134.7266 | 91 | Complete curve; high efficacy | -7.3292 | 2.3332 | 0.9427 | 79.2711 | 213.9977 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 74.524 | 225.8348 | 183.7696 | 233.1661 | 192.207 | 130.2439 | 74.8439 | 101.4578 | 75.213 | 88.158 | 64.0647 | 74.524 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 91 | Complete curve; high efficacy | -9 | 0 | 0.9736 | 48.7803 | 48.7803 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 47.83 | 166.158 | 106.5335 | 67.3448 | 35.2031 | 47.2803 | 44.6563 | 48.7803 | 46.7036 | 51.7045 | 56.8882 | 47.83 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 90 | Complete curve; high efficacy | -9 | 0 | 0.8207 | 46.4226 | 46.4226 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.4032 | 205.1041 | 113.3989 | 45.0423 | 60.9659 | 55.9706 | 82.4919 | 46.4226 | 18.2592 | 10.6648 | 8.4697 | 5.4032 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 1.4818 | 67.8056 | 89 | Complete curve; high efficacy | -5.8292 | 4.9549 | 0.7621 | 141.433 | 209.2386 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 116.0869 | 187.3686 | 222.298 | 199.2101 | 217.5801 | 185.2508 | 221.0682 | 234.3031 | 161.6854 | 158.4572 | 150.9575 | 116.0869 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 89 | Complete curve; high efficacy | -9 | 0 | 0.9591 | 38.8706 | 38.8706 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 39.1109 | 165.4745 | 147.9893 | 92.1226 | 38.8706 | 47.6528 | 15.9643 | 14.5577 | 9.1645 | 7.8078 | 7.0708 | 39.1109 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 89 | Complete curve; high efficacy | -9 | 0 | 0.9388 | 41.1421 | 41.1421 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 3.8961 | 184.0933 | 141.733 | 91.783 | 118.6691 | 84.4271 | 41.1421 | 40.4161 | 26.2497 | 18.5223 | 5.7273 | 3.8961 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 89 | Complete curve; high efficacy | -9 | 0 | 0.9888 | 40.8379 | 40.8379 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 26.1407 | 121.6554 | 195.8384 | 155.5113 | 88.1063 | 68.0947 | 37.7656 | 40.8379 | 40.0991 | 27.9716 | 31.773 | 26.1407 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0382 | 92.5734 | 88 | Complete curve; high efficacy | -7.418 | 0.4 | 0.8897 | 52.7945 | 145.3679 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 51.9291 | 116.2057 | 136.3435 | 103.0924 | 91.9654 | 79.4739 | 82.0269 | 83.1013 | 67.373 | 61.555 | 57.4999 | 51.9291 | QC'd by ChemPacific | |||||||||||||||
| Cytotoxic | 0.0743 | 134.5354 | 88 | Complete curve; high efficacy | -7.1292 | 1.21 | 0.9307 | 57.9113 | 192.4467 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 49.7147 | 175.8519 | 207.2976 | 185.8686 | 162.8742 | 143.0486 | 63.0491 | 99.1074 | 67.3805 | 57.9379 | 49.2515 | 49.7147 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 88 | Complete curve; high efficacy | -9 | 0 | 0.8758 | 33.7212 | 33.7212 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.1324 | 152.4612 | 97.5893 | 68.7499 | 32.2642 | 58.8159 | 47.2578 | 33.7212 | 8.8049 | 4.8186 | 3.5433 | 4.1324 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 3.7221 | 85.2239 | 87 | Complete curve; high efficacy | -5.4292 | 4.9549 | 0.891 | 150.0271 | 235.251 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 154.7033 | 204.9209 | 231.691 | 212.9559 | 243.8102 | 227.9286 | 234.025 | 230.2626 | 264.0915 | 159.589 | 149.6383 | 154.7033 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 1.3207 | 106.1003 | 87 | Complete curve; high efficacy | -5.8792 | 1.8265 | 0.9417 | 105.4088 | 211.509 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 114.0374 | 223.8378 | 192.8578 | 196.2457 | 228.3532 | 212.5214 | 209.5506 | 192.8647 | 146.6919 | 120.1282 | 91.3668 | 114.0374 | QC'd by XcessBio | |||||||||||||||
| Cytotoxic | 0.1482 | 151.4987 | 87 | Complete curve; high efficacy | -6.8292 | 0.7 | 0.98 | 56.0265 | 207.5252 | -1.1 | 0 1 0 0 0 0 0 0 0 0 0 | 51.814 | 202.2596 | 122.7624 | 197.3713 | 167.7834 | 153.3308 | 139.0984 | 85.596 | 79.1403 | 68.5178 | 69.5035 | 51.814 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0935 | 70.6056 | 87 | Complete curve; high efficacy | -7.0292 | 4.5045 | 0.9613 | 52.9846 | 123.5901 | -1.1 | 0 1 0 0 0 0 0 0 0 0 0 | 41.374 | 115.1832 | 175.7294 | 133.236 | 122.1014 | 112.515 | 54.2553 | 57.0952 | 63.7337 | 53.567 | 50.7817 | 41.374 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 87 | Complete curve; high efficacy | -9 | 0 | 0.9576 | 30.2511 | 30.2511 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.7137 | 142.2621 | 159.7504 | 41.7891 | 40.524 | 22.5735 | 21.9929 | 37.0563 | 30.2511 | 15.9156 | 14.2865 | 7.7137 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 87 | Complete curve; high efficacy | -9 | 0 | 0.9353 | 30.6525 | 30.6525 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.0983 | 153.4905 | 88.4577 | 56.6365 | 28.9731 | 43.3437 | 33.8307 | 30.6525 | 18.3845 | 11.7562 | 11.5903 | 10.0983 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2635 | 171.4641 | 86 | Complete curve; high efficacy | -6.5792 | 4.9549 | 0.903 | 55.2524 | 226.7165 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 87.6192 | 224.0953 | 196.7275 | 198.1303 | 295.2794 | 221.4309 | 194.6875 | 46.5565 | 51.5148 | 33.1518 | 58.5883 | 87.6192 | QC'd by Selleck |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | -9 | % | |
| Inhibition | = | 5 | % | |
| Inhibition | = | -14.9 | % | Outside typical range |
| Inhibition | = | 14 | % | |
| Inhibition | = | 26.5 | % | |
| Inhibition | = | 25.9 | % | |
| Inhibition | = | 2.9 | % | |
| Inhibition | = | 25.7 | % | |
| Inhibition | = | 1.3 | % | |
| Inhibition | = | -10.1 | % | Outside typical range |
| Inhibition | = | 6.6 | % | |
| Inhibition | = | 23.6 | % | |
| Inhibition | = | 7 | % | |
| Inhibition | = | 18.3 | % | |
| Inhibition | = | 15 | % | |
| Inhibition | = | -4.6 | % | |
| Inhibition | = | 55.3 | % | |
| Inhibition | = | 19.7 | % | |
| Inhibition | = | 1.6 | % | |
| Inhibition | = | -16.1 | % | Outside typical range |
| Phenotype | Potency | Efficacy | Analysis Comment | FF-overN-Activity_Score | FF-overN-Curve_Description | FF-overN-Fit_LogAC50 | FF-overN-Fit_HillSlope | FF-overN-Fit_R2 | FF-overN-Fit_InfiniteActivity | FF-overN-Fit_ZeroActivity | FF-overN-Fit_CurveClass | FF-overN-Excluded_Points | FF-overN-Max_Response | FF-overN-Activity at 0.0000389080 uM | FF-overN-Activity at 0.0001066275 uM | FF-overN-Activity at 0.0001907270 uM | FF-overN-Activity at 0.0004536066 uM | FF-overN-Activity at 0.0007545096 uM | FF-overN-Activity at 0.0009784578 uM | FF-overN-Activity at 0.00290 uM | FF-overN-Activity at 0.00507 uM | FF-overN-Activity at 0.00876 uM | FF-overN-Activity at 0.016 uM | FF-overN-Activity at 0.026 uM | FF-overN-Activity at 0.052 uM | FF-overN-Activity at 0.080 uM | FF-overN-Activity at 0.235 uM | FF-overN-Activity at 0.459 uM | FF-overN-Activity at 0.739 uM | FF-overN-Activity at 1.169 uM | FF-overN-Activity at 2.226 uM | FF-overN-Activity at 6.007 uM | FF-overN-Activity at 11.47 uM | FF-overN-Activity at 19.12 uM | FF-overN-Activity at 25.20 uM | FF-overN-Activity at 57.49 uM | FF-overN-Activity at 115.7 uM | FF-overN-Activity at 221.8 uM | FF-overN-Activity at 288.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -6 | 3.5722 | 0.9998 | 8 | -4.573 | 4 | 0 0 0 1 | 0.0919 | -4.6442 | 3.1713 | 7.9059 | 0.0919 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.7 | 3.5722 | 0.955 | 11 | -10.4556 | 4 | 0 0 0 0 | 10.3819 | -7.9209 | -13.2963 | -7.8629 | 10.3819 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.1 | 3.9295 | 0.9982 | -20.5535 | -1.4154 | 4 | 0 0 0 0 | -20.4612 | -1.7364 | -0.7629 | -17.0693 | -20.4612 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.5 | 1 | 0.6282 | -19.163 | -1 | 4 | 0 0 0 0 | -14.3025 | 0.9125 | -7.5415 | -3.4541 | -14.3025 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 2.2526 | 0.9995 | -16.7735 | 3.5 | 4 | 0 0 0 0 | -16.7304 | 3.5028 | -6.5545 | -16.8946 | -16.7304 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5 | 0.6 | 0.9765 | -26.0622 | 0.057 | 4 | 0 0 0 0 | -20.0519 | -0.7858 | -6.9465 | -12.3383 | -20.0519 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.5 | 1.4487 | 0.9277 | -11.1274 | 1 | 4 | 0 0 0 0 | -7.6062 | 2.4742 | -0.4153 | -0.9904 | -7.6062 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.35 | 0.6 | 0.9824 | -10.0654 | 9.5 | 4 | 0 0 0 0 | -7.5545 | 7.8538 | 2.9441 | -1.9949 | -7.5545 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.4936 | 1.9596 | 1.2945 | 6.6505 | 2.4936 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.55 | 2.5334 | 0.6159 | -11.4423 | -23.9956 | 4 | 0 0 0 0 | -13.2853 | -18.831 | -28.7463 | -22.7697 | -13.2853 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.0756 | 0 | 0 | -9.752 | -4.0756 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.65 | 1.6436 | 0.9984 | -26.3723 | 6.5 | 4 | 0 0 0 0 | -20.7269 | 6.8952 | 5.4769 | -1.6781 | -20.7269 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.35 | 4.9549 | 0.8085 | -22.1835 | 1.5 | 4 | 0 0 0 0 | -16.8196 | 1.0548 | -3.7533 | 7.1078 | -16.8196 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -9.2421 | -7.2234 | -5.2389 | -3.1916 | -9.2421 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.9119 | -16.3463 | -12.7285 | -15.6237 | -12.9119 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.468 | -15.2266 | 3 | 4 | 0 0 0 0 | -8.9707 | 0 | -26.8555 | -10.0921 | -8.9707 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6823 | 3.8566 | 7.6151 | 8.0028 | 2.6823 | QC'd by Sytravon | ||||||||||||||||||||||||||||||
| Inactive | 0 | -6.8 | 4.9549 | 0.4875 | -11.1688 | 2 | 4 | 0 0 0 1 | -1.2431 | 0 | -17.6407 | -4.4754 | -1.2431 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -4.55 | 2.3531 | 0.986 | -25.9932 | 3.5 | 4 | 0 0 0 0 | -21.2443 | 5.1247 | 1.651 | 0.2461 | -21.2443 | QC'd by Sytravon | ||||||||||||||||||||||||||
| Inactive | 0 | -5.1 | 4.095 | 0.7467 | -1.9217 | 6 | 4 | 0 0 0 0 | -2.0181 | 2.9034 | 8.923 | -0.4967 | -2.0181 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0093 | 104.6527 | 88 | Complete curve; high efficacy | -8.0292 | 1.9673 | 0.9946 | 43.2871 | 147.9397 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 46.9856 | 151.2515 | 136.3124 | 112.1568 | 60.3474 | 41.2891 | 43.6006 | 45.5367 | 40.8584 | 41.4875 | 44.248 | 46.9856 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 0.0526 | 90.7291 | 87 | Complete curve; high efficacy | -7.2792 | 1.2475 | 0.969 | 49.3002 | 140.0293 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.2116 | 136.8931 | 136.6639 | 140.7519 | 111.5654 | 96.3382 | 58.163 | 55.064 | 58.6659 | 57.3681 | 48.8529 | 36.2116 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1865 | 111.0998 | 86 | Complete curve; high efficacy | -6.7292 | 1.5579 | 0.9597 | 58.0636 | 169.1634 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 30.8392 | 165.6134 | 164.7399 | 166.9572 | 172.8379 | 153.7472 | 111.4217 | 72.2937 | 71.4323 | 70.5615 | 64.8202 | 30.8392 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.1049 | 99.2537 | 86 | Complete curve; high efficacy | -6.9792 | 3.132 | 0.8788 | 51.4415 | 150.6952 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.3763 | 133.6762 | 159.094 | 152.6324 | 154.4225 | 134.3854 | 64.9851 | 70.6294 | 68.5418 | 58.5559 | 55.5813 | 4.3763 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.3317 | 94.9929 | 84 | Complete curve; high efficacy | -6.4792 | 0.3 | 0.9521 | 37.641 | 132.6338 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 50.4436 | 114.4568 | 123.9845 | 113.8331 | 96.152 | 92.1624 | 89.6664 | 81.8815 | 79.9224 | 68.1558 | 59.6137 | 50.4436 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.7427 | 84.9044 | 84 | Complete curve; high efficacy | -6.1292 | 2.2526 | 0.933 | 45.6644 | 130.5688 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.4643 | 134.3384 | 115.1991 | 125.3701 | 119.0101 | 144.1666 | 143.8172 | 97.9891 | 50.7825 | 53.0518 | 54.3899 | 36.4643 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.8333 | 75.354 | 84 | Complete curve; high efficacy | -6.0792 | 3.99 | 0.9614 | 46.5835 | 121.9376 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.0973 | 124.2208 | 119.0164 | 110.2614 | 120.2463 | 126.3612 | 130.9298 | 108.8859 | 50.9325 | 50.2586 | 56.0536 | 33.0973 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.3722 | 88.0762 | 84 | Complete curve; high efficacy | -6.4292 | 4.4495 | 0.9703 | 37.6549 | 125.7311 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 44.0074 | 106.5992 | 127.2247 | 130.6238 | 138.3415 | 127.8948 | 120.6987 | 48.2184 | 35.9135 | 36.3641 | 34.926 | 44.0074 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0093 | 130.6425 | 84 | Complete curve; high efficacy | -8.0292 | 0.9 | 0.9867 | 24.621 | 155.2635 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 18.1076 | 143.3641 | 125.7098 | 98.5685 | 66.0334 | 36.9882 | 37.4695 | 36.8721 | 31.0273 | 25.0064 | 19.2735 | 18.1076 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.4686 | 84.3499 | 83 | Complete curve; high efficacy | -6.3292 | 3.0654 | 0.8927 | 37.763 | 122.1129 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.9174 | 100.9718 | 133.1095 | 113.0152 | 128.6977 | 133.2765 | 119.5843 | 64.2784 | 53.3781 | 48.5286 | 44.75 | 8.9174 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.3317 | 88.6774 | 83 | Complete curve; high efficacy | -6.4792 | 1.6259 | 0.9909 | 34.1483 | 122.8257 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 32.8455 | 112.8257 | 122.9968 | 126.477 | 124.3559 | 121.5352 | 96.4604 | 60.3971 | 43.4033 | 34.0922 | 32.8733 | 32.8455 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.2957 | 104.4395 | 83 | Complete curve; high efficacy | -6.5292 | 0.6 | 0.9636 | 33.4657 | 137.9052 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 30.41 | 139.5422 | 127.9789 | 115.7906 | 133.779 | 110.193 | 87.9596 | 73.5955 | 58.1049 | 55.3613 | 47.9141 | 30.41 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 2.3485 | 86.6758 | 83 | Complete curve; high efficacy | -5.6292 | 4.095 | 0.9684 | 53.6121 | 140.2879 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 51.2528 | 135.5146 | 146.9511 | 127.3268 | 148.5202 | 130.0159 | 143.2286 | 148.4195 | 122.3701 | 57.6127 | 55.7427 | 51.2528 | QC'd by LINCS | |||||||||||||||
| Cytotoxic | 0.5899 | 78.4815 | 83 | Complete curve; high efficacy | -6.2292 | 1 | 0.962 | 39.6422 | 118.1236 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.8849 | 113.0988 | 105.5924 | 123.1519 | 126.3882 | 114.8478 | 93.4484 | 78.3964 | 61.996 | 52.621 | 41.6161 | 36.8849 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 1.6626 | 85.9672 | 83 | Complete curve; high efficacy | -5.7792 | 2.4729 | 0.9295 | 40.7279 | 126.6952 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 28.4756 | 118.8121 | 112.7597 | 122.0662 | 124.4452 | 131.3159 | 149.7541 | 122.8382 | 80.2944 | 49.8125 | 50.9941 | 28.4756 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0743 | 90.7413 | 83 | Complete curve; high efficacy | -7.1292 | 1.9673 | 0.9464 | 25.6492 | 116.3905 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.9198 | 106.5785 | 111.2723 | 128.5693 | 109.6739 | 79.4144 | 37.1158 | 33.6722 | 41.618 | 29.6887 | 19.1474 | 5.9198 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.4176 | 196.8504 | 83 | Complete curve; high efficacy | -6.3792 | 0.3 | 0.9606 | -31.7676 | 165.0828 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.8348 | 135.921 | 148.6439 | 123.1507 | 111.4731 | 78.5446 | 71.3085 | 64.7602 | 62.72 | 28.6854 | 14.0462 | 2.8348 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.5258 | 95.9955 | 83 | Complete curve; high efficacy | -6.2792 | 0.4 | 0.9753 | 35.9633 | 131.9588 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 50.6988 | 124.3759 | 129.0401 | 111.2096 | 110.6664 | 98.3191 | 99.2745 | 82.505 | 77.9575 | 59.8532 | 53.1365 | 50.6988 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.1865 | 153.2974 | 82 | Complete curve; high efficacy | -6.7292 | 0.4 | 0.9838 | -19.1976 | 134.0998 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 1.5971 | 128.3939 | 102.501 | 95.9576 | 90.3493 | 76.1127 | 59.6546 | 43.6414 | 25.0549 | 4.9279 | 1.7 | 1.5971 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 0.4686 | 112.6369 | 82 | Complete curve; high efficacy | -6.3292 | 0.7 | 0.966 | 16.772 | 129.4089 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.877 | 117.2722 | 122.3984 | 135.2437 | 130.0817 | 105.7415 | 80.3609 | 67.0393 | 51.7534 | 40.541 | 30.1694 | 13.877 | QC'd by Selleck |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.009 | ED50 | = | 0.009 | uM |
| 14.58 | ED50 | = | 14.58 | uM |
| 2.76 | ED50 | = | 2.76 | uM |
| 2.81 | ED50 | = | 2.81 | uM |
| 0.5 | ED50 | = | 0.5 | uM |
| 0.001 | ED50 | = | 0.001 | uM |
| 5.88 | ED50 | = | 5.88 | uM |
| 0.011 | ED50 | = | 0.011 | uM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0132 | 78.8888 | 88 | Complete curve; high efficacy | -7.8792 | 3.5117 | 0.9951 | 47.2347 | 126.1235 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 42.2827 | 127.6613 | 122.708 | 120.2024 | 61.1126 | 51.2885 | 45.5161 | 47.7407 | 46.3578 | 47.5339 | 48.0543 | 42.2827 | QC'd by SigmaAldrich | |||||||||||||||
| Cytotoxic | 0.0187 | 94.4991 | 87 | Complete curve; high efficacy | -7.7292 | 1.9673 | 0.9923 | 43.1973 | 137.6963 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 47.5181 | 141.319 | 129.8171 | 127.5041 | 86.8076 | 49.0942 | 47.0499 | 42.277 | 40.9385 | 37.8151 | 44.8621 | 47.5181 | QC'd by ACC | |||||||||||||||
| Cytotoxic | 0.5258 | 73.9868 | 87 | Complete curve; high efficacy | -6.2792 | 1.5386 | 0.9608 | 75.2185 | 149.2053 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 66.1566 | 142.7053 | 154.8249 | 147.903 | 146.0134 | 146.4254 | 144.006 | 104.2739 | 88.0969 | 90.9594 | 71.6495 | 66.1566 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.0059 | 140.4545 | 87 | Complete curve; high efficacy | -8.2292 | 1.4163 | 0.9687 | 36.1127 | 176.5672 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.8624 | 168.6765 | 147.5154 | 96.3491 | 54.2002 | 41.5445 | 37.5728 | 42.2093 | 41.7422 | 40.4833 | 43.4946 | 10.8624 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 0.0132 | 79.7444 | 87 | Complete curve; high efficacy | -7.8792 | 0.6 | 0.8986 | 41.6151 | 121.3595 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 26.1462 | 113.0499 | 103.1376 | 82.2031 | 81.4852 | 58.6938 | 53.3145 | 53.6692 | 54.5379 | 37.1186 | 56.479 | 26.1462 | QC'd by SigmaAldrich | |||||||||||||||
| Cytotoxic | 0.1663 | 78.9427 | 86 | Complete curve; high efficacy | -6.7792 | 3.9295 | 0.9459 | 49.4968 | 128.4395 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 39.1638 | 119.9619 | 118.7114 | 121.8873 | 145.134 | 135.6602 | 77.5019 | 49.3716 | 42.7048 | 55.4887 | 60.9156 | 39.1638 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.1177 | 99.5229 | 86 | Complete curve; high efficacy | -6.9292 | 0.5 | 0.9784 | 53.5004 | 153.0233 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 54.2364 | 146.2425 | 146.4285 | 127.5196 | 118.6607 | 112.3725 | 102.0037 | 86.3517 | 70.5974 | 62.7254 | 70.1683 | 54.2364 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2348 | 79.9222 | 86 | Complete curve; high efficacy | -6.6292 | 1.4641 | 0.9791 | 58.9416 | 138.8638 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 62.4132 | 143.4278 | 135.9313 | 129.1028 | 144.3799 | 129.2524 | 105.2039 | 73.5025 | 70.4619 | 53.7397 | 57.6396 | 62.4132 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0187 | 133.2619 | 86 | Complete curve; high efficacy | -7.7292 | 0.6 | 0.9441 | 35.7906 | 169.0525 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 27.5582 | 156.1894 | 139.4018 | 135.4374 | 91.1086 | 61.2241 | 66.0949 | 67.7171 | 53.5961 | 42.5842 | 30.9652 | 27.5582 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.0296 | 79.812 | 85 | Complete curve; high efficacy | -7.5292 | 3.132 | 0.8367 | 30.4945 | 110.3065 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -0.4219 | 91.4427 | 118.502 | 121.2802 | 87.4178 | 39.06 | 30.3783 | 26.004 | 28.8116 | 31.886 | 64.9696 | -0.4219 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.4686 | 72.5584 | 85 | Complete curve; high efficacy | -6.3292 | 1.4781 | 0.898 | 58.4082 | 130.9666 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.5241 | 121.5091 | 138.67 | 123.1995 | 141.6082 | 124.8321 | 119.0843 | 85.2035 | 70.5438 | 62.7606 | 78.2039 | 36.5241 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.5749 | 89.3171 | 85 | Complete curve; high efficacy | -6.2404 | 3.5117 | 0.9381 | 53.4216 | 142.7387 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 42.1397 | 122.2594 | 133.5752 | 138.8262 | 155.9137 | 150.9759 | 155.3277 | 133.8332 | 70.1507 | 56.1404 | 64.459 | 42.1397 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1049 | 90.1126 | 85 | Complete curve; high efficacy | -6.9792 | 1.1 | 0.96 | 42.4601 | 132.5727 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 48.0597 | 134.7202 | 138.2028 | 122.4795 | 111.2704 | 105.466 | 77.8849 | 45.233 | 45.4972 | 30.8237 | 55.2725 | 48.0597 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0418 | 80.3578 | 85 | Complete curve; high efficacy | -7.3792 | 0.6 | 0.8511 | 33.6315 | 113.9892 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 11.0841 | 101.2736 | 106.7715 | 96.7166 | 82.135 | 70.4809 | 40.1055 | 51.5054 | 51.4536 | 54.1375 | 41.9436 | 11.0841 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.6619 | 94.773 | 85 | Complete curve; high efficacy | -6.1792 | 1.4781 | 0.9803 | 53.7716 | 148.5446 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 55.0629 | 148.0214 | 138.5482 | 154.1536 | 143.4321 | 157.4598 | 136.5884 | 99.8634 | 77.2433 | 58.4344 | 52.8195 | 55.0629 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2093 | 116.5034 | 85 | Complete curve; high efficacy | -6.6792 | 1.331 | 0.9045 | 46.5044 | 163.0078 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.0869 | 143.6239 | 161.4686 | 168.1578 | 159.9801 | 164.4887 | 97.6706 | 64.7846 | 68.4913 | 71.4763 | 50.625 | 13.0869 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2957 | 96.4482 | 84 | Complete curve; high efficacy | -6.5292 | 1.8265 | 0.9793 | 36.1131 | 132.5613 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 27.7595 | 137.6757 | 133.1247 | 125.0579 | 141.4133 | 118.8792 | 106.6696 | 52.9758 | 40.6195 | 40.7565 | 44.3485 | 27.7595 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.3722 | 96.57 | 84 | Complete curve; high efficacy | -6.4292 | 1.4787 | 0.9808 | 40.3311 | 136.901 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 41.4841 | 141.6948 | 138.6029 | 123.988 | 145.2114 | 122.9084 | 114.8164 | 75.0526 | 46.3655 | 45.8328 | 38.6829 | 41.4841 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0132 | 99.5422 | 84 | Complete curve; high efficacy | -7.8792 | 0.5 | 0.8598 | 25.2368 | 124.779 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.6254 | 113.8403 | 106.9304 | 67.8854 | 57.7379 | 56.7173 | 56.0064 | 46.2734 | 43.489 | 29.1571 | 4.4532 | 33.6254 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 2.0931 | 75.0602 | 84 | Complete curve; high efficacy | -5.6792 | 4.9549 | 0.9483 | 60.3489 | 135.4091 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 60.7384 | 119.1757 | 138.3496 | 139.0789 | 136.1425 | 149.2097 | 137.4143 | 127.2154 | 116.9325 | 54.5422 | 66.8667 | 60.7384 | QC'd by ChemAxon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inconclusive | 2.0931 | 52.3778 | 10 | Complete curve; partial efficacy; poor fit | -5.6792 | 1.21 | 0.8868 | 207.717 | 155.3392 | 1.4 | 0 0 0 0 1 0 0 0 0 0 1 | 147.1 | 164.4833 | 155.0085 | 150.5868 | 148.3401 | 116.6514 | 156.9711 | 173.7174 | 168.6881 | 199.2135 | 202.8962 | 147.1 | QC'd by Microsource | |||||||||||||||
| Inconclusive | 0.0057 | 12.5196 | 10 | Complete curve; partial efficacy; poor fit | -8.2404 | 4.9549 | 0.312 | 131.5823 | 119.0627 | 1.4 | 0 0 0 0 0 0 0 0 0 0 1 | 127.1473 | 120.0823 | 122.1295 | 115.8993 | 137.6706 | 122.1335 | 127.163 | 123.7971 | 150.7316 | 133.1825 | 125.6113 | 127.1473 | QC'd by SIGMA | |||||||||||||||
| Inconclusive | 0.0019 | 21 | 10 | Complete curve; partial efficacy; poor fit | -8.7292 | 1.1 | 0.8356 | 134.2114 | 113.2114 | 1.4 | 0 0 0 0 0 0 0 0 0 0 1 | 119.1302 | 117.2114 | 127.4759 | 130.4637 | 129.9536 | 131.9164 | 134.6866 | 133.4534 | 131.6405 | 137.8111 | 137.2931 | 119.1302 | QC'd by Pharmeks | |||||||||||||||
| Inconclusive | 0.0662 | 21.5 | 10 | Complete curve; partial efficacy; poor fit | -7.1792 | 1.9673 | 0.9617 | 136.1907 | 114.6907 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 137.9456 | 114.6907 | 115.3457 | 114.9342 | 114.9118 | 125.4369 | 132.2852 | 136.9063 | 134.4597 | 139.5384 | 132.1379 | 137.9456 | QC'd by Sequoia | |||||||||||||||
| Inconclusive | 0.1482 | 21.0998 | 10 | Complete curve; partial efficacy; poor fit | -6.8292 | 0.8 | 0.8442 | 149.6919 | 128.5921 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 151.9116 | 131.6919 | 128.2754 | 129.76 | 129.967 | 133.7039 | 147.8377 | 137.7359 | 147.2819 | 148.9579 | 147.0679 | 151.9116 | QC'd by Tocris | |||||||||||||||
| Inconclusive | 0.0833 | 30.5 | 10 | Complete curve; partial efficacy; poor fit | -7.0792 | 0.3 | 0.9065 | 152.817 | 122.317 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 149.8479 | 126.317 | 131.9239 | 133.2597 | 133.1414 | 138.2988 | 138.8257 | 144.3744 | 142.6826 | 141.1244 | 150.4849 | 149.8479 | QC'd by APAC | |||||||||||||||
| Inconclusive | 0.003 | 23 | 10 | Complete curve; partial efficacy; poor fit | -8.5292 | 0.7 | 0.9042 | 116.6731 | 93.6731 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 115.0235 | 97.6731 | 106.1567 | 108.9656 | 113.5207 | 111.3295 | 114.3155 | 115.674 | 116.5526 | 117.8964 | 119.9437 | 115.0235 | QC'd by SigmaAldrich | |||||||||||||||
| Inconclusive | 0.0019 | 25.5 | 10 | Complete curve; partial efficacy | -8.7292 | 1.5579 | 0.7725 | 134.9997 | 109.4997 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 138.6831 | 113.4997 | 125.8748 | 129.6566 | 135.9028 | 133.275 | 139.8144 | 131.171 | 127.5454 | 138.1274 | 135.3784 | 138.6831 | QC'd by SigmaAldrich | |||||||||||||||
| Inactive | 0 | -5.0292 | 0.8 | 0.4643 | 103.7426 | 121.9544 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 106.6946 | 111.4544 | 125.2432 | 128.5053 | 127.1929 | 113.4715 | 124.3917 | 121.815 | 114.296 | 116.6521 | 111.8738 | 106.6946 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | 4 | 125.6815 | 122.8795 | 130.2888 | 125.1136 | 125.6652 | 130.3074 | 128.7078 | 129.9384 | 126.7494 | 127.6785 | 129.7132 | 125.6815 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inactive | 0 | 4 | 136.2326 | 163.4273 | 142.6615 | 146.3348 | 166.6634 | 150.6103 | 158.3404 | 165.0578 | 162.7658 | 150.3198 | 139.9664 | 136.2326 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inactive | 0 | -7.3792 | 0.8 | 0.6066 | 126.3684 | 141.9019 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 126.5818 | 144.4019 | 133.558 | 143.8479 | 137.0521 | 128.3337 | 135.1801 | 122.2906 | 134.5644 | 123.4653 | 125.8628 | 126.5818 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -4.9292 | 4.9549 | 0.7372 | 120.4574 | 134.0138 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 120.7168 | 134.5138 | 134.0383 | 138.0285 | 138.2397 | 129.2732 | 130.6596 | 135.9635 | 130.2877 | 134.4747 | 123.0085 | 120.7168 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -6.8792 | 3.132 | 0.4017 | 111.9315 | 106.5265 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 105.5505 | 105.9315 | 109.5176 | 101.4274 | 110.4744 | 106.5334 | 110.4821 | 115.977 | 107.3312 | 113.281 | 111.1989 | 105.5505 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -4.6792 | 4.5045 | 0.6481 | 132.5399 | 143.839 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 132.7564 | 143.839 | 141.5609 | 139.3268 | 147.1235 | 144.923 | 140.6337 | 146.4103 | 146.2306 | 145.3224 | 141.4193 | 132.7564 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -4.5792 | 0.9 | 0.6882 | 159.3525 | 129.3525 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 151.1525 | 125.3525 | 127.8444 | 130.5681 | 128.6677 | 140.8596 | 130.7582 | 127.8002 | 131.1106 | 130.9549 | 139.8805 | 151.1525 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -6.9792 | 0.4 | 0.9481 | 115.5257 | 97.0483 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 114.5356 | 99.5257 | 98.7112 | 102.3247 | 103.7206 | 107.7162 | 106.0966 | 108.4061 | 110.7209 | 110.6769 | 114.5412 | 114.5356 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | -5.1792 | 2.4064 | 0.5201 | 113.1718 | 140.1235 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 115.0077 | 144.1235 | 142.7954 | 132.4372 | 151.4407 | 117.6804 | 133.3272 | 147.8257 | 140.0962 | 131.6466 | 114.5804 | 115.0077 | QC'd by BIOMOL | ||||||||||||||||||
| Inactive | 0 | 4 | 129.9994 | 131.8514 | 126.6454 | 132.768 | 130.4791 | 123.0823 | 132.8921 | 130.718 | 134.7376 | 125.1039 | 126.4003 | 129.9994 | QC'd by BIOMOL | ||||||||||||||||||||||||
| Inactive | 0 | -5.9792 | 3.5117 | 0.878 | 99.8725 | 117.8095 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 106.7355 | 120.8095 | 114.2948 | 118.894 | 116.6347 | 119.8485 | 116.4782 | 116.0413 | 102.2434 | 98.241 | 95.0287 | 106.7355 | QC'd by BIOMOL |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000386857 uM | Activity at 0.0001060182 uM | Activity at 0.0002019424 uM | Activity at 0.0004510146 uM | Activity at 0.0009668607 uM | Activity at 0.00168 uM | Activity at 0.00290 uM | Activity at 0.00509 uM | Activity at 0.00877 uM | Activity at 0.025 uM | Activity at 0.041 uM | Activity at 0.083 uM | Activity at 0.136 uM | Activity at 0.247 uM | Activity at 0.490 uM | Activity at 1.070 uM | Activity at 2.238 uM | Activity at 4.221 uM | Activity at 6.448 uM | Activity at 12.37 uM | Activity at 30.23 uM | Activity at 57.68 uM | Activity at 114.0 uM | Activity at 227.8 uM | Activity at 383.5 uM | Activity at 573.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 3.7924 | 3.15 | 0.963 | 2.3829 | 3.4088 | 3.7221 | 3.7924 | QC'd by MedChem Express | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.2789 | 3.5102 | 1.528 | 1.9238 | 4.6346 | 6.4182 | 1.2789 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.0037 | -4.4248 | -0.615 | -1.2841 | -0.0588 | -4.0514 | 0.0037 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.0131 | -5.3427 | -2.388 | -5.1553 | -1.5524 | -1.7506 | -3.0131 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.373 | 0.8235 | 0.0316 | 2.107 | 1.7002 | -1.9138 | 3.373 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.2123 | -4.9482 | 0.0182 | 2.4902 | -0.0466 | 3.4729 | 2.2123 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -6.8722 | -2.3397 | -1.6401 | -4.488 | -0.7912 | -2.054 | -6.8722 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6887 | 2.9795 | 4.8757 | 2.0264 | 2.2902 | 4.458 | 2.6887 | QC'd by MedChem Express | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.8031 | -1.1794 | -1.5257 | -1.5947 | 1.0625 | -2.7807 | -3.8031 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -10.2079 | -6.2462 | -2.2383 | -3.1976 | -2.6796 | -7.2482 | -10.2079 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.2044 | 1.1558 | 1.2797 | 1.8267 | -0.4088 | 0.0627 | 3.2044 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.9309 | -1.3351 | -3.9232 | -1.9433 | -5.1495 | -5.1305 | -8.9309 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.583 | -2.8916 | -5.1264 | -4.8462 | -1.1066 | 0.1205 | -2.583 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.7511 | 0.2404 | -3.0231 | -3.8049 | -6.4833 | 1.0107 | -2.7511 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.502 | 1.0269 | 0.0012 | 1.2652 | 0.3956 | 0.7999 | -4.502 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.2916 | 1.5967 | 1.7255 | 4.1293 | 0.6629 | 1.259 | 2.2916 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.0438 | -1.4768 | -0.4907 | 0.2776 | 2.287 | -0.8523 | 3.0438 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.3119 | -0.9159 | -1.5721 | -0.7878 | 0.5085 | -2.4781 | -4.3119 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.058 | 5.2803 | 5.2865 | 7.8954 | 10.1632 | 4.5574 | 1.058 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.9292 | -2.6967 | -2.5902 | -0.5082 | 2.8487 | 4.351 | 2.9292 | QC'd by Analyticon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0105 | 87.3903 | 86 | Complete curve; high efficacy | -7.9792 | 1.5579 | 0.9893 | 32.5525 | 119.9428 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 32.5973 | 120.122 | 108.6701 | 92.3587 | 49.688 | 44.8549 | 32.1314 | 33.6031 | 34.7632 | 28.33 | 32.0483 | 32.5973 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0083 | 76.0847 | 86 | Complete curve; high efficacy | -8.0792 | 2.4064 | 0.9788 | 34.0695 | 110.1542 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 24.173 | 108.041 | 107.7583 | 81.9136 | 39.5165 | 42.5568 | 37.701 | 32.5007 | 33.6579 | 37.0598 | 31.0166 | 24.173 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.0187 | 77.5428 | 86 | Complete curve; high efficacy | -7.7292 | 1.7885 | 0.9627 | 34.3529 | 111.8957 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.0008 | 112.3533 | 115.0658 | 89.9199 | 78.4117 | 30.4902 | 34.7307 | 34.3546 | 33.0928 | 38.5201 | 40.8034 | 33.0008 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.059 | 88.7005 | 85 | Complete curve; high efficacy | -7.2292 | 0.6 | 0.9694 | 36.3948 | 125.0953 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 28.5989 | 117.1885 | 119.5312 | 102.4696 | 90.6458 | 85.8623 | 60.6364 | 51.8299 | 52.2662 | 49.7345 | 41.1285 | 28.5989 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0332 | 77.1281 | 85 | Complete curve; high efficacy | -7.4792 | 0.7 | 0.9655 | 31.2029 | 108.331 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.5571 | 101.2018 | 101.2655 | 88.8456 | 70.1845 | 69.8422 | 43.6821 | 40.237 | 39.3066 | 37.258 | 36.4047 | 22.5571 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0187 | 79.8587 | 85 | Complete curve; high efficacy | -7.7292 | 3.5117 | 0.9584 | 32.0611 | 111.9199 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.2093 | 112.4294 | 107.1384 | 115.1252 | 60.4131 | 41.9245 | 37.3163 | 31.476 | 37.277 | 35.9287 | 30.8432 | 13.2093 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 0.0935 | 86.4491 | 85 | Complete curve; high efficacy | -7.0292 | 1.1 | 0.9449 | 37.248 | 123.6972 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 26.2605 | 129.9165 | 117.2503 | 108.9438 | 120.538 | 91.5155 | 51.1197 | 56.1591 | 51.8607 | 42.0573 | 32.8998 | 26.2605 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0209 | 93.1293 | 85 | Complete curve; high efficacy | -7.6792 | 1.4641 | 0.9618 | 33.1188 | 126.2481 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.4794 | 117.474 | 125.7046 | 121.8447 | 67.9661 | 56.0556 | 41.3261 | 42.2157 | 33.9271 | 32.3517 | 29.6972 | 22.4794 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0332 | 100.485 | 85 | Complete curve; high efficacy | -7.4792 | 1 | 0.9707 | 31.2298 | 131.7149 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.5067 | 135.567 | 116.3384 | 110.9262 | 105.2526 | 53.9153 | 47.8749 | 42.0574 | 35.3066 | 32.79 | 30.9695 | 25.5067 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.0296 | 93.4421 | 84 | Complete curve; high efficacy | -7.5292 | 3.9295 | 0.9748 | 23.6719 | 117.114 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.7428 | 100 | 130.2442 | 120.833 | 97.5583 | 27.8225 | 21.548 | 19.8313 | 23.189 | 26.6834 | 24.6437 | 25.7428 | QC'd by SigmaAldrich | |||||||||||||||
| Cytotoxic | 0.3722 | 76.551 | 84 | Complete curve; high efficacy | -6.4292 | 1.21 | 0.9308 | 41.5458 | 118.0968 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 26.8735 | 126.0105 | 102.8329 | 112.503 | 124.3981 | 120.1789 | 87.8304 | 70.2014 | 54.1079 | 49.9172 | 50.885 | 26.8735 | QC'd by ChemieTek | |||||||||||||||
| Cytotoxic | 0.1321 | 81.2414 | 84 | Complete curve; high efficacy | -6.8792 | 4.9549 | 0.9422 | 34.404 | 115.6454 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 26.3475 | 111.8181 | 103.4247 | 109.6276 | 115.8533 | 135.6981 | 44.7754 | 39.681 | 48.6523 | 28.6518 | 29.1124 | 26.3475 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.1482 | 82.7015 | 84 | Complete curve; high efficacy | -6.8292 | 3.9295 | 0.9807 | 32.7831 | 115.4845 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 29.9601 | 112.1327 | 117.5155 | 121.9023 | 104.2805 | 119.0695 | 55.4553 | 42.5564 | 33.0266 | 30.9156 | 28.9386 | 29.9601 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.059 | 76.7002 | 84 | Complete curve; high efficacy | -7.2292 | 1.5095 | 0.9763 | 29.9655 | 106.6658 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.9818 | 106.9151 | 109.4753 | 101.0757 | 90.3292 | 71.8808 | 34.5614 | 30.8078 | 40.7566 | 34.0928 | 28.4921 | 21.9818 | QC'd by SantaCruz Bio | |||||||||||||||
| Cytotoxic | 0.0209 | 88.8023 | 83 | Complete curve; high efficacy | -7.6792 | 3.5117 | 0.9512 | 16.2799 | 105.0822 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 3.7081 | 100.414 | 107.4471 | 102.6609 | 64.9713 | 4.9833 | 9.8401 | 14.9979 | 17.739 | 26.4967 | 34.0224 | 3.7081 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.0418 | 93.5745 | 83 | Complete curve; high efficacy | -7.3792 | 2.1876 | 0.9984 | 17.8156 | 111.39 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.4361 | 109.284 | 114.2073 | 106.6704 | 95.6714 | 45.8603 | 21.918 | 18.8834 | 16.5069 | 16.3283 | 16.9846 | 17.4361 | QC'd by ACC | |||||||||||||||
| Cytotoxic | 0.0833 | 78.2328 | 83 | Complete curve; high efficacy | -7.0792 | 0.8 | 0.9055 | 21.999 | 100.2318 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.1095 | 90.1163 | 103.2646 | 89.0182 | 86.3226 | 67.7142 | 35.3475 | 39.8085 | 35.9143 | 36.9216 | 28.8365 | 2.1095 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0743 | 90.1373 | 83 | Complete curve; high efficacy | -7.1292 | 0.6 | 0.9394 | 23.0787 | 113.2161 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 14.6398 | 104.4157 | 102.1008 | 106.6361 | 85.9834 | 63.3333 | 50.6564 | 40.159 | 53.4023 | 31.9176 | 25.5587 | 14.6398 | QC'd by Axon Medchem | |||||||||||||||
| Cytotoxic | 0.0418 | 84.7687 | 83 | Complete curve; high efficacy | -7.3792 | 1.2221 | 0.9654 | 21.7645 | 106.5332 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 18.8147 | 105.5736 | 99.2727 | 109.2188 | 68.5704 | 62.9029 | 25.883 | 28.2112 | 25.4089 | 22.8606 | 21.0498 | 18.8147 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0469 | 101.0674 | 83 | Complete curve; high efficacy | -7.3292 | 0.9 | 0.9567 | 22.9637 | 124.0311 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 7.6524 | 111.1073 | 130.7357 | 106.6193 | 90.5192 | 65.0382 | 38.8797 | 39.5498 | 34.1324 | 32.2425 | 24.9349 | 7.6524 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.2348 | 112.8849 | 84 | Complete curve; high efficacy | -6.6292 | 0.4 | 0.9392 | 37.0886 | 149.9734 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 47.4866 | 100.2991 | 140.8419 | 123.7999 | 110.5725 | 117.5645 | 87.8253 | 78.2498 | 85.5312 | 67.1052 | 48.088 | 47.4866 | QC'd by SantaCruz Bio | |||||||||||||||
| Cytotoxic | 0.0332 | 135.8677 | 84 | Complete curve; high efficacy | -7.4792 | 0.4 | 0.8686 | 24.8504 | 160.7181 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 9.5856 | 132.6885 | 149.7338 | 116.7486 | 73.7789 | 73.9897 | 69.7305 | 68.0186 | 54.4158 | 55.9508 | 40.4479 | 9.5856 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 2.0931 | 100.1183 | 83 | Complete curve; high efficacy | -5.6792 | 0.4 | 0.9534 | 50.966 | 151.0844 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 67.4421 | 149.8224 | 143.8978 | 144.1774 | 136.6925 | 121.0787 | 121.338 | 115.4935 | 112.6965 | 98.7929 | 74.8281 | 67.4421 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0132 | 104.0082 | 83 | Complete curve; high efficacy | -7.8792 | 1.9282 | 0.9887 | 15.4484 | 119.4565 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.6572 | 119.4565 | 113.3958 | 98.0703 | 46.3447 | 19.7386 | 22.7636 | 17.9014 | 20.6219 | 15.882 | 12.5126 | 4.6572 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0235 | 123.0254 | 83 | Complete curve; high efficacy | -7.6292 | 0.4 | 0.8337 | 19.8641 | 142.8896 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.2641 | 131.0145 | 115.5436 | 90.2951 | 53.9052 | 71.2151 | 62.3387 | 57.1604 | 61.9695 | 14.8102 | 35.3827 | 12.2641 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 0.2093 | 85.2987 | 83 | Complete curve; high efficacy | -6.6792 | 0.7 | 0.9334 | 25.0186 | 110.3173 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 27.0991 | 109.8173 | 117.7375 | 96.0653 | 79.1894 | 96.8309 | 75.5364 | 51.6992 | 33.8263 | 28.1861 | 36.4133 | 27.0991 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 3.3173 | 81.3074 | 83 | Complete curve; high efficacy | -5.4792 | 2.3332 | 0.9315 | 57.6371 | 138.9446 | -1.1 | 0 0 0 0 1 0 0 0 0 0 0 | 49.2543 | 138.4338 | 143.9848 | 151.4142 | 126.0089 | 95.5126 | 125.5596 | 148.3456 | 124.313 | 78.153 | 69.7657 | 49.2543 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0059 | 36.9664 | 82 | Complete curve; partial efficacy | -8.2292 | 2.3332 | 0.9077 | 119.6572 | 156.6236 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 121.5044 | 156.5384 | 152.389 | 136.5428 | 116.1001 | 121.0618 | 114.6459 | 112.3913 | 119.9242 | 122.9008 | 128.5083 | 121.5044 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0235 | 114.2094 | 82 | Complete curve; high efficacy | -7.6292 | 0.5 | 0.9763 | 14.7696 | 128.979 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.4187 | 119.1896 | 95.7224 | 79.6245 | 80.2426 | 57.6913 | 43.0075 | 36.2366 | 30.0952 | 23.1099 | 20.651 | 10.4187 | QC'd by FLUKA | |||||||||||||||
| Cytotoxic | 3.7221 | 80.8703 | 82 | Complete curve; high efficacy | -5.4292 | 4.9549 | 0.9032 | 34.983 | 115.8532 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 31.7555 | 109.5885 | 98.898 | 113.8737 | 107.8306 | 136.1674 | 134.0604 | 103.0938 | 120.47 | 49.9278 | 37.4029 | 31.7555 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0935 | 90.5119 | 82 | Complete curve; high efficacy | -7.0292 | 2.4064 | 0.9076 | 11.9163 | 102.4282 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.6066 | 79.817 | 96.8282 | 103.1563 | 135.2423 | 67.228 | 33.4551 | 13.6779 | 9.6245 | 10.7757 | 11.223 | 12.6066 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1663 | 94.7615 | 82 | Complete curve; high efficacy | -6.7792 | 2.2526 | 0.986 | 16.386 | 111.1475 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.149 | 108.3556 | 124.8245 | 103.3906 | 106.2074 | 102.2469 | 58.7851 | 21.2153 | 18.0773 | 19.6772 | 16.0325 | 13.149 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.5258 | 104.1543 | 82 | Complete curve; high efficacy | -6.2792 | 1 | 0.9414 | 18.3838 | 122.5381 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 11.0314 | 104.3828 | 126.1461 | 116.2417 | 132.0669 | 128.1681 | 83.3544 | 61.5529 | 52.6567 | 32.9587 | 21.7534 | 11.0314 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.1321 | 103.7873 | 82 | Complete curve; high efficacy | -6.8792 | 0.9 | 0.966 | 14.4792 | 118.2664 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.9536 | 125.3305 | 107.6763 | 112.1488 | 100.7026 | 73.0699 | 75.9515 | 28.2884 | 18.6045 | 19.0646 | 16.6527 | 17.9536 | QC'd by Axon Medchem | |||||||||||||||
| Cytotoxic | 0.0132 | 114.5121 | 82 | Complete curve; high efficacy | -7.8792 | 2.0479 | 0.9903 | 14.6838 | 129.1959 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.3585 | 136.7296 | 116.4775 | 107.7082 | 42.6989 | 23.6219 | 11.1681 | 15.7268 | 18.0954 | 13.3214 | 14.3346 | 13.3585 | QC'd by ChemieTek | |||||||||||||||
| Cytotoxic | 0.1321 | 156.0134 | 82 | Complete curve; high efficacy | -6.8792 | 0.4 | 0.9789 | -13.9595 | 142.0539 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.982 | 129.411 | 119.3857 | 103.9503 | 100.8911 | 63.908 | 56.4902 | 49.4204 | 32.4488 | 5.1022 | 3.5537 | 2.982 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 3.7221 | 84.0366 | 82 | Complete curve; high efficacy | -5.4292 | 1.9887 | 0.8892 | 33.1062 | 117.1428 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.583 | 104.9664 | 128.4651 | 118.0164 | 124.0429 | 93.0546 | 124.0918 | 125.7379 | 103.1971 | 56.4284 | 52.5045 | 22.583 | QC'd by XcessBio | |||||||||||||||
| Cytotoxic | 1.3207 | 84.3781 | 82 | Complete curve; high efficacy | -5.8792 | 4.4495 | 0.9108 | 28.6573 | 113.0354 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 50.6955 | 98.1375 | 111.271 | 125.1555 | 106.5195 | 116.7283 | 107.7109 | 122.3031 | 49.8241 | 27.9365 | 5.972 | 50.6955 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.5258 | 93.3798 | 82 | Complete curve; high efficacy | -6.2792 | 2.3332 | 0.983 | 19.1033 | 112.4831 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.8591 | 105.468 | 124.7832 | 114.5473 | 109.601 | 102.2654 | 109.9065 | 61.3632 | 23.8506 | 21.1462 | 20.5224 | 16.8591 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0526 | 98.0552 | 82 | Complete curve; high efficacy | -7.2792 | 1.5095 | 0.9868 | 15.7184 | 113.7736 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.9644 | 114.8405 | 118.2779 | 99.4879 | 95.3835 | 61.4123 | 21.1637 | 23.8746 | 15.9208 | 20.0472 | 11.5883 | 12.9644 | QC'd by Axon Medchem |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0105 | 76.7421 | 98 | Complete curve; high efficacy | -7.9792 | 0.4 | 0.8143 | 106.1488 | 182.891 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 97.0213 | 175.2098 | 149.2496 | 135.4049 | 151.407 | 123.166 | 130.2765 | 116.1855 | 114.3842 | 112.5027 | 122.7118 | 97.0213 | QC'd by SigmaAldrich | |||||||||||||||
| Cytotoxic | 0.0209 | 59.6064 | 90 | Complete curve; high efficacy | -7.6792 | 2.3332 | 0.8743 | 65.0446 | 124.6509 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 42.5491 | 114.2054 | 125.0887 | 133.6383 | 90.3996 | 69.0769 | 75.4333 | 62.8924 | 74.9842 | 66.9826 | 68.2413 | 42.5491 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0187 | 99.3872 | 89 | Complete curve; high efficacy | -7.7292 | 0.7 | 0.9809 | 54.5973 | 153.9845 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 52 | 144.7606 | 143.678 | 116.2189 | 96.5819 | 92.3133 | 70.1166 | 62.4789 | 59.1128 | 61.5841 | 52.5675 | 52 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.4176 | 68.9597 | 88 | Complete curve; high efficacy | -6.3792 | 3.5117 | 0.8951 | 89.8298 | 158.7896 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 95.9522 | 121.7497 | 145.5234 | 145.5172 | 164.4127 | 183.3401 | 150.4309 | 108.3356 | 77.5118 | 95.8824 | 89.8236 | 95.9522 | QC'd by Axon Medchem | |||||||||||||||
| Cytotoxic | 0.5899 | 69.1819 | 88 | Complete curve; high efficacy | -6.2292 | 3.99 | 0.7629 | 95.3406 | 164.5224 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 109.573 | 149.3937 | 173.4718 | 129.8513 | 191.2497 | 150.3213 | 190.3378 | 133.8647 | 83.1872 | 96.4136 | 91.5262 | 109.573 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0743 | 107.0548 | 87 | Complete curve; high efficacy | -7.1292 | 0.8 | 0.9845 | 54.8206 | 161.8754 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 57.9387 | 151.8563 | 163.9611 | 143.7973 | 136.7288 | 112.9196 | 83.162 | 76.8733 | 68.1774 | 53.2269 | 52.6378 | 57.9387 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1482 | 83.5427 | 87 | Complete curve; high efficacy | -6.8292 | 4.4495 | 0.958 | 60.4745 | 144.0173 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 69.2734 | 130.5346 | 130.6652 | 147.3751 | 155.1668 | 153.9418 | 81.6955 | 63.296 | 59.2608 | 55.6163 | 55.5134 | 69.2734 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 1.177 | 117.976 | 87 | Complete curve; high efficacy | -5.9292 | 0.3 | 0.8809 | 103.6252 | 221.6012 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 124.3584 | 204.1012 | 213.7323 | 210.6584 | 195.2614 | 187.4914 | 165.4267 | 159.6533 | 180.5857 | 156.7486 | 132.0473 | 124.3584 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.0059 | 86.112 | 87 | Complete curve; high efficacy | -8.2292 | 3.9295 | 0.9408 | 35.788 | 121.9 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.9728 | 119.2292 | 123.804 | 60.9061 | 49.6123 | 39.0107 | 36.6521 | 41.3552 | 44.3418 | 29.6223 | 31.9796 | 16.9728 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.6619 | 77.7986 | 87 | Complete curve; high efficacy | -6.1792 | 1.4641 | 0.9055 | 87.7533 | 165.5518 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 81.2811 | 136.4201 | 144.0668 | 155.7612 | 179.4399 | 178.5787 | 159.509 | 126.3915 | 103.3855 | 100.1929 | 87.1849 | 81.2811 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1321 | 89.8904 | 86 | Complete curve; high efficacy | -6.8792 | 0.8 | 0.951 | 49.0129 | 138.9033 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 40.8231 | 126.0203 | 148.1813 | 124.8099 | 131.8805 | 103.3715 | 79.0164 | 73.446 | 67.021 | 55.4405 | 53.3845 | 40.8231 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.4176 | 102.2587 | 86 | Complete curve; high efficacy | -6.3792 | 0.9 | 0.9558 | 64.4239 | 166.6826 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 62.0508 | 169.9186 | 163.4857 | 169.1241 | 146.548 | 155.8497 | 143.5232 | 95.5095 | 85.8266 | 89.7822 | 63.0216 | 62.0508 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 1.4818 | 76.0482 | 86 | Complete curve; high efficacy | -5.8292 | 1.6436 | 0.9611 | 86.8287 | 162.8769 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | 82.8262 | 126.6031 | 167.7674 | 148.1546 | 170.4052 | 160.7596 | 163.2256 | 153.9322 | 115.8888 | 102.7391 | 87.3843 | 82.8262 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.935 | 70.2991 | 85 | Complete curve; high efficacy | -6.0292 | 1.1 | 0.9449 | 64.9721 | 135.2712 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 54.1264 | 136.8416 | 133.7919 | 124.0367 | 139.8306 | 136.3935 | 126.542 | 109.4313 | 83.562 | 79.4602 | 79.2579 | 54.1264 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1049 | 113.2337 | 85 | Complete curve; high efficacy | -6.9792 | 1.1 | 0.9467 | 39.4295 | 152.6631 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 32.5405 | 140.1803 | 150.363 | 153.1014 | 157.3692 | 94.8722 | 71.3759 | 73.0522 | 48.5931 | 36.3782 | 39.1494 | 32.5405 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0166 | 145.9135 | 85 | Complete curve; high efficacy | -7.7792 | 0.7 | 0.9824 | 29.6583 | 175.5718 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 34.6378 | 162.9357 | 140.528 | 136.1473 | 83.9944 | 77.3378 | 54.5051 | 36.9278 | 32.9789 | 33.614 | 29.9243 | 34.6378 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.7427 | 87.8078 | 85 | Complete curve; high efficacy | -6.1292 | 1.8265 | 0.89 | 61.3799 | 149.1877 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 43.6517 | 125.4482 | 151.4934 | 151.5693 | 138.7177 | 162.0934 | 165.3929 | 104.4842 | 85.5886 | 70.2374 | 69.1832 | 43.6517 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0026 | 72.1457 | 85 | Complete curve; high efficacy | -8.5792 | 1.2221 | 0.9437 | 24.7418 | 96.8875 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.2124 | 89.7403 | 60.5669 | 40.6941 | 33.8688 | 35.3476 | 27.5307 | 28.4133 | 21.9975 | 21.2917 | 22.4943 | 16.2124 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.935 | 100.6421 | 85 | Complete curve; high efficacy | -6.0292 | 0.7 | 0.923 | 61.7833 | 162.4254 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 57.3523 | 168.1282 | 144.1115 | 151.7026 | 171.4086 | 158.4019 | 133.5552 | 112.5955 | 103.3282 | 85.4669 | 88.3683 | 57.3523 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 2.6351 | 88.8323 | 85 | Complete curve; high efficacy | -5.5792 | 0.8 | 0.9009 | 92.8317 | 181.664 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 98.7032 | 172.664 | 175.775 | 187.4451 | 189.4966 | 178.714 | 170.8024 | 149.3555 | 161.8016 | 111.5356 | 120.777 | 98.7032 | QC'd by Selleck |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Delta TM | = | 5.443 | C | Thermal Shift Assay |
| Delta TM | = | -0.3085 | C | Thermal Shift Assay |
| Delta TM | = | -0.7 | C | |
| Delta TM | = | -0.03 | C | Thermal Shift Assay |
| Delta TM | = | 11.17 | C | Thermal Shift Assay |
| Delta TM | = | -1.553 | C | Thermal Shift Assay |
| Delta TM | = | -0.29 | C | Thermal Shift Assay |
| Delta TM | = | -0.3615 | C | Thermal Shift Assay |
| Delta TM | = | 0.0664 | C | Thermal Shift Assay |
| Delta TM | = | -0.66 | C | |
| Delta TM | = | -0.06 | C | Thermal Shift Assay |
| Delta TM | = | -0.21 | C | Thermal Shift Assay |
| Delta TM | = | -0.26 | C | Thermal Shift Assay |
| Delta TM | = | -1.145 | C | Thermal Shift Assay |
| Delta TM | = | -0.6697 | C | Thermal Shift Assay |
| Delta TM | = | 0 | C | Thermal Shift Assay |
| Delta TM | = | -0.4876 | C | Thermal Shift Assay |
| Delta TM | = | 2.74 | C | Thermal Shift Assay |
| Delta TM | = | 0.22 | C | Thermal Shift Assay |
| Delta TM | = | -0.06 | C | Thermal Shift Assay |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0935 | 83.1337 | 87 | Complete curve; high efficacy | -7.0292 | 0.6 | 0.9732 | 52.9139 | 136.0477 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 54.7559 | 135.1374 | 118.648 | 125.1116 | 118.3367 | 96.3669 | 79.5974 | 75.1495 | 71.3903 | 59.6922 | 54.2396 | 54.7559 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0332 | 111.7251 | 86 | Complete curve; high efficacy | -7.4792 | 0.3 | 0.9262 | 42.1257 | 153.8508 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 51.7825 | 144.6362 | 112.8549 | 103.8285 | 95.2192 | 88.9231 | 87.265 | 80.9661 | 70.7181 | 65.5995 | 53.4647 | 51.7825 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 0.0418 | 82.7514 | 85 | Complete curve; high efficacy | -7.3792 | 0.5 | 0.9759 | 33.8657 | 116.617 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 28.5726 | 108.622 | 98.6869 | 93.7987 | 83.8286 | 67.4168 | 56.4383 | 56.9697 | 48.1109 | 46.3428 | 37.7443 | 28.5726 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0296 | 92.0907 | 85 | Complete curve; high efficacy | -7.5292 | 0.5 | 0.9383 | 35.476 | 127.5667 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 29.5556 | 114.1336 | 120.8945 | 88.7261 | 81.5755 | 76.2025 | 54.6824 | 55.6484 | 57.3045 | 45.911 | 37.1374 | 29.5556 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.1865 | 70.3869 | 84 | Complete curve; high efficacy | -6.7292 | 2.7202 | 0.9761 | 38.0815 | 108.4684 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 47.1917 | 108.8739 | 108.2531 | 101.5408 | 112.4163 | 108.1385 | 70.3357 | 43.6652 | 34.5392 | 28.361 | 41.6648 | 47.1917 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.4176 | 71.6673 | 84 | Complete curve; high efficacy | -6.3792 | 2.4064 | 0.9479 | 43.4067 | 115.074 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.3089 | 105.574 | 126.981 | 118.3238 | 117.612 | 103.7019 | 109.6834 | 63.4438 | 52.5864 | 53.6306 | 39.1222 | 33.3089 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.1049 | 108.1591 | 84 | Complete curve; high efficacy | -6.9792 | 0.3 | 0.955 | 31.5875 | 139.7466 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 43.3364 | 131.0144 | 114.5692 | 101.7563 | 97.1956 | 81.0289 | 79.2851 | 79.034 | 69.8399 | 55.065 | 52.7031 | 43.3364 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0166 | 112.884 | 83 | Complete curve; high efficacy | -7.7792 | 2.7202 | 0.9889 | 16.1533 | 129.0373 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.2676 | 116.3272 | 134.3166 | 126.0141 | 55.7945 | 23.8385 | 15.9339 | 16.9523 | 14.5303 | 14.2658 | 15.8321 | 13.2676 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.4686 | 94.7258 | 83 | Complete curve; high efficacy | -6.3292 | 0.6 | 0.9557 | 29.0284 | 123.7542 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 35.6827 | 133.5399 | 103.9822 | 117.9539 | 112.0859 | 105.559 | 83.2992 | 74.0842 | 64.5113 | 41.0297 | 41.6372 | 35.6827 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2635 | 100.8755 | 83 | Complete curve; high efficacy | -6.5792 | 0.9 | 0.8969 | 25.7615 | 126.637 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.542 | 104.9981 | 131.3946 | 122.3505 | 135.6872 | 112.05 | 66.0485 | 57.8396 | 53.7976 | 41.5332 | 37.9975 | 4.542 | QC'd by ChemAxon | |||||||||||||||
| Cytotoxic | 0.0469 | 103.2658 | 83 | Complete curve; high efficacy | -7.3292 | 1.4787 | 0.9945 | 24.4756 | 127.7413 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.0142 | 133.8948 | 120.7681 | 119.4508 | 105.6156 | 65.7525 | 34.7398 | 31.8181 | 24.4769 | 24.1709 | 24.9208 | 22.0142 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.4686 | 92.4712 | 83 | Complete curve; high efficacy | -6.3292 | 2.3332 | 0.972 | 28.9592 | 121.4304 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 29.8907 | 112.9759 | 141.5986 | 120.5517 | 113.8929 | 115.8225 | 112.4976 | 62.8706 | 33.5238 | 28.9592 | 28.8711 | 29.8907 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2348 | 89.2044 | 83 | Complete curve; high efficacy | -6.6292 | 1.4641 | 0.9775 | 29.1453 | 118.3497 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 30.577 | 122.3185 | 120.0124 | 103.9641 | 116.9025 | 116.6825 | 75.5785 | 53.397 | 29.7764 | 27.6303 | 31.594 | 30.577 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 2.6351 | 88.3639 | 83 | Complete curve; high efficacy | -5.5792 | 1 | 0.8333 | 53.4354 | 141.7993 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 69.1826 | 150.707 | 126.8073 | 140.1173 | 122.6532 | 128.5218 | 127.1755 | 136.3873 | 123.3444 | 63.4982 | 61.6305 | 69.1826 | QC'd by Chemscene | |||||||||||||||
| Cytotoxic | 1.049 | 94.6969 | 82 | Complete curve; high efficacy | -5.9792 | 1.9282 | 0.9864 | 26.5166 | 121.2135 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 22.4036 | 111.8163 | 115.5011 | 118.7274 | 126.8177 | 125.7155 | 124.4111 | 99.2392 | 53.4896 | 34.1597 | 26.654 | 22.4036 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.1321 | 81.4391 | 82 | Complete curve; high efficacy | -6.8792 | 1 | 0.9705 | 13.2025 | 94.6416 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 6.2699 | 84.6416 | 100.2144 | 88.0054 | 89.8294 | 66.8701 | 45.1052 | 25.589 | 27.2655 | 21.168 | 10.1269 | 6.2699 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0833 | 92.8523 | 82 | Complete curve; high efficacy | -7.0792 | 0.4 | 0.9706 | 12.2421 | 105.0944 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 15.2318 | 97.3014 | 84.0705 | 87.115 | 64.4661 | 59.8416 | 48.8602 | 38.5001 | 40.2779 | 31.4269 | 21.9661 | 15.2318 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0235 | 80.8069 | 82 | Complete curve; high efficacy | -7.6292 | 0.6 | 0.9889 | 14.6909 | 95.4978 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 11.7976 | 88.1312 | 84.022 | 66.5827 | 54.9265 | 41.2161 | 33.272 | 29.0748 | 23.7083 | 16.2035 | 15.8475 | 11.7976 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0012 | 59.1239 | 82 | Complete curve; partial efficacy | -8.9292 | 4.9549 | 0.8587 | 99.4449 | 158.5687 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 103.2631 | 152.6148 | 94.4922 | 95.0001 | 94.3426 | 94.4109 | 100.4664 | 111.3588 | 107.5709 | 103.8685 | 92.1541 | 103.2631 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.4176 | 94.6905 | 82 | Complete curve; high efficacy | -6.3792 | 2.1876 | 0.9861 | 24.3029 | 118.9934 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.4583 | 113.0531 | 121.9635 | 115.8336 | 128.0296 | 109.3466 | 109.2746 | 55.2918 | 34.1038 | 26.5126 | 20.0235 | 21.4583 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.1482 | 96.1905 | 85 | Complete curve; high efficacy | -6.8292 | 3.9295 | 0.9924 | 44.5048 | 140.6953 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 37.5464 | 136.9515 | 141.9942 | 144.5132 | 137.0086 | 139.2747 | 69.4708 | 50.2051 | 43.4747 | 41.4134 | 50.9304 | 37.5464 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 0.0129 | 83.5366 | 84 | Complete curve; high efficacy | -7.8904 | 1.4787 | 0.9978 | 23.8147 | 107.3513 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 23.9151 | 110.1823 | 102.3434 | 96.9951 | 70.7527 | 40.6202 | 28.66 | 25.8815 | 24.6553 | 21.8719 | 25.2135 | 23.9151 | QC'd by Chemscene | |||||||||||||||
| Cytotoxic | 0.0235 | 92.4647 | 84 | Complete curve; high efficacy | -7.6292 | 1.9673 | 0.9567 | 23.2254 | 115.6902 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.0573 | 111.7434 | 116.8232 | 109.3919 | 75.4472 | 32.9909 | 33.7059 | 30.0263 | 30.2649 | 32.1706 | 12.7685 | 4.0573 | QC'd by ChemieTek | |||||||||||||||
| Cytotoxic | 0.2881 | 75.8805 | 84 | Complete curve; high efficacy | -6.5404 | 1.8265 | 0.9683 | 41.6685 | 117.5491 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 36.3204 | 119.5479 | 107.4971 | 113.5971 | 126.3084 | 112.3175 | 118.4846 | 79.9745 | 45.9661 | 45.1223 | 48.3071 | 36.3204 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.2957 | 81.0096 | 84 | Complete curve; high efficacy | -6.5292 | 3.1925 | 0.9261 | 40.4734 | 121.483 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 11.322 | 115.4342 | 118.2478 | 121.3497 | 132.2979 | 117.0883 | 107.0927 | 49.9135 | 46.6548 | 51.6487 | 50.6374 | 11.322 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||
| Cytotoxic | 0.2635 | 116.5095 | 84 | Complete curve; high efficacy | -6.5792 | 0.6 | 0.9706 | 41.249 | 157.7585 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 40.8193 | 148.2389 | 152.8144 | 145.5181 | 150.8832 | 117.9007 | 95.7355 | 82.3682 | 80.7695 | 61.7212 | 51.1085 | 40.8193 | QC'd by Toronto Research | |||||||||||||||
| Cytotoxic | 0.0526 | 88.208 | 83 | Complete curve; high efficacy | -7.2792 | 1.2876 | 0.9942 | 23.4223 | 111.6302 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.5003 | 110.0308 | 111.5061 | 103.8454 | 94.6012 | 59.3844 | 38.8394 | 30.8492 | 24.8325 | 26.4131 | 22.2217 | 17.5003 | QC'd by LC Labs | |||||||||||||||
| Cytotoxic | 0.0526 | 75.9024 | 83 | Complete curve; high efficacy | -7.2792 | 2.0479 | 0.9737 | 21.1749 | 97.0774 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 18.3476 | 101.8034 | 86.0254 | 99.4825 | 90.0803 | 50.3844 | 29.2288 | 30.8578 | 23.3748 | 16.2456 | 14.5431 | 18.3476 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0526 | 79.9256 | 83 | Complete curve; high efficacy | -7.2792 | 1.3723 | 0.9663 | 23.9977 | 103.9232 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.6139 | 98.4232 | 100.1087 | 114.2863 | 77.5004 | 61.6508 | 32.0154 | 31.6054 | 25.7323 | 23.8408 | 27.9084 | 17.6139 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0209 | 90.4807 | 83 | Complete curve; high efficacy | -7.6792 | 0.9 | 0.9775 | 17.1515 | 107.6322 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 6.4719 | 96.9766 | 103.3615 | 85.5749 | 58.3174 | 41.0676 | 31.1754 | 22.0076 | 23.023 | 21.4144 | 19.2811 | 6.4719 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0053 | 93.6423 | 83 | Complete curve; high efficacy | -8.2792 | 1 | 0.9697 | 14.5291 | 108.1714 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.1496 | 99.2849 | 81.9982 | 49.1336 | 31.0686 | 31.2874 | 22.5896 | 21.2096 | 13.4352 | 11.2475 | 10.2585 | 8.1496 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0148 | 94.6905 | 83 | Complete curve; high efficacy | -7.8292 | 1.1705 | 0.982 | 17.423 | 112.1135 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.0947 | 103.9614 | 109.0536 | 82.8529 | 55.0007 | 27.8871 | 30.3566 | 24.6009 | 18.1235 | 14.688 | 13.7931 | 12.0947 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0935 | 96.6424 | 83 | Complete curve; high efficacy | -7.0292 | 1.6604 | 0.9922 | 24.5734 | 121.2158 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.6091 | 121.7166 | 119.6038 | 122.5533 | 110.0231 | 90.718 | 41.6609 | 37.9316 | 22.3882 | 22.6779 | 22.4003 | 25.6091 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0469 | 82.9678 | 83 | Complete curve; high efficacy | -7.3292 | 4.9549 | 0.9179 | 22.6763 | 105.644 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 2.6388 | 101.9106 | 107.1814 | 103.9277 | 109.2884 | 34.5811 | 38.9659 | 38.5481 | 33.3514 | 23.3035 | 2.6195 | 2.6388 | QC'd by NCI | |||||||||||||||
| Cytotoxic | 0.0296 | 105.7871 | 83 | Complete curve; high efficacy | -7.5292 | 0.5 | 0.8834 | 22.0136 | 127.8007 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.7056 | 117.0952 | 117.3948 | 102.7791 | 58.6408 | 55.6178 | 51.2518 | 52.8649 | 46.0625 | 39.7928 | 25.4459 | 4.7056 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0209 | 126.3344 | 83 | Complete curve; high efficacy | -7.6792 | 0.8 | 0.989 | 17.1119 | 143.4463 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 16.0678 | 134.7593 | 122.167 | 111.5868 | 76.2473 | 54.6662 | 37.3452 | 23.489 | 31.1023 | 10.6587 | 18.9539 | 16.0678 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 0.0074 | 100.2703 | 83 | Complete curve; high efficacy | -8.1292 | 2.0479 | 0.9936 | 16.8213 | 117.0916 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 23.4575 | 117.6101 | 105.1974 | 73.0401 | 25.8505 | 13.918 | 14.8472 | 15.0411 | 16.0162 | 16.5042 | 18.3596 | 23.4575 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0235 | 108.8889 | 82 | Complete curve; high efficacy | -7.6292 | 0.7 | 0.994 | 11.7255 | 120.6144 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 13.4791 | 114.5312 | 97.3221 | 86.1436 | 74.135 | 46.9964 | 29.7854 | 23.381 | 15.473 | 13.1449 | 13.4733 | 13.4791 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.0235 | 110.596 | 82 | Complete curve; high efficacy | -7.6292 | 1.6266 | 0.9764 | 12.0566 | 122.6526 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.2889 | 128.4612 | 120.2462 | 94.575 | 86.249 | 20.7415 | 16.1119 | 13.6858 | 12.9514 | 13.591 | 13.5681 | 12.2889 | QC'd by FLUKA | |||||||||||||||
| Cytotoxic | 0.0418 | 84.2481 | 82 | Complete curve; high efficacy | -7.3792 | 0.8 | 0.9425 | 13.6326 | 97.8807 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 6.9077 | 82.5934 | 102.655 | 86.9085 | 64 | 41.114 | 32.793 | 28.1192 | 27.8185 | 19.7373 | 7.4804 | 6.9077 | QC'd by Otava |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Delta TM | = | 2.866 | C | Thermal Shift Assay |
| Delta TM | = | -0.1161 | C | Thermal Shift Assay |
| Delta TM | = | 0.32 | C | |
| Delta TM | = | 0.12 | C | Thermal Shift Assay |
| Delta TM | = | 1.321 | C | Thermal Shift Assay |
| Delta TM | = | -0.3289 | C | Thermal Shift Assay |
| Delta TM | = | 0.97 | C | Thermal Shift Assay |
| Delta TM | = | -0.00477 | C | Thermal Shift Assay |
| Delta TM | = | 0.8545 | C | Thermal Shift Assay |
| Delta TM | = | 0.25 | C | |
| Delta TM | = | 0.05 | C | Thermal Shift Assay |
| Delta TM | = | 0.01 | C | Thermal Shift Assay |
| Delta TM | = | 0.57 | C | Thermal Shift Assay |
| Delta TM | = | -0.2514 | C | Thermal Shift Assay |
| Delta TM | = | -0.09405 | C | Thermal Shift Assay |
| Delta TM | = | 0.1211 | C | Thermal Shift Assay |
| Delta TM | = | 0.2152 | C | Thermal Shift Assay |
| Delta TM | = | 4.95 | C | Thermal Shift Assay |
| Delta TM | = | 0.78 | C | Thermal Shift Assay |
| Delta TM | = | 0.49 | C | Thermal Shift Assay |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.347 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.717 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.13 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -4.4 | 4.9549 | 0.7 | -26.5489 | -2.5 | 4 | 0 0 0 0 | -18.7908 | -9.9553 | 1.4556 | 1.5083 | -18.7908 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -6.3 | 4.9549 | 0.8372 | 0.7335 | 13 | 4 | 0 0 0 0 | 3.8783 | 11.0087 | 0 | -1.4721 | 3.8783 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | -7.0767 | 0 | 0 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -6.3 | 4.9549 | 0.4226 | 2.5 | -6.0532 | 4 | 0 0 0 1 | -1.1886 | -4.6277 | 7.6987 | -2.282 | -1.1886 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -4.85 | 4.095 | 0.9177 | -14.9072 | 3 | 4 | 0 0 0 0 | -14.0893 | 5.8884 | 0 | 0 | -14.0893 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -4.45 | 4.9549 | 0.9565 | 7 | -5.2106 | 4 | 0 0 0 0 | 4.4674 | -6.4255 | -3.9724 | -5.7764 | 4.4674 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.1862 | -0.5632 | 8.2671 | 9.2494 | 5.1862 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -6.3 | 4.9549 | 0.6755 | -15.5767 | 3.5 | 4 | 0 0 0 1 | 0 | 0 | -21.7306 | -9.3152 | 0 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -4.45 | 4.9549 | 0.6676 | -12.8912 | 3 | 4 | 0 0 0 0 | -9.4927 | 0 | 0 | 9.4652 | -9.4927 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -6.3 | 4.9549 | 0.3745 | -10.5729 | 14 | 4 | 0 0 0 1 | 4.1396 | 10.0525 | -25.8941 | 4.7866 | 4.1396 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.6711 | 2.7533 | 3.7028 | 0 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.6287 | -7.1208 | -7.4233 | 1.4494 | -3.6287 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.35 | 4.9549 | 0.7286 | 10.5 | -0.4715 | 4 | 0 0 0 0 | 8.002 | 3.2258 | -4.5596 | 13.1472 | 8.002 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -5.75 | 2.3332 | 0.9993 | -13.3247 | 15.5 | 4 | 0 0 0 1 | 14.8748 | 14.9002 | 0 | -12.7706 | 14.8748 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -5.4 | 4.9549 | 0.7927 | 9 | -1.1062 | 4 | 0 0 0 0 | 5.9401 | 0.6656 | -3.0052 | 11.9289 | 5.9401 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6019 | 0 | 0 | 0 | 2.6019 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.4483 | -2.3916 | -0.3049 | 2.6987 | 3.4483 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | -0.5979 | 3.0488 | 2.099 | 0 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3887 | 9.716 | 11.4329 | 13.4933 | 4.3887 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | -6.893 | 0 | 0 | QC'd by Sytravon |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0002299000 uM | Activity at 0.0009353959 uM | Activity at 0.00184 uM | Activity at 0.00468 uM | Activity at 0.00919 uM | Activity at 0.016 uM | Activity at 0.027 uM | Activity at 0.051 uM | Activity at 0.092 uM | Activity at 0.155 uM | Activity at 0.256 uM | Activity at 0.462 uM | Activity at 0.846 uM | Activity at 1.283 uM | Activity at 2.310 uM | Activity at 4.246 uM | Activity at 6.551 uM | Activity at 11.58 uM | Activity at 25.26 uM | Activity at 38.52 uM | Activity at 57.54 uM | Activity at 116.1 uM | Activity at 221.6 uM | Activity at 288.3 uM | Panel ID | Panel Name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0.0891 | 20.4377 | 0 | -7.05 | 4.9549 | 0.5243 | 16 | -4.4377 | 4 | 0 0 0 0 0 | 13.1195 | -1.6147 | 23.0221 | 4.9232 | 22.4364 | 13.1195 | 3 | PA-1 | |||||||||||||||||||||
| Inactive | 0.5012 | 19.512 | 0 | -6.3 | 4.5045 | 0.9837 | 2.5 | -17.012 | 4 | 0 0 0 0 0 | 4.6148 | -17.0933 | -15.139 | 2.0203 | 0.9631 | 4.6148 | 4 | SKOV3 | |||||||||||||||||||||
| Inactive | 0.0891 | 10.1784 | 0 | -7.05 | 4.9549 | 0.4664 | -7.6784 | 2.5 | 4 | 0 0 0 0 0 | -7.2247 | 0.9983 | -11.3986 | -10.48 | -0.961 | -7.2247 | 5 | C33A | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 6.8018 | -1.7943 | 7.9288 | 7.7169 | 7.1557 | 6.8018 | 6 | JEG-3 | ||||||||||||||||||||||||||
| Inactive | 0.631 | 5.8754 | 0 | -6.2 | 4.9549 | 0.6533 | 5 | -0.8754 | 4 | 0 0 0 0 0 | 4.9978 | 0.7404 | -1.9795 | 8.0951 | 2.3607 | 4.9978 | 7 | Es-2 | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -1.5659 | 2.9339 | -4.8958 | -4.7951 | 1.5969 | -1.5659 | 8 | Hek293T | ||||||||||||||||||||||||||
| Inactive | 0.0891 | 9.995 | 0 | -7.05 | 4.9549 | 0.3786 | -7.495 | 2.5 | 4 | 0 0 0 0 0 | -5.4128 | 1.1477 | -11.5205 | -0.3743 | -12.9125 | -5.4128 | 9 | Tov112D | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -3.2957 | 3.8308 | 1.4062 | -4.436 | -2.7163 | -3.2957 | 10 | Tov-21-G | ||||||||||||||||||||||||||
| Inactive | 0.7079 | 14.6604 | 0 | -6.15 | 4.9549 | 0.9994 | 11.5 | -3.1604 | 4 | 0 0 0 0 1 | 1.8313 | -3.0503 | -3.0355 | 11.1111 | 11.2024 | 1.8313 | 11 | OV90 | |||||||||||||||||||||
| Inactive | 2.5119 | 11.0392 | 0 | -5.6 | 1.6259 | 0.9918 | 4.5 | -6.5392 | 4 | 0 0 0 0 0 | 4.3244 | -5.7563 | -6.6993 | -3.0441 | 3.0217 | 4.3244 | 12 | CASKI | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 4.0002 | 9.2609 | 1.7307 | 16.1689 | 8.2706 | 4.0002 | 1 | CAOV3 | ||||||||||||||||||||||||||
| Inactive | 0.1 | 12.4224 | 0 | -7 | 1.6436 | 0.8881 | -1.9224 | 10.5 | 4 | 0 0 0 0 0 | -4.5186 | 7.7607 | 0.4819 | -0.6217 | -0.7957 | -4.5186 | 2 | HeLa | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 9.027 | 13.2513 | 1.7412 | 13.5275 | 17.6857 | 9.027 | 3 | PA-1 | ||||||||||||||||||||||||||
| Inactive | 0.3162 | 18 | 0 | -6.5 | 4.4495 | 0.9637 | 7 | 25 | 4 | 0 0 0 0 1 | 19.6871 | 25.2034 | 21.5131 | 5.0173 | 9.4271 | 19.6871 | 4 | SKOV3 | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0.3369 | 0.4452 | -0.9125 | 5.7292 | 4.44 | 0.3369 | 5 | C33A | ||||||||||||||||||||||||||
| Inactive | 0.0631 | 10.5 | 0 | -7.2 | 4.9549 | 0.8451 | 2 | 12.5 | 4 | 0 0 0 0 0 | 1.0879 | 10.8386 | 0.1902 | 2.4619 | 4.6395 | 1.0879 | 6 | JEG-3 | |||||||||||||||||||||
| Inactive | 0.5012 | 9.5598 | 0 | -6.3 | 4.9549 | 0.9517 | 0 | -9.5598 | 4 | 0 0 0 0 0 | -0.0179 | -8.4158 | -10.4665 | 0.9667 | -1.2439 | -0.0179 | 7 | Es-2 | |||||||||||||||||||||
| Inactive | 0.0631 | 14.8119 | 0 | -7.2 | 4.9549 | 0.534 | -5.8119 | 9 | 4 | 0 0 0 0 1 | 0.2814 | 6.5861 | -12.7599 | 1.4268 | -6.0897 | 0.2814 | 8 | Hek293T | |||||||||||||||||||||
| Inactive | 8.9125 | 8.541 | 0 | -5.05 | 4.045 | 0.614 | 8 | -0.541 | 4 | 0 0 0 0 0 | 7.7519 | 3.7595 | -4.2009 | -0.5734 | 0.6635 | 7.7519 | 9 | Tov112D | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 1.0625 | -0.4666 | 0.2533 | -1.2691 | -7.1333 | 1.0625 | 10 | Tov-21-G |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 9.3597 | 0 | 0 | 0 | 0 | 0 | 2.2289 | 0 | 9.3597 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.8748 | -21.4867 | 4 | 4 | 0 0 0 0 0 0 0 0 | -17.0722 | 6.1042 | 2.8293 | 0 | 7.4025 | 0 | 6.1286 | 5.2151 | -17.0722 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -8.275 | 1.1705 | 0.6611 | 2 | -6.667 | 4 | 0 0 0 0 0 0 0 0 | -1.0776 | -6.3892 | -2.9698 | -1.7372 | 5.874 | 0.3532 | 2.419 | 2.3477 | -1.0776 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | -4.425 | 4.9549 | 0.4933 | -23.5282 | -3 | 4 | 0 0 0 0 0 0 0 0 | -17.9402 | 0.3948 | -8.1012 | -10.4184 | -5.5544 | 1.8102 | -4.7765 | 5.7051 | -17.9402 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 7.8331 | 0 | 0 | 9.3496 | 0 | 8.3936 | 8.8574 | 0 | QC'd by Sequoia | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.1346 | 2.0873 | 2.8787 | 2.1981 | 0 | 1.0717 | 0 | 0 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.7477 | 0 | 7.719 | 6.3706 | 0 | 0 | 0 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3259 | 8.1273 | 0 | 0 | 7.3085 | 6.1485 | 9.7634 | 0 | 1.3259 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -6.775 | 4.9549 | 0.7871 | -25.4234 | -14.7892 | 4 | 1 0 0 0 0 0 0 1 | -14.8266 | -40.4001 | -18.8558 | -14.3881 | -11.9076 | -28.2695 | -23.675 | -23.6904 | -14.8266 | QC'd by Microsource | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 3.2238 | 5.3823 | 0 | 7.5034 | 0 | 0 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.4377 | -10.0741 | 2 | 4 | 0 0 0 0 0 0 0 0 | -7.9784 | 0 | 0 | 6.8904 | -2.1283 | 0 | 0.7614 | 9.8865 | -7.9784 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1184 | 4.7394 | 4.4107 | -0.6138 | 5.1674 | 0 | 2.3218 | -1.3941 | -2.1184 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0.2342 | 2.9725 | 5.1318 | 0 | 2.0235 | 0 | 0.0589 | 0 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -8.725 | 0.6 | 0.7945 | 4.5 | -11.9886 | 4 | 0 0 0 0 0 0 0 1 | -9.0185 | -8.3238 | -0.4567 | 0.9031 | 0.0721 | 3.3394 | 7.7262 | 3.0826 | -9.0185 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -9.125 | 4.9549 | 0.5569 | 5 | -5.3552 | 4 | 0 0 0 0 0 0 0 1 | -2.6103 | -2.796 | 6.9995 | 3.4228 | 1.6101 | 8.0983 | 7.0134 | 2.0138 | -2.6103 | QC'd by Specs | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.9896 | 0 | 0 | 9.6344 | 0 | 0 | 4.2786 | 0 | 0.9896 | QC'd by GVK | ||||||||||||||||||||||||||
| Inactive | 0 | -5.525 | 4.095 | 0.6337 | -3.6963 | 3 | 4 | 0 0 0 0 0 0 0 0 | -3.4671 | 3.2926 | 6.7211 | 0 | 4.9171 | 0 | 2.2046 | -3.4969 | -3.4671 | QC'd by Prestwick | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.1269 | 3.0732 | 0 | 6.5383 | 2.8274 | 0 | -3.4128 | 8.3114 | 3.1269 | QC'd by Labotest | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 2.578 | 6.6592 | 0 | 0 | 0 | 3.3663 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6761 | 0 | 0 | 8.9375 | 0 | 0 | 0.408 | 0 | 2.6761 | QC'd by Prestwick Chemical; Inc. |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.0015 | 95.0131 | 100 | Complete curve; high efficacy | -8.8295 | 4.9549 | 0.995 | -92.9859 | 2.0272 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.2587 | -1.6791 | -84.9271 | -90.9202 | -90.8631 | -90.7375 | -92.2911 | -92.6732 | -94.1019 | -94.0673 | -96.0913 | -96.2587 | QC'd by SIGMA | ||||||||||||||||
| Inhibitor | 0.0017 | 96.0144 | 100 | Complete curve; high efficacy | -8.7683 | 3.2475 | 0.9987 | -95.3786 | 0.6358 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9294 | 1.7123 | -0.1391 | -34.4453 | -93.3159 | -93.9442 | -94.1795 | -94.3745 | -94.7424 | -94.9325 | -95.6129 | -96.9294 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0017 | 101.1335 | 100 | Complete curve; high efficacy | -8.7683 | 4.5045 | 0.9988 | -96.4557 | 4.6778 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.6254 | 2.9383 | 5.3252 | -23.8352 | -93.6078 | -94.3407 | -94.7755 | -96.5382 | -96.9802 | -98.093 | -97.488 | -98.6254 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0014 | 95.7664 | 100 | Complete curve; high efficacy | -8.8683 | 3.0654 | 0.9932 | -91.7312 | 4.0352 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3736 | 0 | 6.5073 | -50.3576 | -85.2142 | -89.4583 | -90.3553 | -90.6328 | -93.2878 | -91.6178 | -92.6738 | -94.3736 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0027 | 92.0567 | 99 | Complete curve; high efficacy | -8.575 | 3.99 | 0.9971 | -93.082 | -1.0254 | -1.1 | 0 0 0 0 0 0 0 0 | -97.5703 | -1.153 | -56.5542 | -91.9507 | -92.331 | -93.0234 | -92.9105 | -92.2466 | -97.5703 | QC'd by Alfa Aesar | |||||||||||||||||||
| Inhibitor | 0.0027 | 86.1528 | 99 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9984 | -92.0573 | -5.9045 | -1.1 | 0 0 0 0 0 0 0 0 | -92.9872 | -5.0961 | -62.3948 | -91.5014 | -91.2009 | -92.0539 | -90.8793 | -91.9519 | -92.9872 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.0021 | 98.4878 | 99 | Complete curve; high efficacy | -8.675 | 4.5045 | 0.9983 | -91.9795 | 6.5083 | -1.1 | 0 0 0 0 0 0 0 0 | -94.0485 | 5.8681 | -73.3835 | -89.9758 | -90.798 | -91.9458 | -91.2065 | -93.7497 | -94.0485 | QC'd by Bosche | |||||||||||||||||||
| Inhibitor | 7.0E-4 | 82.7334 | 99 | Complete curve; high efficacy | -9.175 | 0.6 | 0.8847 | -82.6567 | 0.0767 | -1.1 | 0 0 0 0 0 0 0 0 | -94.3569 | -37.5208 | -62.7186 | -72.7916 | -74.3825 | -79.8918 | -76.6331 | -78.5528 | -94.3569 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0037 | 95.0819 | 99 | Complete curve; high efficacy | -8.4362 | 1.2221 | 0.9994 | -94.5205 | 0.5614 | -1.1 | 0 0 0 0 0 0 0 | -93.7704 | -1.1631 | 0.6157 | -11.9264 | -47.6173 | -82.383 | -92.7843 | -93.7704 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 0.0033 | 94.0479 | 99 | Complete curve; high efficacy | -8.4795 | 3.5117 | 0.9958 | -93.9623 | 0.0856 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.8774 | 1.2665 | -23.1756 | -88.8678 | -90.2585 | -91.8229 | -92.3997 | -94.1271 | -95.2991 | -93.6757 | -95.8566 | -97.8774 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0047 | 102.0075 | 98 | Complete curve; high efficacy | -8.3295 | 2.2481 | 0.997 | -94.1763 | 7.8312 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.7173 | 5.6987 | -9.7434 | -65.3554 | -90.638 | -91.2058 | -92.371 | -92.7427 | -94.2549 | -94.3053 | -96.979 | -98.7173 | QC'd by GVK | ||||||||||||||||
| Inhibitor | 0.0047 | 100.429 | 98 | Complete curve; high efficacy | -8.325 | 3.6772 | 0.9994 | -93.2276 | 7.2013 | -1.1 | 0 0 0 0 0 0 0 0 | -94.7435 | 8.1328 | -8.6557 | -90.5176 | -92.1158 | -93.5383 | -93.4255 | -92.4974 | -94.7435 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 0.0038 | 96.7634 | 98 | Complete curve; high efficacy | -8.425 | 3.99 | 0.9994 | -92.0205 | 4.743 | -1.1 | 0 0 0 0 0 0 0 0 | -93.5167 | 4.0536 | -21.1619 | -91.8053 | -91.1174 | -91.9789 | -90.7784 | -91.2901 | -93.5167 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0045 | 90.5397 | 98 | Complete curve; high efficacy | -8.3466 | 4.5045 | 0.9995 | -92.4565 | -1.9167 | -1.1 | 0 0 0 0 0 0 0 | -93.156 | -4.128 | -89.5728 | -91.2217 | -93.3904 | -92.524 | -93.0057 | -93.156 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.2987 | 98 | Complete curve; high efficacy | -8.288 | 4.9549 | 0.9993 | -92.6581 | 5.6406 | -1.1 | 0 0 0 0 0 0 0 | -93.5941 | 0 | -91.9394 | -91.381 | -91.3804 | -93.5391 | -93.3571 | -93.5941 | QC'd by ChemieTek | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.8546 | 98 | Complete curve; high efficacy | -8.288 | 0.6 | 0.9861 | -94.1197 | 4.7349 | -1.1 | 0 0 0 0 0 0 0 | -93.9318 | -33.6729 | -64.3585 | -76.1096 | -84.2151 | -92.4038 | -93.1111 | -93.9318 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 0.004 | 86.0426 | 98 | Complete curve; high efficacy | -8.3992 | 4.5045 | 0.9996 | -92.288 | -6.2454 | -1.1 | 0 0 0 0 0 0 0 | -91.795 | -7.0299 | -86.4668 | -91.4418 | -93.2202 | -92.6549 | -92.4417 | -91.795 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0046 | 98.0203 | 98 | Complete curve; high efficacy | -8.338 | 3.5117 | 0.9996 | -93.1684 | 4.8519 | -1.1 | 0 0 0 0 0 0 0 | -93.7644 | -11.8828 | -91.4502 | -92.2553 | -94.1095 | -92.9439 | -93.2642 | -93.7644 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 0.0042 | 104.4497 | 98 | Complete curve; high efficacy | -8.3795 | 4.9549 | 0.9968 | -93.9204 | 10.5293 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.6259 | 8.6675 | 7.5142 | -90.2575 | -91.0844 | -91.1114 | -92.6871 | -93.2743 | -95.4523 | -94.079 | -95.5345 | -96.6259 | QC'd by BioAustralis | ||||||||||||||||
| Inhibitor | 0.0042 | 94.9421 | 98 | Complete curve; high efficacy | -8.3795 | 2.8473 | 0.9968 | -94.7591 | 0.183 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9399 | 0.6808 | -16.1375 | -78.234 | -91.1234 | -91.9081 | -92.3507 | -95.4781 | -97.4887 | -95.7111 | -95.4747 | -96.9399 | QC'd by ActiveBioChem |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.008 | 82.2034 | 84 | Complete curve; high efficacy | -8.0992 | 1.01 | 0.9669 | 21.0427 | 103.2462 | -1.1 | 0 0 0 0 0 0 0 | 13.1884 | 95.4748 | 59.0672 | 35.8423 | 31.6652 | 21.9238 | 22.0706 | 13.1884 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 81.0572 | 83 | Complete curve; high efficacy | -7.5862 | 4.9549 | 0.923 | 16.4972 | 97.5544 | -1.1 | 0 0 0 0 0 0 0 | 2.5125 | 97.0035 | 93.2685 | 8.947 | 36.6707 | 23.4209 | 12.5374 | 2.5125 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.8199 | 85.2901 | 83 | Complete curve; high efficacy | -6.0862 | 1.7529 | 0.994 | 32.3577 | 117.6478 | -1.1 | 0 0 0 0 0 0 0 | 34.7953 | 115.2038 | 115.6711 | 122.13 | 98.3734 | 49.1232 | 31.0106 | 34.7953 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.01 | 90.4383 | 83 | Complete curve; high efficacy | -7.9992 | 1.0641 | 0.9856 | 19.9781 | 110.4164 | -1.1 | 0 0 0 0 0 0 0 | 13.8267 | 101.7041 | 71.2241 | 35.8056 | 28.6279 | 25.0828 | 19.4787 | 13.8267 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0092 | 105.8361 | 83 | Complete curve; high efficacy | -8.0362 | 4.095 | 0.9984 | 16.204 | 122.0401 | -1.1 | 0 0 0 0 0 0 0 | 13.8473 | 120.9689 | 28.8486 | 18.131 | 17.3683 | 17.3537 | 14.6878 | 13.8473 | QC'd by SIGMA | ||||||||||||||||||||
| Cytotoxic | 0.4683 | 84.0955 | 83 | Complete curve; high efficacy | -6.3295 | 4.4495 | 0.969 | 29.5128 | 113.6083 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.2667 | 108.9911 | 100.6389 | 111.6185 | 114.5273 | 123.8697 | 121.8467 | 50.4844 | 36.163 | 35.4913 | 26.9501 | 21.2667 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.1048 | 82.7642 | 82 | Complete curve; high efficacy | -6.9795 | 1.4163 | 0.9838 | 12.6322 | 95.3964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.5755 | 88.3117 | 93.0926 | 98.2096 | 96.7434 | 61.0096 | 38.8636 | 20.851 | 15.783 | 15.7035 | 9.9048 | 10.5755 | QC'd by BIOMOL | ||||||||||||||||
| Cytotoxic | 0.1778 | 91.155 | 82 | Complete curve; high efficacy | -6.75 | 0.6 | 0.9671 | 13.9433 | 105.0983 | -1.1 | 0 0 0 0 0 0 0 | 9.949 | 96.7816 | 88.0056 | 52.4837 | 44.6307 | 29.7677 | 23.4253 | 9.949 | QC'd by Waterstone | ||||||||||||||||||||
| Cytotoxic | 0.0106 | 101.8256 | 82 | Complete curve; high efficacy | -7.975 | 2.7202 | 0.9927 | 11.1635 | 112.9891 | -1.1 | 0 0 0 0 0 0 0 0 | 10.2995 | 105.5432 | 116.5795 | 42.3861 | 10.2101 | 10.8286 | 11.4633 | 11.6468 | 10.2995 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.6684 | 97.5838 | 82 | Complete curve; high efficacy | -6.175 | 2.3332 | 0.9902 | 18.8259 | 116.4097 | -1.1 | 0 0 0 0 0 0 0 0 | 15.8771 | 121.1891 | 108.6953 | 122.087 | 113.8515 | 96.8463 | 25.1626 | 23.9853 | 15.8771 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 0.0422 | 99.1812 | 82 | Complete curve; high efficacy | -7.375 | 1.3443 | 0.9933 | 10.554 | 109.7352 | -1.1 | 0 0 0 0 0 0 0 0 | 10.7613 | 114.3989 | 100.7838 | 90.7065 | 44.4742 | 11.2028 | 13.8457 | 11.3616 | 10.7613 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 0.0075 | 84.1066 | 82 | Complete curve; high efficacy | -8.125 | 4.9549 | 0.9983 | 9.4344 | 93.541 | -1.1 | 0 0 0 0 0 0 0 0 | 6.5354 | 91.7985 | 94.1104 | 12.6655 | 11.0929 | 8.6327 | 9.9971 | 10.0754 | 6.5354 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.4217 | 85.9203 | 82 | Complete curve; high efficacy | -6.375 | 0.8 | 0.9622 | 21.4982 | 107.4185 | -1.1 | 0 0 0 0 0 0 0 0 | 16.639 | 100.4185 | 107.3168 | 112.8293 | 84.5993 | 67.8817 | 38.3542 | 37.8797 | 16.639 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 0.1458 | 95.7444 | 82 | Complete curve; high efficacy | -6.8362 | 1.5579 | 0.9766 | 14.7016 | 110.446 | -1.1 | 0 0 0 0 0 0 0 | 4.7392 | 104.3625 | 115.3478 | 84.3787 | 31.7905 | 25.5998 | 18.0336 | 4.7392 | QC'd by Microsource | ||||||||||||||||||||
| Cytotoxic | 0.0036 | 107.2473 | 82 | Complete curve; high efficacy | -8.444 | 4.9549 | 0.9989 | 8.6172 | 115.8646 | -1.1 | 0 0 0 0 0 0 0 | 7.4398 | 110.6482 | 9.2236 | 10.0332 | 9.492 | 8.9141 | 6.3221 | 7.4398 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.1636 | 80.2947 | 82 | Complete curve; high efficacy | -6.7862 | 2.0479 | 0.9763 | 17.795 | 98.0898 | -1.1 | 0 0 0 0 0 0 0 | 6.7352 | 100.4625 | 95.5674 | 85.028 | 29.2532 | 27.683 | 20.0892 | 6.7352 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0231 | 97.6406 | 82 | Complete curve; high efficacy | -7.6362 | 4.9549 | 0.9995 | 10.3864 | 108.027 | -1.1 | 0 0 0 0 0 0 0 | 10.177 | 107.941 | 98.6844 | 9.8351 | 11.6961 | 11.6717 | 8.8001 | 10.177 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 1.5877 | 86.3274 | 82 | Complete curve; high efficacy | -5.7992 | 1.331 | 0.9642 | 23.21 | 109.5374 | -1.1 | 0 0 0 0 0 0 0 | 29.2744 | 118.4556 | 99.7114 | 104.7412 | 100.9923 | 85.0976 | 33.9221 | 29.2744 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 89.4885 | 82 | Complete curve; high efficacy | -7.8362 | 1.2876 | 0.9952 | 9.3441 | 98.8326 | -1.1 | 0 0 0 0 0 0 0 | 7.0005 | 90.7029 | 51.5567 | 22.536 | 11.8774 | 9.8565 | 8.188 | 7.0005 | QC'd by SynKinase | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 96.8431 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9948 | 8.9496 | 105.7927 | -1.1 | 0 0 0 0 0 0 0 | 3.839 | 102.1209 | 12.4453 | 11.4448 | 10.8821 | 9.8966 | 7.7027 | 3.839 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0166 | 89.5276 | 84 | Complete curve; high efficacy | -7.7795 | 2.0937 | 0.9442 | 25.8586 | 115.3863 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.6755 | 108.6505 | 117.9375 | 108.1166 | 52.7453 | 48.9938 | 23.9892 | 28.8508 | 25.6865 | 29.0357 | 27.3193 | 5.6755 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.02 | 81.2231 | 83 | Complete curve; high efficacy | -7.6992 | 0.8 | 0.9723 | 16.8197 | 98.0429 | -1.1 | 0 0 0 0 0 0 0 | 8.455 | 90.2193 | 74.5452 | 44.2913 | 28.1409 | 27.059 | 21.5506 | 8.455 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0326 | 86.5937 | 83 | Complete curve; high efficacy | -7.4862 | 0.7 | 0.953 | 18.8792 | 105.4729 | -1.1 | 0 0 0 0 0 0 0 | 8.4532 | 96.8084 | 73.0667 | 45.4397 | 34.5525 | 29.7666 | 27.4306 | 8.4532 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.016 | 83.3126 | 82 | Complete curve; high efficacy | -7.7964 | 4.9549 | 0.9968 | 9.6075 | 92.9201 | -1.1 | 0 0 0 0 0 0 0 0 | 9.7773 | 89.2976 | 96.4187 | 11.9953 | 9.7167 | 8.8677 | 9.7542 | 10.3503 | 9.7773 | QC'd by LightBiologicals | |||||||||||||||||||
| Cytotoxic | 0.0106 | 94.2951 | 82 | Complete curve; high efficacy | -7.975 | 3.132 | 0.9955 | 11.6947 | 105.9898 | -1.1 | 0 0 0 0 0 0 0 0 | 11.6947 | 100.9198 | 109.3944 | 35.8242 | 11.7569 | 10.7934 | 12.3836 | 13.3145 | 11.6947 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.0027 | 88.9753 | 82 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9992 | 8.9074 | 97.8826 | -1.1 | 0 0 0 0 0 0 0 0 | 6.9034 | 97.9914 | 42.2936 | 9.9686 | 9.1038 | 8.2217 | 9.3052 | 9.0933 | 6.9034 | QC'd by Alfa Aesar | |||||||||||||||||||
| Cytotoxic | 0.0084 | 80.5139 | 82 | Complete curve; high efficacy | -8.075 | 4.9549 | 0.9973 | 8.8938 | 89.4076 | -1.1 | 0 0 0 0 0 0 0 0 | 6.3577 | 87.1572 | 91.3499 | 12.9571 | 11.0421 | 10.3402 | 8.9116 | 9.8618 | 6.3577 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.0051 | 97.542 | 82 | Complete curve; high efficacy | -8.294 | 4.5045 | 0.9992 | 8.7153 | 106.2574 | -1.1 | 0 0 0 0 0 0 0 | 7.9842 | 105.0472 | 13.7629 | 9.4904 | 9.8464 | 7.6546 | 7.149 | 7.9842 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 94.4998 | 82 | Complete curve; high efficacy | -7.6862 | 4.095 | 0.9984 | 11.2634 | 105.7632 | -1.1 | 0 0 0 0 0 0 0 | 10.8677 | 105.3873 | 87.5417 | 14.4142 | 11.9765 | 9.1461 | 9.2097 | 10.8677 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.4611 | 93.5292 | 82 | Complete curve; high efficacy | -6.3362 | 1.4641 | 0.9637 | 18.0367 | 111.5659 | -1.1 | 0 0 0 0 0 0 0 | 6.0375 | 113.1729 | 110.6758 | 104.0276 | 72.579 | 24.3332 | 35.3731 | 6.0375 | QC'd by ChemieTek | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 83.4079 | 82 | Complete curve; high efficacy | -7.5862 | 1.1705 | 0.9942 | 10.3799 | 93.7878 | -1.1 | 0 0 0 0 0 0 0 | 5.5192 | 87.4844 | 66.3422 | 28.5401 | 16.4338 | 12.1449 | 11.8707 | 5.5192 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0206 | 80.2779 | 82 | Complete curve; high efficacy | -7.6862 | 3.6772 | 0.9705 | 14.5871 | 94.865 | -1.1 | 0 0 0 0 0 0 0 | 7.2915 | 96.262 | 74.9595 | 27.5419 | 14.6063 | 13.1849 | 10.6575 | 7.2915 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 99.9965 | 82 | Complete curve; high efficacy | -7.5862 | 1.1105 | 0.9627 | 10.993 | 110.9895 | -1.1 | 0 0 0 0 0 0 0 | 3.5224 | 101.8192 | 78.6727 | 30.3442 | 20.1042 | 25.1119 | 4.4796 | 3.5224 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 90.7895 | 82 | Complete curve; high efficacy | -7.8362 | 1.3437 | 0.996 | 9.1094 | 99.8989 | -1.1 | 0 0 0 0 0 0 0 | 6.2123 | 91.4196 | 53.8318 | 19.2776 | 13.6662 | 8.5618 | 7.4372 | 6.2123 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.6513 | 81.7203 | 82 | Complete curve; high efficacy | -6.1862 | 1.4787 | 0.9896 | 21.402 | 103.1224 | -1.1 | 0 0 0 0 0 0 0 | 21.0506 | 108.9081 | 95.7413 | 101.2028 | 78.0357 | 34.6634 | 24.9893 | 21.0506 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.013 | 84.0074 | 82 | Complete curve; high efficacy | -7.8862 | 1.4163 | 0.9944 | 10.0699 | 94.0773 | -1.1 | 0 0 0 0 0 0 0 | 5.9786 | 86.0882 | 47.3557 | 17.8996 | 13.5824 | 10.5199 | 10.422 | 5.9786 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.082 | 85.0686 | 82 | Complete curve; high efficacy | -7.0862 | 0.91 | 0.9915 | 14.099 | 99.1676 | -1.1 | 0 0 0 0 0 0 0 | 10.2171 | 94.6065 | 84.9239 | 59.8081 | 27.5521 | 23.6905 | 16.7893 | 10.2171 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 84.6353 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9982 | 8.8501 | 93.4854 | -1.1 | 0 0 0 0 0 0 0 | 6.5017 | 90.3725 | 11.9975 | 10.2939 | 10.111 | 9.5279 | 8.2521 | 6.5017 | QC'd by APExBIO | ||||||||||||||||||||
| Cytotoxic | 0.009 | 82.7243 | 82 | Complete curve; high efficacy | -8.044 | 1.2876 | 0.9917 | 10.512 | 93.2363 | -1.1 | 0 0 0 0 0 0 0 | 7.7344 | 85.5143 | 46.4791 | 22.475 | 13.1909 | 9.7487 | 11.7333 | 7.7344 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 4.0E-4 | 94.196 | 82 | Complete curve; high efficacy | -9.375 | 2.4064 | 0.9988 | 7.7324 | 101.9284 | -1.1 | 0 0 0 0 0 0 0 | 7.3587 | 100.7694 | 74.7197 | 9.8839 | 9.6058 | 8.6476 | 8.4903 | 7.3587 | QC'd by SIGMA |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000420468 uM | Activity at 0.0001060182 uM | Activity at 0.0001893301 uM | Activity at 0.0004489405 uM | Activity at 0.0009664426 uM | Activity at 0.00171 uM | Activity at 0.00292 uM | Activity at 0.00536 uM | Activity at 0.00931 uM | Activity at 0.020 uM | Activity at 0.041 uM | Activity at 0.085 uM | Activity at 0.146 uM | Activity at 0.251 uM | Activity at 0.501 uM | Activity at 1.073 uM | Activity at 2.225 uM | Activity at 4.221 uM | Activity at 6.452 uM | Activity at 12.64 uM | Activity at 29.84 uM | Activity at 57.50 uM | Activity at 114.0 uM | Activity at 227.6 uM | Activity at 379.2 uM | Activity at 573.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | -8.3336 | -1.4117 | -0.6141 | -1.8079 | 0.0446 | -8.3336 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.75 | 4.9549 | 0.364 | -29.4824 | 3.3805 | 4 | 0 0 0 0 1 | -1.3954 | 3.2535 | 0.7839 | -59.1373 | 6.0E-4 | -1.3954 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -6.75 | 3.132 | 0.7843 | 0.8702 | 12.5 | 4 | 0 0 0 0 0 | 4.4963 | 10.2975 | -0.4426 | -1.3582 | 0.1626 | 4.4963 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.0548 | -1.7066 | -2.8833 | -2.005 | 0.3693 | 2.0548 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.6422 | 0.4339 | -3.0268 | -4.4255 | -2.8516 | -5.6422 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.2315 | -0.9193 | -0.9625 | 13.7196 | -1.9704 | 0.2315 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5.05 | 4.9549 | 0.5023 | -0.0525 | 7.5 | 4 | 0 0 0 0 1 | 5.313 | 2.7111 | 12.7202 | 1.5451 | -0.0438 | 5.313 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3883 | -3.3207 | -0.3808 | -0.1461 | -2.971 | 4.3883 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.7635 | -0.6995 | -1.7294 | 6.1024 | 1.8317 | 5.7635 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.3 | 1.0693 | 0.8616 | -4.2573 | 9.5 | 4 | 0 0 0 0 0 | -1.8811 | 11.1484 | 8.5502 | 5.9885 | 4.608 | -1.8811 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.7273 | -3.4115 | -0.1881 | -2.6331 | -1.6916 | -1.7273 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.3895 | -3.0627 | -1.1001 | 4.7802 | 0.8642 | 4.3895 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -5 | 4.9549 | 0.6649 | 10.5 | 0.7021 | 4 | 0 0 0 0 0 | 13.7837 | 4.4863 | -3.5816 | 7.2204 | 7.3678 | 13.7837 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.0179 | 3.343 | 6.8931 | 2.2936 | 4.5224 | 6.0179 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 11.3207 | 3.0878 | 5.164 | 2.5572 | 5.3615 | 11.3207 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 8.7383 | 3.2664 | 2.7307 | 3.2405 | 1.8463 | 8.7383 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4.05 | 2.7202 | 0.9497 | -18.9142 | -2.2922 | 4 | 0 0 0 0 0 | -14.0952 | -1.0768 | -4.0059 | -2.4795 | -5.6228 | -14.0952 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.7765 | -2.2569 | -3.9959 | -1.3451 | 0.1566 | -7.7765 | QC'd by Sytravon | |||||||||||||||||||||||||||||
| Inactive | 0 | -4 | 4.9549 | 0.7054 | -25.0658 | -0.5 | 4 | 0 0 0 0 0 | -17.5549 | -2.6051 | -3.8192 | -2.6993 | 6.0774 | -17.5549 | QC'd by Sytravon | |||||||||||||||||||||||||
| Inactive | 0 | -5.8 | 4.9549 | 0.4109 | -5.3905 | 4 | 4 | 0 0 0 0 0 | -2.4904 | 3.804 | 2.4492 | -14.0754 | 0.8551 | -2.4904 | QC'd by Sytravon |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Cell Viability | = | 146.93 | % | Luminescence |
| Cell Viability | = | 92.42 | % | Luminescence |
| Cell Viability | = | 137.32 | % | Object Area |
| Cell Viability | = | 95.84 | % | Object Area |
| Cell Viability | = | 30.1 | % | Luminescence |
| Cell Viability | = | 45.18 | % | Luminescence |
| Cell Viability | = | 84.35 | % | Object Area |
| Cell Viability | = | 67.45 | % | Object Area |
| Cell Viability | = | 3.322 | % | Luminescence |
| Cell Viability | = | 3.495 | % | Luminescence |
| Cell Viability | = | 9.147 | % | Object Area |
| Cell Viability | = | 11.54 | % | Object Area |
| Cell Viability | = | 79.36 | % | Luminescence |
| Cell Viability | = | 89.56 | % | Luminescence |
| Cell Viability | = | 109.07 | % | Object Area |
| Cell Viability | = | 103.32 | % | Object Area |
| Cell Viability | = | 2.387 | % | Luminescence |
| Cell Viability | = | 3.908 | % | Luminescence |
| Cell Viability | = | 8.346 | % | Object Area |
| Cell Viability | = | 9.337 | % | Object Area |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Cell Viability | = | 110.58 | % | Luminescence |
| Cell Viability | = | 91.32 | % | Luminescence |
| Cell Viability | = | 96.41 | % | Object Area |
| Cell Viability | = | 86.99 | % | Object Area |
| Cell Viability | = | 121.35 | % | Luminescence |
| Cell Viability | = | 105.02 | % | Luminescence |
| Cell Viability | = | 98.38 | % | Object Area |
| Cell Viability | = | 111.73 | % | Object Area |
| Cell Viability | = | 107.52 | % | Luminescence |
| Cell Viability | = | 104.61 | % | Luminescence |
| Cell Viability | = | 121.53 | % | Object Area |
| Cell Viability | = | 94.42 | % | Object Area |
| Cell Viability | = | 89.19 | % | Luminescence |
| Cell Viability | = | 98.57 | % | Luminescence |
| Cell Viability | = | 86.74 | % | Object Area |
| Cell Viability | = | 117.35 | % | Object Area |
| Cell Viability | = | 123.06 | % | Luminescence |
| Cell Viability | = | 81.11 | % | Luminescence |
| Cell Viability | = | 103.62 | % | Object Area |
| Cell Viability | = | 93.88 | % | Object Area |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Cell Viability | = | 133.3 | % | Luminescence |
| Cell Viability | = | 129.12 | % | Luminescence |
| Cell Viability | = | 96.49 | % | Object Area |
| Cell Viability | = | 84.49 | % | Object Area |
| Cell Viability | = | 88.97 | % | Luminescence |
| Cell Viability | = | 82.19 | % | Luminescence |
| Cell Viability | = | 63.58 | % | Object Area |
| Cell Viability | = | 57.5 | % | Object Area |
| Cell Viability | = | 15.16 | % | Luminescence |
| Cell Viability | = | 27.56 | % | Luminescence |
| Cell Viability | = | 31.67 | % | Object Area |
| Cell Viability | = | 31.58 | % | Object Area |
| Cell Viability | = | 80.49 | % | Luminescence |
| Cell Viability | = | 55.99 | % | Luminescence |
| Cell Viability | = | 115.36 | % | Object Area |
| Cell Viability | = | 103.89 | % | Object Area |
| Cell Viability | = | 14.26 | % | Luminescence |
| Cell Viability | = | 12.85 | % | Luminescence |
| Cell Viability | = | 15.33 | % | Object Area |
| Cell Viability | = | 14.47 | % | Object Area |
| Standard Type | Standard Relation | Standard Value | Activity Comment |
|---|---|---|---|
| Proliferation | = | 0.2575 | |
| Proliferation | = | 0.05104 | |
| Proliferation | = | 0.2702 | |
| Proliferation | = | 0.005874 | Significantly Altered Human Hepatocyte Proliferation |
| Proliferation | = | 0.9 | |
| Proliferation | = | 0 | Significantly Altered Human Hepatocyte Proliferation |
| Proliferation | = | 0.003154 | Significantly Altered Human Hepatocyte Proliferation |
| Proliferation | = | 0.02591 | |
| Proliferation | = | 0.1212 | |
| Proliferation | = | 0.002627 | Significantly Altered Human Hepatocyte Proliferation |
| Proliferation | = | 0.2187 | |
| Proliferation | = | 0.05128 | |
| Proliferation | = | 0.3569 | |
| Proliferation | = | 0.874 | |
| Proliferation | = | 0.03665 | |
| Proliferation | = | 0.04298 | |
| Proliferation | = | 0.02286 | |
| Proliferation | = | 0.1604 | |
| Proliferation | = | 0.882 | |
| Proliferation | = | 0.7724 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| ER-phagy suppression | = | 176.07 | % | Very Strong Suppressor |
| ER-phagy suppression | = | 134.35 | % | Very Strong Suppressor |
| ER-phagy suppression | = | 114.59 | % | Very Strong Suppressor |
| ER-phagy suppression | = | 104.14 | % | Very Strong Suppressor |
| ER-phagy suppression | = | 11.37 | % | |
| ER-phagy suppression | = | -2.822 | % | |
| ER-phagy suppression | = | -4.115 | % | |
| ER-phagy suppression | = | -4.142 | % | |
| ER-phagy suppression | = | 35.01 | % | |
| ER-phagy suppression | = | 19.49 | % | |
| ER-phagy suppression | = | 15.62 | % | |
| ER-phagy suppression | = | 9.495 | % | |
| ER-phagy suppression | = | -13.45 | % | |
| ER-phagy suppression | = | -24.79 | % | |
| ER-phagy suppression | = | -11.7 | % | |
| ER-phagy suppression | = | -13.18 | % | |
| ER-phagy suppression | = | -2.095 | % | |
| ER-phagy suppression | = | 14.41 | % | |
| ER-phagy suppression | = | 8.467 | % | |
| ER-phagy suppression | = | 13.31 | % |
| pKd_min | pKd_max | pIC50_min | pIC50_max | pEC50_min | pEC50_max | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|---|---|
| 9.3 | 9.3 | Inhibitor | Inhibition | |||||
| 7.6 | 7.6 | Inhibitor | Irreversible inhibition | 28352114 | ||||
| 7 | 7 | Inhibitor | Inhibition | |||||
| 8.8 | 9.3 | Inhibitor | Inhibition | 26641137,17154430 | ||||
| 8.7 | 8.7 | Inhibitor | Inhibition | 21113169 | ||||
| 9.5 | 9.5 | Inhibitor | Inhibition | 22228807 | ||||
| 8.2 | 8.2 | Inhibitor | Inhibition | 25701252 | ||||
| 9 | 9 | Inhibitor | Inhibition | 22621397 | ||||
| 8.4 | 8.4 | Inhibitor | Inhibition | 24915291 | ||||
| 4.8 | 4.8 | Inhibitor | Inhibition | 10092645 | ||||
| 8.5 | 8.5 | Inhibitor | Inhibition | 24900538 | ||||
| 8.7 | 8.7 | Inhibitor | Inhibition | 26006010 | ||||
| 7.8 | 7.8 | Inhibitor | Inhibition | 25593320 | ||||
| 6.4 | 6.4 | Inhibitor | Inhibition | 22394077 | ||||
| Inhibitor | Inhibition | |||||||
| 10 | 10 | Inhibitor | Inhibition | |||||
| 8.4 | 8.4 | Inhibitor | Inhibition | |||||
| 9.8 | 9.8 | Inhibitor | Inhibition | |||||
| 8.4 | 8.4 | Inhibitor | Inhibition | 24915291 | ||||
| 8.7 | 8.7 | Inhibitor | Inhibition | 21958547 |
| Standard Type | Standard Relation | Standard Value | Standard Units | Data Validity Comment |
|---|---|---|---|---|
| Inhibition | = | 13.77 | % | |
| Inhibition | = | 2.35 | % | |
| Inhibition | = | 21.17 | % | |
| Inhibition | = | 18.36 | % | |
| Inhibition | = | 5.381 | % | |
| Inhibition | = | 18.17 | % | |
| Inhibition | = | 10.15 | % | |
| Inhibition | = | 29.56 | % | |
| Inhibition | = | 18.27 | % | |
| Inhibition | = | 11.42 | % | |
| Inhibition | = | 15.4 | % | |
| Inhibition | = | 7.437 | % | |
| Inhibition | = | -3.216 | % | |
| Inhibition | = | 18 | % | |
| Inhibition | = | 1.021 | % | |
| Inhibition | = | 16.4 | % | |
| Inhibition | = | 2.544 | % | |
| Inhibition | = | 19.11 | % | |
| Inhibition | = | 26.15 | % | |
| Inhibition | = | 5.133 | % |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073560 uM | Activity at 0.0000367800 uM | Activity at 0.0000735600 uM | Activity at 0.0001677464 uM | Activity at 0.0003678000 uM | Activity at 0.0007363003 uM | Activity at 0.00153 uM | Activity at 0.00368 uM | Activity at 0.00723 uM | Activity at 0.00914 uM | Activity at 0.018 uM | Activity at 0.039 uM | Activity at 0.092 uM | Activity at 0.191 uM | Activity at 0.460 uM | Activity at 0.910 uM | Activity at 1.182 uM | Activity at 2.302 uM | Activity at 4.834 uM | Activity at 11.49 uM | Activity at 23.94 uM | Activity at 57.45 uM | Activity at 115.4 uM | Activity at 193.5 uM | Activity at 288.3 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.0964 | 121.5245 | 87 | Complete curve; high efficacy | -5.96 | 0.6 | 0.996 | -99.001 | 22.5235 | -1.1 | 0 0 0 0 0 0 0 0 | -91.4164 | 21.201 | 18.0897 | 11.5563 | 3.2362 | -23.6097 | -54.3722 | -70.1237 | -91.4164 | QC'd by GVK | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3029 | 6.409 | 5.7452 | -8.1274 | 11.4345 | 12.799 | 5.9113 | 7.1389 | 1.3029 | QC'd by Vitas | |||||||||||||||||||||||||
| Inhibitor | 0.055 | 96.7494 | 90 | Complete curve; high efficacy | -7.26 | 0.6 | 0.9836 | -74.1574 | 22.592 | -1.1 | 0 0 0 0 0 0 0 0 | -78.8495 | 12.3459 | 12.9899 | -11.4013 | -37.5586 | -53.042 | -61.5426 | -65.313 | -78.8495 | QC'd by Bosche | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -9.339 | -4.094 | -2.8674 | 4.5071 | -4.4459 | -5.3433 | -2.4671 | 3.5091 | -9.339 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | -6.61 | 4.9549 | 0.7785 | 2.5 | -6.0941 | 4 | 0 0 0 0 0 0 0 1 | -8.7946 | -5.07 | -2.6335 | -5.97 | -10.4951 | 3.4911 | 2.0588 | 1.9174 | -8.7946 | QC'd by SIGMA | |||||||||||||||||||||
| Inhibitor | 34.6713 | 39.827 | 10 | Single point of activity | -4.46 | 2.3031 | 0.825 | -41.327 | -1.5 | -3 | 0 0 0 0 0 0 0 0 | -31.9392 | 3.6009 | -5.2617 | 2.2295 | 4.1407 | -8.6455 | -6.9529 | -4.2362 | -31.9392 | QC'd by Microsource | ||||||||||||||||||
| Inactive | 0 | 4 | 0 0 0 0 0 0 0 0 | -13.8986 | 20.6492 | 16.422 | 11.6893 | 9.5011 | 16.6467 | -2.6177 | -2.1673 | -13.8986 | QC'd by Vitas | ||||||||||||||||||||||||||
| Inhibitor | 15.4871 | 78.5667 | 41 | Partial curve; partial efficacy | -4.81 | 0.8 | 0.995 | -76.672 | 1.8947 | -2.2 | 0 0 0 0 0 0 0 0 | -58.0849 | 2.7342 | 0.6745 | 4.0214 | -0.609 | -3.975 | -12.9528 | -31.6593 | -58.0849 | QC'd by Sequoia | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 26.6445 | 12.4429 | -0.6442 | 19.3784 | 7.3352 | 0.3513 | 4.2285 | 7.4344 | 26.6445 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | -5.9213 | 4.9549 | 0.7942 | 3.5 | -5.6452 | 4 | 0 0 0 0 0 0 1 | -9.4213 | -2.1113 | -8.4544 | -4.6822 | -8.2265 | 4.1606 | 2.7472 | -9.4213 | QC'd by Tocris | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.8012 | -11.1342 | -2.192 | 0 | -10.8176 | -0.6934 | -3.3166 | -1.4979 | -2.8012 | QC'd by SIGMA | |||||||||||||||||||||||||
| Inactive | 0 | -5.76 | 4.9549 | 0.5104 | 28.8996 | -2.448 | 4 | 0 1 0 0 0 0 0 1 | -2.305 | 23.7377 | -36.8683 | -4.4543 | -19.5675 | -9.3801 | 22.2432 | 29.0984 | -2.305 | QC'd by Vitas | |||||||||||||||||||||
| Inhibitor | 12.3018 | 87.4011 | 42 | Partial curve; high efficacy | -4.91 | 0.6 | 0.9549 | -73.5501 | 13.8509 | -2.1 | 0 0 0 0 0 0 0 0 | -54.8735 | 22.1453 | 8.3684 | 12.1328 | 9.0141 | -1.3852 | -8.6537 | -22.9862 | -54.8735 | QC'd by Microsource | ||||||||||||||||||
| Inhibitor | 27.5404 | 50.2393 | 10 | Single point of activity | -4.56 | 1.7529 | 0.9401 | -50.1648 | 0.0744 | -3 | 0 0 0 0 0 0 0 0 | -39.14 | 2.8036 | -3.0335 | 1.3596 | -6.0162 | 5.1159 | -1.7887 | -9.2175 | -39.14 | QC'd by Microsource | ||||||||||||||||||
| Inactive | 0 | -5.31 | 0.6 | 0.8041 | -16.0136 | 17 | 4 | 0 0 0 0 0 0 0 0 | -11.678 | 17.6825 | 13.4358 | 21.7597 | 6.5197 | 17.4375 | -0.6278 | -0.9036 | -11.678 | QC'd by Enzo | |||||||||||||||||||||
| Inhibitor | 15.4871 | 77.5471 | 10 | Partial curve; partial efficacy; poor fit | -4.81 | 1.111 | 0.829 | -67.106 | 10.4411 | -2.4 | 0 0 0 0 0 0 0 0 | -53.0541 | 0.7435 | 24.1655 | 2.7053 | 1.7382 | 25.7669 | -4.8999 | -19.2859 | -53.0541 | QC'd by Bosche | ||||||||||||||||||
| Inactive | 0 | -6.36 | 1.4641 | 0.8922 | -22.4758 | 4.5 | 4 | 0 0 0 0 0 0 0 0 | -25.4997 | 2.5425 | 6.3039 | 7.767 | -1.9911 | -6.3102 | -26.2299 | -15.2464 | -25.4997 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | -4.51 | 1.9673 | 0.499 | 14 | 26.5 | 4 | 0 0 0 0 0 0 0 0 | 16.8462 | 25.5317 | 32.6702 | 20.2852 | 28.5693 | 25.6359 | 26.9817 | 25.0297 | 16.8462 | QC'd by GVK | |||||||||||||||||||||
| Inhibitor | 0.8709 | 47.2788 | 24 | Complete curve; partial efficacy | -6.06 | 4.9549 | 0.9676 | -45.6766 | 1.6021 | -1.2 | 0 0 0 0 0 0 0 1 | -20.5127 | 8.2743 | 0.9756 | -1.5573 | -1.3097 | 0.8922 | -49.683 | -41.1152 | -20.5127 | QC'd by Enzo | ||||||||||||||||||
| Inactive | 0 | -6.06 | 4.9549 | 0.439 | 9 | -0.6762 | 4 | 0 0 0 0 0 0 0 1 | -0.013 | 1.9538 | 1.5464 | -4.3135 | 0.312 | -2.7682 | 16.9354 | 0.8252 | -0.013 | QC'd by Sequoia |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| Standard Type | Standard Relation | Standard Value | Standard Units | Activity Comment |
|---|---|---|---|---|
| Delta TM | = | 0.05675 | C | Thermal Shift Assay |
| Delta TM | = | 0.06056 | C | Thermal Shift Assay |
| Delta TM | = | -0.26 | C | |
| Delta TM | = | 0.05 | C | Thermal Shift Assay |
| Delta TM | = | 0.2158 | C | Thermal Shift Assay |
| Delta TM | = | 0.1132 | C | Thermal Shift Assay |
| Delta TM | = | -0.21 | C | Thermal Shift Assay |
| Delta TM | = | 0.07973 | C | Thermal Shift Assay |
| Delta TM | = | 0.3724 | C | Thermal Shift Assay |
| Delta TM | = | -0.3 | C | |
| Delta TM | = | -0.04 | C | Thermal Shift Assay |
| Delta TM | = | -0.08 | C | Thermal Shift Assay |
| Delta TM | = | -0.49 | C | Thermal Shift Assay |
| Delta TM | = | 0.08515 | C | Thermal Shift Assay |
| Delta TM | = | 0.01057 | C | Thermal Shift Assay |
| Delta TM | = | 0 | C | Thermal Shift Assay |
| Delta TM | = | 0.1944 | C | Thermal Shift Assay |
| Delta TM | = | 2.51 | C | Thermal Shift Assay |
| Delta TM | = | -0.01 | C | Thermal Shift Assay |
| Delta TM | = | -0.24 | C | Thermal Shift Assay |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000311982 uM | Activity at 0.0000854986 uM | Activity at 0.0001248848 uM | Activity at 0.0002290931 uM | Activity at 0.0004033765 uM | Activity at 0.0007802858 uM | Activity at 0.00138 uM | Activity at 0.00235 uM | Activity at 0.00481 uM | Activity at 0.00706 uM | Activity at 0.021 uM | Activity at 0.031 uM | Activity at 0.063 uM | Activity at 0.111 uM | Activity at 0.190 uM | Activity at 0.335 uM | Activity at 0.569 uM | Activity at 1.004 uM | Activity at 1.715 uM | Activity at 3.506 uM | Activity at 5.147 uM | Activity at 15.26 uM | Activity at 23.20 uM | Activity at 45.80 uM | Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.0469 | 89.9077 | 85 | Complete curve; high efficacy | -7.3292 | 0.9 | 0.9846 | 34.8594 | 124.7671 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 38.7443 | 116.6148 | 123.331 | 115.21 | 92.8873 | 73.4829 | 54.772 | 43.4467 | 43.5031 | 38.0902 | 26.3771 | 38.7443 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0332 | 90.1227 | 84 | Complete curve; high efficacy | -7.4792 | 2.5334 | 0.9876 | 27.2436 | 117.3663 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 29.451 | 110.6569 | 116.5957 | 125.8883 | 91.6652 | 43.2912 | 22.6682 | 27.4503 | 27.296 | 30.8607 | 28.1959 | 29.451 | QC'd by BIOMOL | |||||||||||||||
| Cytotoxic | 0.1482 | 64.2052 | 84 | Complete curve; high efficacy | -6.8292 | 1.3443 | 0.9383 | 35.6777 | 99.8829 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 18.766 | 92.8829 | 102.3239 | 101.1046 | 96.6743 | 86.6893 | 58.7449 | 43.9201 | 47.146 | 46.6117 | 35.324 | 18.766 | QC'd by SynKinase | |||||||||||||||
| Cytotoxic | 0.0264 | 104.2869 | 83 | Complete curve; high efficacy | -7.5792 | 2.2526 | 0.992 | 19.9841 | 124.271 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 17.5117 | 129.8899 | 116.807 | 122.5291 | 84.3033 | 25.7885 | 20.4178 | 22.5481 | 20.3122 | 19.5264 | 25.1408 | 17.5117 | QC'd by SIGMA | |||||||||||||||
| Cytotoxic | 0.0026 | 26.639 | 83 | Complete curve; partial efficacy | -8.5792 | 1.9887 | 0.8564 | 111.547 | 138.1859 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 108.481 | 135.6859 | 126.6133 | 115.6739 | 109.1315 | 116.6885 | 116.992 | 110.3541 | 110.2737 | 107.2368 | 115.0049 | 108.481 | QC'd by ACC | |||||||||||||||
| Cytotoxic | 0.2348 | 80.9696 | 83 | Complete curve; high efficacy | -6.6292 | 1.7885 | 0.9852 | 32.18 | 113.1497 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 33.7541 | 104.2396 | 122.5796 | 115.8743 | 108.3231 | 105.9957 | 78.9064 | 47.5433 | 30.7817 | 31.3515 | 34.6789 | 33.7541 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 83 | Complete curve; high efficacy | -9 | 0 | 0.9963 | 13.1609 | 13.1609 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.6553 | 125.3758 | 112.2776 | 41.107 | 13.6048 | 13.3498 | 13.1609 | 11.3327 | 10.0488 | 8.4891 | 6.571 | 4.6553 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.001 | 0 | 83 | Complete curve; high efficacy | -9 | 0 | 0.9806 | 14.9523 | 14.9523 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 1.9606 | 113.653 | 91.1159 | 25.1632 | 17.0695 | 19.8001 | 14.8492 | 13.6626 | 14.9523 | 8.4811 | 5.0472 | 1.9606 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0118 | 107.8863 | 83 | Complete curve; high efficacy | -7.9292 | 1.9282 | 0.9638 | 19.892 | 127.7783 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 4.9614 | 125.3701 | 124.7044 | 100.3893 | 41.4106 | 32.8725 | 32.2073 | 26.7442 | 25.7142 | 17.8322 | 6.232 | 4.9614 | QC'd by AG Scientific | |||||||||||||||
| Cytotoxic | 0.3722 | 94.8501 | 83 | Complete curve; high efficacy | -6.4292 | 0.6 | 0.9911 | 26.0632 | 120.9133 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.7075 | 114.6134 | 119.7084 | 115.335 | 105.9492 | 97.072 | 79.8367 | 67.7103 | 51.9429 | 44.6343 | 40.4132 | 25.7075 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.2957 | 83.5595 | 83 | Complete curve; high efficacy | -6.5292 | 1.7137 | 0.9713 | 32.2123 | 115.7718 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 25.1892 | 117.5987 | 113.5632 | 114.8624 | 123.4575 | 97.6347 | 94.8536 | 50.2858 | 31.6617 | 42.4403 | 35.2874 | 25.1892 | QC'd by Prestwick Chemical; Inc. | |||||||||||||||
| Cytotoxic | 0.1049 | 110.0627 | 82 | Complete curve; high efficacy | -6.9792 | 4.9549 | 0.9913 | 14.2288 | 124.2915 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 8.833 | 111.9056 | 125.2889 | 132.6917 | 124.9518 | 117.9395 | 18.405 | 15.0029 | 17.1325 | 16.9881 | 13.2814 | 8.833 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0935 | 106.2763 | 82 | Complete curve; high efficacy | -7.0292 | 1.8617 | 0.9807 | 19.6881 | 125.9644 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 5.9721 | 122.2096 | 130.9365 | 117.8896 | 131.1332 | 85.3818 | 41.7212 | 27.4247 | 23.6651 | 24.3506 | 21.4138 | 5.9721 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 0.0074 | 77.6035 | 82 | Complete curve; high efficacy | -8.1292 | 1.3723 | 0.9859 | 8.3981 | 86.0016 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 3.4882 | 79.6142 | 78.6467 | 44.7864 | 24.4134 | 15.5364 | 12.3349 | 10.7944 | 9.0209 | 8.1213 | 6.1952 | 3.4882 | QC'd by Cayman | |||||||||||||||
| Cytotoxic | 2.9566 | 89.1793 | 82 | Complete curve; high efficacy | -5.5292 | 0.8 | 0.9055 | 29.8253 | 119.0047 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 37.0236 | 127.0025 | 110.5416 | 116.0121 | 109.5326 | 121.7776 | 119.8096 | 95.6259 | 84.7068 | 49.3428 | 66.2435 | 37.0236 | QC'd by NCGCChem | |||||||||||||||
| Cytotoxic | 0.4686 | 129.1588 | 82 | Complete curve; high efficacy | -6.3292 | 0.9 | 0.9803 | 18.9796 | 148.1384 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 19.266 | 162.4576 | 139.7546 | 143.1217 | 130.0758 | 136.3624 | 104.8341 | 82.8594 | 44.907 | 27.3838 | 31.4075 | 19.266 | QC'd by JohnsHopkins | |||||||||||||||
| Cytotoxic | 1.177 | 97.3818 | 82 | Complete curve; high efficacy | -5.9292 | 0.7 | 0.8859 | 29.6487 | 127.0306 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 44.9605 | 136.9675 | 105.3073 | 113.3963 | 109.5793 | 122.1768 | 119.7556 | 91.2193 | 58.5261 | 61.4379 | 37.5983 | 44.9605 | QC'd by Microsource | |||||||||||||||
| Cytotoxic | 0.1177 | 103.3496 | 82 | Complete curve; high efficacy | -6.9292 | 2.4729 | 0.9946 | 17.3097 | 120.6593 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 12.8645 | 123.9931 | 123.868 | 120.9824 | 111.7642 | 104.5314 | 39.7811 | 21.6656 | 22.4885 | 16.3913 | 16.3741 | 12.8645 | QC'd by Selleck | |||||||||||||||
| Cytotoxic | 1.4818 | 102.7888 | 82 | Complete curve; high efficacy | -5.8292 | 1.01 | 0.9911 | 28.4021 | 131.191 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 30.4075 | 130.6744 | 126.7233 | 128.4612 | 133.7271 | 130.3488 | 120.9413 | 104.3808 | 68.9141 | 57.4808 | 35.842 | 30.4075 | QC'd by Tocris | |||||||||||||||
| Cytotoxic | 3.7221 | 79.6867 | 82 | Complete curve; high efficacy | -5.4292 | 3.99 | 0.976 | 40.7926 | 120.4793 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 31.948 | 114.7205 | 115.9019 | 124.3465 | 123.1905 | 115.4231 | 126.7717 | 120.1747 | 119.8326 | 59.3098 | 49.1242 | 31.948 | QC'd by Axon Medchem |